FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Cruz, LF
   de Figueiredo, GF
   Pedro, LP
   Amorin, YM
   Andrade, JT
   Passos, TF
   Rodrigues, FF
   Souza, ILA
   Goncalves, TPR
   Lima, LARD
   Ferreira, JMS
   Araujo, MGD
AF Cruz, Luisa Ferreira
   de Figueiredo, Geisa Fantini
   Pedro, Lidiane Paula
   Amorin, Yuri Martins
   Andrade, Jessica Tauany
   Passos, Tiago Faustino
   Rodrigues, Felipe Fernandes
   Antunes Souza, Israel Lucas
   Rodrigues Goncalves, Thais Paula
   Rodrigues dos Santos Lima, Luciana Alves
   Siqueira Ferreira, Jaqueline Maria
   de Freitas Araujo, Marcelo Gonzaga
TI Umbelliferone (7-hydroxycoumarin): A non-toxic antidiarrheal and
   antiulcerogenic coumarin
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Coumarin; Umbelliferone; Diarrhea; Mutagenicity; Antiulcerogenic
ID IN-VIVO; ANTIOXIDANT; TOXICITY; PROSTAGLANDINS; MICRONUCLEI; METABOLISM;
   CHAMOMILE; EXTRACT; TRANSIT; DELAY
AB Gastrointestinal diseases are very common problems; available treatments are very limited and come with a range of side effects. Coumarins are an extensive class of phenolic compounds that can be found in plants, fungi and bacteria. The 7-hydroxycoumarin, also known as umbelliferone (UMB), is a compound that comes from coumarin and has been showing biological activities in other studies. As of this scenario, the present study was designed to evaluate the acute oral toxicity, mutagenic, antidiarrheal, anti-bacterial, and antiulcerogenic effects, and antioxidant capacity of UMB. An investigation was conducted through the hippocratic screening method and through histopathological analysis in animals to evaluate the effects of acute oral administration of a dose of 50, 100 and 200 mg/kg of UMB. A micronucleus test on peripheral blood of Swiss mice, which were orally treated with three doses (50, 100 and 200 mg/kg), was conducted to evaluate mutagenic activities. The antiulcerogenic activity was accomplished through the ethanol-induced damage method. Antidiarrheal activities were tested for inducing diarrhea with castor oil and evaluating intestinal transit duration; additionally, the antimicrobial effect against some enteropathogenic bacteria was analyzed. Finally, the antioxidant capability was determined by the capacity of the UMB sample to kidnap the stable radical 2,2-diphenyl-1-picrylhydrazyl. Of the evaluated doses, signs of toxicity after acute administration of the compound were not observed. UMB presented antiulcerogenic activity (100 and 200 mg/kg), which was explained because of its antioxidant capacity. A gastro protective effect was similar to the positive control, and the UMB was able to significantly reduce intestinal transit, and also diarrheal symptoms. Furthermore, UMB had an anti-bacterial effect with minimum inhibitory concentration fluctuating between 62.5 and 1000 mu g/mL. Based on these findings, we can suggest that UMB has important biological activities in vivo and in vitro and is not toxic under the evaluated circumstances, which demonstrates its large potential for pharmacological use.
C1 [Cruz, Luisa Ferreira; de Figueiredo, Geisa Fantini; Pedro, Lidiane Paula; Amorin, Yuri Martins; Passos, Tiago Faustino; Rodrigues, Felipe Fernandes; Antunes Souza, Israel Lucas; de Freitas Araujo, Marcelo Gonzaga] Univ Fed Sao Joao del Rei, Lab Pharmacol, Sebastiao Goncalves Coelho 400, BR-35501296 Divinopolis, MG, Brazil.
   [Andrade, Jessica Tauany; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Lab Med Microbiol, Sebastiao Goncalves Coelho 400, BR-35501296 Divinopolis, MG, Brazil.
   [Rodrigues Goncalves, Thais Paula; Rodrigues dos Santos Lima, Luciana Alves] Univ Fed Sao Joao del Rei, Lab Phytochem, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
RP Cruz, LF (corresponding author), Univ Fed Sao Joao del Rei, Lab Pharmacol, Sebastiao Goncalves Coelho 400, BR-35501296 Divinopolis, MG, Brazil.; Cruz, LF (corresponding author), Univ Fed Sao Joao del Rei, Lab Pharmacol, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
EM luisaferreiradacruz@gmail.com
OI MARENA, GABRIEL DAVI/0000-0002-4573-5743; Ferreira da Cruz,
   Luisa/0000-0001-6880-3596
FU University of Sao Joao Del Rey
FX This study was financially supported by the research grants of the
   University of Sao Joao Del Rey.
CR Almasaudi SB, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3643824
   Antonisamy P, 2014, CHEM-BIOL INTERACT, V224, P157, DOI 10.1016/j.cbi.2014.09.020
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P837, DOI 10.1016/S0278-6915(01)00024-2
   Arab HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122417
   Araldi RP, 2015, BIOMED PHARMACOTHER, V72, P74, DOI 10.1016/j.biopha.2015.04.004
   Araujo S.G., 2013, BIOCH BIOTECHNOL REP, V2, DOI [10.5433/2316-5200.2013v2n1p35, DOI 10.5433/2316-5200.2013V2N1P35]
   Biljali Sefedin, 2012, Folia Med (Plovdiv), V54, P42
   Botham PA, 2004, TOXICOL IN VITRO, V18, P227, DOI 10.1016/S0887-2333(03)00143-7
   Cheng SX, 2016, WORLD J GASTROENTERO, V22, P2711, DOI 10.3748/wjg.v22.i9.2711
   Cruzan G, 2009, REGUL TOXICOL PHARM, V55, P205, DOI 10.1016/j.yrtph.2009.07.002
   de Lima FO, 2011, J NAT PROD, V74, P596, DOI 10.1021/np100621c
   Diaz A, 2014, REV BRAS FARMACOGN, V24, P419, DOI 10.1016/j.bjp.2014.07.016
   DiPasquale L.C., 2001, PRINCIPLES METHODS T, V4, P853
   Edwards AJ, 2000, FOOD CHEM TOXICOL, V38, P403, DOI 10.1016/S0278-6915(00)00016-8
   EGAN D, 1990, DRUG METAB REV, V22, P503, DOI 10.3109/03602539008991449
   Fabricant DS, 2001, ENVIRON HEALTH PERSP, V109, P69, DOI 10.2307/3434847
   Fedato RP, 2014, J APPL TOXICOL, V34, P33, DOI 10.1002/jat.2823
   Furtado MA, 2008, MUTAT RES-GEN TOX EN, V657, P150, DOI 10.1016/j.mrgentox.2008.09.003
   Guideline OO, 2001, OECD GUID TEST CHEM, V2, P12
   Gulcin I, 2006, LIFE SCI, V78, P803, DOI 10.1016/j.lfs.2005.05.103
   Halaihel N, 2000, J VIROL, V74, P9464, DOI 10.1128/JVI.74.20.9464-9470.2000
   Hayashi M, 2016, GENES ENVIRON, V38, DOI 10.1186/s41021-016-0044-x
   Hayes A. Wallace, 2019, LOOMISS ESSENTIALS T, DOI [10.1016/C2017-0-01670-1., DOI 10.1016/C2017-0-01670-1]
   Hoult JRS, 1996, GEN PHARMACOL-VASC S, V27, P713, DOI 10.1016/0306-3623(95)02112-4
   HSU WH, 1982, EUR J PHARMACOL, V83, P55, DOI 10.1016/0014-2999(82)90285-0
   Kumar V, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-273
   Lake BG, 1999, FOOD CHEM TOXICOL, V37, P423, DOI 10.1016/S0278-6915(99)00010-1
   Lanas A, 2017, LANCET, V390, P613, DOI 10.1016/S0140-6736(16)32404-7
   Li HB, 2017, J PHARM PHARMACOL, V69, P1253, DOI 10.1111/jphp.12774
   Lopez-Gonzalez JS, 2004, LUNG CANCER-J IASLC, V43, P275, DOI 10.1016/j.lungcan.2003.09.005
   MACGREGOR JT, 1980, ENVIRON MUTAGEN, V2, P509, DOI 10.1002/em.2860020408
   MACKAY JM, 1992, MUTAT RES, V271, P97, DOI 10.1016/0165-1161(92)90036-L
   Maistro EL, 2015, J TOXICOL ENV HEAL A, V78, P109, DOI 10.1080/15287394.2014.943865
   MALONE MH, 1962, LLOYD, V25, P320
   Mythilypriya R, 2007, J HEALTH SCI, V53, P351, DOI 10.1248/jhs.53.351
   Navarro-Garcia VM, 2011, MYCOSES, V54, pE569, DOI 10.1111/j.1439-0507.2010.01993.x
   Oyagi A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-45
   Polatoglu K, 2013, J AOAC INT, V96, P1222, DOI 10.5740/jaoacint.SGEPolatoglu
   Porwal M, 2017, SCI PHARM, V85, DOI 10.3390/scipharm85030029
   Prazeres LDKT, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1983137
   Qnais EY, 2007, PHARM BIOL, V45, P715, DOI 10.1080/13880200701575304
   ROBERT A, 1979, GASTROENTEROLOGY, V77, P433
   Ryan E.T., 2019, HUNTERS TROPICAL MED
   Salau VF, 2020, J FUNCT FOODS, V67, DOI 10.1016/j.jff.2020.103847
   Sebai H, 2014, J ETHNOPHARMACOL, V152, P327, DOI 10.1016/j.jep.2014.01.015
   Selendy J.M.H., 2019, WATER SANITATION REL
   Sepulveda B, 2016, BIOORG MED CHEM LETT, V26, P5732, DOI 10.1016/j.bmcl.2016.10.056
   Shareef H, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-479
   Suchitra AD, 2003, WORLD J GASTROENTERO, V9, P779, DOI 10.3748/wjg.v9.i4.779
   TENNANT RW, 1993, ENVIRON HEALTH PERSP, V100, P307, DOI 10.2307/3431536
   Thomson ABR, 2010, WORLD J GASTROENTERO, V16, P2323, DOI 10.3748/wjg.v16.i19.2323
   Vasconcelos JF, 2009, EUR J PHARMACOL, V609, P126, DOI 10.1016/j.ejphar.2009.03.027
   WAYNE P, 2008, M27A3 CLSI, V28, P6
   Wu PE, 2017, ANN EMERG MED, V70, P245, DOI 10.1016/j.annemergmed.2017.04.008
   Yin LJ, 2014, AM J PHYSIOL-CELL PH, V306, pC687, DOI 10.1152/ajpcell.00174.2013
   Yoo JH, 2018, J DAIRY SCI, V101, P3758, DOI 10.3168/jds.2017-13872
   Zinovieva Maryna L., 2017, J PHARM PHARMACOL, V5, DOI [10.17265/2328-2150/2017.05.002., DOI 10.17265/2328-2150/2017.05.002]
NR 57
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD SEP
PY 2020
VL 129
AR 110432
DI 10.1016/j.biopha.2020.110432
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA NJ9RA
UT WOS:000566379700013
PM 32768935
OA Other Gold
DA 2020-09-29
ER

PT J
AU Herrera, KMS
   da Silva, FK
   de Lima, WG
   Barbosa, CD
   Goncalves, AMMN
   Viana, GHR
   Soares, AC
   Ferreira, JMS
AF Herrera, Karina M. S.
   da Silva, Fernanda K.
   de Lima, William G.
   Barbosa, Camila de S.
   Goncalves, Alessandra M. M. N.
   Viana, Gustavo H. R.
   Soares, Adriana C.
   Ferreira, Jaqueline M. S.
TI Antibacterial and antibiofilm activities of synthetic analogs of
   3-alkylpyridine marine alkaloids
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Article
DE Alkaloid; Antibacterial; Biofilm; Cytotoxicity; Klebsiella pneumoniae;
   Staphylococcus aureus
ID RESISTANCE
AB Nowadays, the emergence of superbugs is one of the most serious public health problems. Strains of Staphylococcus aureus and Klebsiella pneumoniae, resistant to many antimicrobials available in clinical practice, have become increasingly common. The development of new drugs for the treatment of infections caused by these pathogens is necessary and urgent. A series of 11 analogs of marine 3-alkylpyridine alkaloids was evaluated in vitro for its antibacterial potential. Compound 6, a synthetic analog of viscosaline, exhibited significant activity against S. aureus, including an MRSA strain (MIC = 2 mu g/mL). Additionally, it exhibited a 25% reduction in mature biofilm and a good selectivity index (SI > 16). None of the compounds exhibited activity against K. pneumoniae, but analog 6 was able to act in planktonic cells in the presence of polymyxin B at sub-inhibitory concentration. Compound 6 has promising anti-staphylococcal activity and future assays are encouraged to investigate their therapeutic potential.
C1 [Herrera, Karina M. S.; da Silva, Fernanda K.; de Lima, William G.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Barbosa, Camila de S.; Goncalves, Alessandra M. M. N.; Viana, Gustavo H. R.] Univ Fed Sao Joao del Rei UFSJ, Lab Sintese Organ, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Soares, Adriana C.] Univ Fed Sao Joao del Rei UFSJ, Lab Farmacol, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
RP Herrera, KMS (corresponding author), Univ Fed Sao Joao del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
EM kmsherrera@gmail.com
OI Herrera, Karina Marjorie Silva/0000-0002-1259-9087
FU Universidade Federal de Sao Joao del-Rei; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de
   Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)Minas Gerais State
   Research Foundation (FAPEMIG)
FX We would like to thank Universidade Federal de Sao Joao del-Rei,
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG) for
   the support, Agnes Marie Sa Figueiredo (UFRJ, Rio de Janeiro, Brazil)
   for the supply of the MRSA USA 300 strain, and Camyla Alves Leonel
   (UFSJ, Minas Gerais, Brazil) for performing the cytotoxicity assay.
CR Andrade JT, 2018, J ANTIBIOT, V71, P702, DOI 10.1038/s41429-018-0048-9
   Barbosa CD, 2017, ACS OMEGA, V2, P8264, DOI 10.1021/acsomega.7b01302
   Barbosa MCS, 2018, MUTAT RES-GEN TOX EN, V825, P31, DOI 10.1016/j.mrgentox.2017.11.006
   Bhattacharya M, 2015, EXPERT REV ANTI-INFE, V13, P1499, DOI 10.1586/14787210.2015.1100533
   Blaskovich MAT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02123-w
   Boev C, 2017, CRIT CARE NURS CLIN, V29, P51, DOI 10.1016/j.cnc.2016.09.012
   Chanawanno K, 2010, EUR J MED CHEM, V45, P4199, DOI 10.1016/j.ejmech.2010.06.014
   Chung PY, 2014, PATHOG DIS, V70, P231, DOI 10.1111/2049-632X.12141
   Clinical and Laboratory Standards Institute (CLSI), 2019, M100 CLSI S
   CLSI, 2012, M07A9 CLSI
   Cushnie TPT, 2014, INT J ANTIMICROB AG, V44, P377, DOI 10.1016/j.ijantimicag.2014.06.001
   de Oliveira NG, 2020, FUTURE MICROBIOL, V15, P63, DOI 10.2217/fmb-2019-0180
   Hilario FF, 2011, CHEM BIOL DRUG DES, V78, P477, DOI 10.1111/j.1747-0285.2011.01154.x
   Johari SA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/823829
   Liu H, 2020, EUR J MED CHEM, V185, DOI 10.1016/j.ejmech.2019.111804
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Goncalves AMMN, 2014, MAR DRUGS, V12, P4361, DOI 10.3390/md12084361
   Meletis G, 2016, THER ADV INFECT DIS, V3, P15, DOI 10.1177/2049936115621709
   Mohammed YHE, 2018, MICROB PATHOGENESIS, V123, P339, DOI 10.1016/j.micpath.2018.07.002
   O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437
   Peirano G, 2009, J ANTIMICROB CHEMOTH, V63, P265, DOI 10.1093/jac/dkn484
   Pereira J.R.C.S., 2012, BIOMED PREV NUTR, V2, P145, DOI DOI 10.1016/j.bionut.2012.01.003
   Pernak J, 2001, EUR J MED CHEM, V36, P899, DOI 10.1016/S0223-5234(01)80005-2
   Rakesh KP, 2019, BIOORG CHEM, V90, DOI 10.1016/j.bioorg.2019.103093
   Rakesh KP, 2018, RSC ADV, V8, P5473, DOI 10.1039/c7ra13661g
   Rakesh KP, 2018, ACS COMB SCI, V20, P681, DOI 10.1021/acscombsci.8b00088
   Rane RA, 2015, BIOORG CHEM, V61, P66, DOI 10.1016/j.bioorg.2015.06.001
   Ribeiro-Viana RM, 2016, J CHEM INF MODEL, V56, P571, DOI 10.1021/acs.jcim.5b00742
   Rice LB, 2010, INFECT CONT HOSP EP, V31, pS7, DOI 10.1086/655995
   Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067
   Scorciapino MA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030542
   Herrera KMS, 2019, J CHEMOTHERAPY, V31, P127, DOI 10.1080/1120009X.2018.1558751
   Soo VWC, 2017, CURR TOP MED CHEM, V17, P1157, DOI 10.2174/1568026616666160930131737
   Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16407
   Volk CA, 2004, ORG BIOMOL CHEM, V2, P1827, DOI 10.1039/b403413a
   WHO-World Health Organization, 2018, GLOB PRIOR LIST ANT
   Xu M, 2019, BIOORG CHEM, V91, DOI 10.1016/j.bioorg.2019.103133
   Younis W, 2015, CURR PHARM DESIGN, V21, P4106, DOI 10.2174/1381612821666150506154434
   Zha GF, 2019, EUR J MED CHEM, V162, P364, DOI 10.1016/j.ejmech.2018.11.012
   Zha GF, 2017, BIOORG MED CHEM LETT, V27, P3148, DOI 10.1016/j.bmcl.2017.05.032
NR 40
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD JUN
PY 2020
VL 29
IS 6
BP 1084
EP 1089
DI 10.1007/s00044-020-02549-w
EA MAY 2020
PG 6
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA LT2SZ
UT WOS:000530256600001
DA 2020-09-29
ER

PT J
AU Ferreira, LS
   Andrade, JT
   Lima, WG
   Souza, JD
   Chagas, RCR
   Leonel, CA
   Cunha, LC
   Herrera, KMS
   Braga, AV
   Soares, LF
   Ferreira, JMS
AF Ferreira, Lorena S.
   Andrade, Jessica T.
   Lima, William G.
   Souza, Juliano de P.
   Chagas, Rafael C. R.
   Leonel, Camyla A.
   Cunha, Lais C.
   Herrera, Karina M. S.
   Braga, Alysson, V
   Soares, Luis F.
   Ferreira, Jaqueline M. S.
TI SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL ACTIVITY OF NEW Cu (II),
   Co (II) AND Sn (II) COMPLEXES WITH THE SODIUM
   HYDROTRIS(2-MERCAPTOTHIAZOLYL)BORATE LIGAND
SO QUIMICA NOVA
LA English
DT Article
DE Antifungal activity; Antibacterial activity; Chemo-informatics assays;
   Thiazoline; Metal complexes
ID TRANSITION-METAL-COMPLEXES; COPPER(II) COMPLEXES; MOLECULAR DOCKING;
   THIOSEMICARBAZONE; CYTOTOXICITY; CHEMISTRY; CU(II); BORATE; REDOX; INDEX
AB The emergence of antibiotic resistance among microbial pathogens is a serious public health problem, resulting in a constant need of discovering new antibiotics. For this purpose, we synthetized and determined the antimicrobial activity of copper (Cu), cobalt (Co), and tin (Sn) complexes coordinated with scorpionate ligand in a tridentate mode against microorganisms of clinical importance. New complexes with the sodium hydrotris(2-inercaptothiazolyl)borate ligand were characterized by physicochemical and spectroscopic techniques (UV-vis, IR, H-1 and C-13 NMR). Moreover, their antimicrobial activity was evaluated using microdilution broth method. Cytotoxicity was determined in Vero cells and the selectivity index (SI) was calculated. The coordination with metals increased the ligand antimicrobial activity, which showed no activity when evaluated alone (MIC>1,080 mu M). Cu-complex (1) had activity against Candida albicans and C. krusei, with MICs of 130 and 66 mu M, respectively. The compounds had low toxicity on Vero cells and chemo-informatics assays corroborated a low systemic toxic effect. The SI revealed that the compound 1 was 16 times more selective for C. krusei and 8 times more selective for C. albicans in relation to Vero cells. The Cu-complex stands out as a potential prototype for the development of new antifungal agents.
C1 [Ferreira, Lorena S.; Andrade, Jessica T.; Lima, William G.; Souza, Juliano de P.; Chagas, Rafael C. R.; Leonel, Camyla A.; Cunha, Lais C.; Herrera, Karina M. S.; Braga, Alysson, V; Soares, Luis F.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
FU Universidade Federal de Sao Joao Del-Rei; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas Gerais State
   Research Foundation (FAPEMIG); FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG); UFSJ
FX We would like to thank Universidade Federal de Sao Joao DelRei, Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) by financial
   support, and Jessica T. Andrade, William G. Lima are grateful to UFSJ
   and FAPEMIG for a fellowship.
CR Alaghaz ANMA, 2013, J MOL STRUCT, V1035, P383, DOI 10.1016/j.molstruc.2012.11.030
   Andrade JT, 2018, J ANTIBIOT, V71, P702, DOI 10.1038/s41429-018-0048-9
   [Anonymous], 2008, M27A3 CLSI
   Appelt P, 2015, INORG CHIM ACTA, V436, P152, DOI 10.1016/j.ica.2015.07.022
   Baba H, 2011, POLYHEDRON, V30, P3182, DOI 10.1016/j.poly.2011.03.037
   Bakale RP, 2018, J MOL STRUCT, V1154, P92, DOI 10.1016/j.molstruc.2017.10.035
   Bus L., 2013, DIAGN MICROBIOL INFE, V77, P341
   Carvalho RS, 2018, S AFR J BOT, V114, P181, DOI 10.1016/j.sajb.2017.11.010
   Chen CH, 2014, RES CHEM INTERMEDIAT, V40, P2217, DOI 10.1007/s11164-014-1599-4
   Chudzik B, 2017, EUR J PHARM SCI, V97, P9, DOI 10.1016/j.ejps.2016.10.040
   Clinical and Laboratory Standards Institute (CLSI), 2012, M7A6 CLSI
   Dadar M, 2018, MICROB PATHOGENESIS, V117, P128, DOI 10.1016/j.micpath.2018.02.028
   DoidgeHarrison SMSV, 1996, J ORGANOMET CHEM, V516, P199, DOI 10.1016/0022-328X(96)06139-6
   Dorotikova S, 2015, J INORG BIOCHEM, V150, P160, DOI 10.1016/j.jinorgbio.2015.06.017
   Garcia LM, 2013, REV EPIDEMIOL CONTRO, V3, P45, DOI 10.17058/reci.v3i2.3235
   Garner M, 2003, DALTON T, P1181, DOI 10.1039/b209877f
   GEARY WJ, 1971, COORDIN CHEM REV, V7, P81, DOI 10.1016/S0010-8545(00)80009-0
   Hill AF, 1999, ANGEW CHEM INT EDIT, V38, P2759, DOI 10.1002/(SICI)1521-3773(19990917)38:18&lt;2759::AID-ANIE2759&gt;3.0.CO;2-P
   Holmstrup P, 2018, ORAL DIS, V24, P291, DOI 10.1111/odi.12610
   Hughes BC, 2014, CHEM COMMUN, V50, P5273, DOI 10.1039/c3cc47151a
   Joshi R, 2010, J COORD CHEM, V63, P906, DOI 10.1080/00958971003649690
   Kadhum AAH, 2011, MOLECULES, V16, P6969, DOI 10.3390/molecules16086969
   Konstantinovic SS, 2003, J SERB CHEM SOC, V68, P641, DOI 10.2298/JSC0309641K
   Leeson P, 2012, NATURE, V481, P455, DOI 10.1038/481455a
   Lima WG, 2018, J PHARM NEGAT RESULT, V9, P27, DOI 10.4103/jpnr.JPNR_11_17
   Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098
   LITTLE LH, 1962, CAN J CHEM, V40, P2110, DOI 10.1139/v62-324
   Makhaeva GF, 2016, BIOORGAN MED CHEM, V24, P1050, DOI 10.1016/j.bmc.2016.01.031
   Michael E, 2015, ANAESTHESIST, V64, P315, DOI 10.1007/s00101-015-0008-8
   Muraoka TK, 1997, ECLET QUIM, V22, P75
   Netalkar PP, 2015, POLYHEDRON, V100, P215, DOI 10.1016/j.poly.2015.07.075
   Nunes BC, 2016, IND CROP PROD, V92, P277, DOI 10.1016/j.indcrop.2016.08.016
   Rabie UM, 2012, SPECTROCHIM ACTA A, V86, P252, DOI 10.1016/j.saa.2011.10.032
   Rai M, 2017, INT J PHARMACEUT, V532, P139, DOI 10.1016/j.ijpharm.2017.08.127
   Reglinski J, 2015, COORDIN CHEM REV, V297, P181, DOI 10.1016/j.ccr.2015.02.023
   Romanowski SMD, 2004, J BRAZIL CHEM SOC, V15, P897, DOI 10.1590/S0103-50532004000600017
   Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j
   Singh U, 2016, MICROB PATHOGENESIS, V93, P172, DOI 10.1016/j.micpath.2016.02.011
   Soares LF, 2004, J BRAZIL CHEM SOC, V15, P695, DOI 10.1590/S0103-50532004000500014
   Soliman SM, 2017, J MOL STRUCT, V1149, P58, DOI 10.1016/j.molstruc.2017.07.072
   Souza MA, 2013, MEM I OSWALDO CRUZ, V108, P342, DOI 10.1590/S0074-02762013000300013
   Vaidya M. Y., 2017, SCI REP, V5911, P1
   Vinuelas-Zahinos E, 2011, EUR J MED CHEM, V46, P150, DOI 10.1016/j.ejmech.2010.10.030
   Wang J, 2017, J HOSP INFECT, V96, P132, DOI 10.1016/j.jhin.2017.02.014
   Xie DS, 2010, J HOSP INFECT, V76, P150, DOI 10.1016/j.jhin.2010.04.003
   Yao ZJ, 2013, COORDIN CHEM REV, V257, P2522, DOI 10.1016/j.ccr.2013.02.004
   YOKOI H, 1977, INORG CHEM, V16, P1341, DOI 10.1021/ic50172a018
   Zaslona H, 2015, J MOL STRUCT, V1100, P34, DOI 10.1016/j.molstruc.2015.06.067
NR 48
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0100-4042
EI 1678-7064
J9 QUIM NOVA
JI Quim. Nova
PD MAY
PY 2020
VL 43
IS 5
BP 593
EP 598
DI 10.21577/0100-4042.20170526
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA MH3SX
UT WOS:000546654400011
OA DOAJ Gold
DA 2020-09-29
ER

PT J
AU Andrade, JT
   Alves, SLG
   Lima, WG
   Sousa, CDF
   Carmo, LF
   De Sa, NP
   Morais, FB
   Johann, S
   Villar, JAFP
   Ferreira, JMS
AF Andrade, Jessica Tauany
   Alves, Silmara Lucia Grego
   Lima, William Gustavo
   Sousa, Carla Daiane Ferreira
   Carmo, Lucas Fernandes
   De Sa, Nivea Pereira
   Morais, Fernanda Barbara
   Johann, Susana
   Villar, Jose Augusto Ferreira Perez
   Ferreira, Jaqueline Maria Siqueira
TI Pharmacologic potential of new nitro-compounds as antimicrobial agents
   against nosocomial pathogens: design, synthesis, and in vitro
   effectiveness
SO FOLIA MICROBIOLOGICA
LA English
DT Article
ID ANTIFUNGAL; DERIVATIVES; RESISTANCE; ANTIBACTERIAL; INFECTIONS;
   MECHANISM; CYTOTOXICITY; PREVALENCE; SYNERGISM
AB Nosocomial infections are an important cause of morbi-mortality worldwide. The increase in the rate of resistance to conventional drugs in these microorganisms has stimulated the search for new therapeutic options. The nitro moiety (NO2) is an important pharmacophore of molecules with high anti-infective activity. We aimed to synthesize new nitro-derivates and to evaluate their antibacterial and anti-Candida potential in vitro. Five compounds [3-nitro-2-phenylchroman-4-ol (3); 3-nitro-2-phenyl-2H-chromene (4a); 3-nitro-2-(4-chlorophenyl)-2H-chromene (4b); 3-nitro-2-(4-fluorophenyl)-2H-chromene (4c), and 3-Nitro-2-(2,3-dichlorophenyl)-2H-chromene (4d)] were efficiently synthesized by Michael-aldol reaction of 2-hydroxybenzaldehyde with nitrostyrene, resulting in one beta-nitro-alcohol (3) and four nitro-olefins (4a-4d). The antibacterial and anti-Candida potentials were evaluated by assaying minimal inhibitory concentration (MIC), minimum fungicidal concentration (MFC), and minimum bactericidal concentration (MBC). Mono-halogenated nitro-compounds (4b and 4c) showed anti-staphylococcal activity with MIC values of 15.6-62.5 mu g/mL and MBC of 62.5 mu g/mL. However, the activity against Gram-negative strains was showed to be considerably lower and our data suggests that this effect was associated with the outer membrane. Furthermore, nitro-compounds 4c and 4d presented activity against Candida spp. with MIC values ranging from 7.8-31.25 mu g/mL and MFC of 15.6-500 mu g/mL. In addition, these compounds were able to induce damage in fungal cells increasing the release of intracellular material, which was associated with actions on the cell wall independent of quantitative changes in chitin and beta-glucan. Together, these findings show that nitro-compounds can be exploited as anti-staphylococcal and anti-Candida prototypes.
C1 [Andrade, Jessica Tauany; Lima, William Gustavo; Sousa, Carla Daiane Ferreira; Morais, Fernanda Barbara; Ferreira, Jaqueline Maria Siqueira] Universidade Fed Sao Joao, Laboratorio MicroBiol Med, UFSJ, Campus Centro Oeste Dona Lindu/Universidade Fed, BR-35501-293 Divinopolis, MG, Brazil.
   [Alves, Silmara Lucia Grego; Carmo, Lucas Fernandes; Villar, Jose Augusto Ferreira Perez] Universidade Fed Sao Joao, Campus Centro Oeste Dona Lindu, Laboratorio Sintese Organ Nanoestruturas, UFSJ, Divinopolis, MG, Brazil.
   [De Sa, Nivea Pereira; Johann, Susana] Universidade Fed Minas Gerais, Departamento MicroBiol, Instituto Ciencias Biologicas, Belo Horizonte, MG, Brazil.
RP Ferreira, JMS (corresponding author), Universidade Fed Sao Joao, Laboratorio MicroBiol Med, UFSJ, Campus Centro Oeste Dona Lindu/Universidade Fed, BR-35501-293 Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
RI Villar, Jose Augusto Ferreira Perez/AAB-5849-2019; Villar, Jose Augusto
   F. P. Ferreira Perez/V-4142-2018; Lima, William G/C-9258-2018
OI Villar, Jose Augusto Ferreira Perez/0000-0003-1580-0644; Villar, Jose
   Augusto F. P. Ferreira Perez/0000-0003-1580-0644; Lima, William
   G/0000-0001-8946-9363; Pereira de Sa, Nivea/0000-0003-0901-6909
CR Al-Trawneh SA, 2014, EUR J MED CHEM, V86, P364, DOI 10.1016/j.ejmech.2014.08.065
   ANDRADE JT, 2018, J ANTIBIOT, V1, P1
   [Anonymous], 2012, REF METH DIL ANT SUS, pM7
   [Anonymous], 2008, STANDARD, pM27
   Barros Livia Moreira, 2012, Revista de Ciencias Farmaceuticas Basica e Aplicada, V33, P429
   Benenson A.S., 1995, CONTROL COMMUNICABLE
   Bennis S, 2004, LETT APPL MICROBIOL, V38, P454, DOI 10.1111/j.1472-765X.2004.01511.x
   Bhat MA, 2014, BIOORG MED CHEM LETT, V24, P1299, DOI 10.1016/j.bmcl.2014.01.060
   Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011
   Carvalho RS, 2018, S AFR J BOT, V114, P181, DOI 10.1016/j.sajb.2017.11.010
   Escalante A, 2008, J NAT PROD, V71, P1720, DOI 10.1021/np070660i
   Geweely NS, 2009, ARCH MICROBIOL, V191, P687, DOI 10.1007/s00203-009-0497-4
   Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501
   Hernandes MZ, 2010, CURR DRUG TARGETS, V11, P303, DOI 10.2174/138945010790711996
   Inweregbu K, 2005, BJA EDUC, V5, P14, DOI 10.1093/bjaceaccp/mki006
   Kamat Us, 2008, Indian J Community Med, V33, P89, DOI 10.4103/0970-0218.40875
   Khan Hassan Ahmed, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P509, DOI 10.1016/j.apjtb.2015.05.001
   Khoshnood S, 2019, BIOMED PHARMACOTHER, V109, P1809, DOI 10.1016/j.biopha.2018.10.131
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Lima WG, 2018, EUR J CLIN MICROBIOL, V1, P1
   Lima WG, 2017, PHARM NEGATIVE RESUL, V9, P27
   Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098
   Lobana TS, 2017, INORG CHIM ACTA, V461, P248, DOI 10.1016/j.ica.2017.02.032
   Lolekha S, 1981, PHILIPPINES SOC MICR, V10, P103
   Lyu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep27258
   Manjula MK, 2009, EUR J MED CHEM, V44, P280, DOI 10.1016/j.ejmech.2008.02.027
   Maurya IK, 2013, BBA-GEN SUBJECTS, V1830, P5193, DOI 10.1016/j.bbagen.2013.07.016
   Mircus G, 2015, ANTIMICROB AGENTS CH, V59, P5631, DOI 10.1128/AAC.00850-15
   NICHOLAS RO, 1994, MYCOL RES, V98, P694, DOI 10.1016/S0953-7562(09)80419-X
   Papadopoulou MV, 2017, BIOORGAN MED CHEM, V25, P6039, DOI 10.1016/j.bmc.2017.09.037
   Paraskevopoulos G, 2015, BIOORGAN MED CHEM, V23, P7292, DOI 10.1016/j.bmc.2015.10.029
   Premanandh J, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01536
   Prochnow EP, 2016, PHOTODIAGN PHOTODYN, V13, P291, DOI 10.1016/j.pdpdt.2015.08.008
   Rahmani-Nezhad S, 2014, EUR J MED CHEM, V86, P562, DOI 10.1016/j.ejmech.2014.09.017
   Guerra FQS, 2015, EVID-BASED COMPL ALT, DOI 10.1155/2015/925096
   Sekiya-Kawasaki M, 2002, GENETICS, V162, P663
   Septimus EJ, 2018, MED CLIN N AM, V102, P819, DOI 10.1016/j.mcna.2018.04.005
   Shahid HA, 2016, ARAB J CHEM, V9, P668, DOI 10.1016/j.arabjc.2014.11.001
   Smith DH, 2001, METHODS PRINCIPLES M, DOI [10.1002/3527600213, DOI 10.1002/3527600213]
   STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041
   Sumrra SH, 2013, J ENZYM INHIB MED CH, V28, P1291, DOI 10.3109/14756366.2012.735666
   Teixeira OG, 2017, NAT PROD RES, V1, P1
   Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16407
   Theuretzbacher U, 2009, INT J ANTIMICROB AG, V34, P15, DOI 10.1016/j.ijantimicag.2009.02.005
   Turner TB, 2017, INT IMMUNOPHARMACOL, V43, P129, DOI 10.1016/j.intimp.2016.12.009
   Verrelli E, 2014, MATER RES EXPRESS, V1, DOI 10.1088/2053-1591/1/4/046305
   VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639
   WHO, 2017, WHO PUBL LIST BACT W
   World Health Organization, 2014, ANT RES GLOB REP SUR
   World Health Organization Department of Communicable Disease Surveillance and Response, 2002, PREV HOSP ACQ INF PR
   Zhang JP, 2018, CHEMOSPHERE, V203, P368, DOI 10.1016/j.chemosphere.2018.03.143
   Zorzi RR, 2014, BIOORGAN MED CHEM, V22, P2844, DOI 10.1016/j.bmc.2014.03.044
NR 52
TC 0
Z9 0
U1 20
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0015-5632
EI 1874-9356
J9 FOLIA MICROBIOL
JI Folia Microbiol.
PD APR
PY 2020
VL 65
IS 2
BP 393
EP 405
DI 10.1007/s12223-019-00747-7
PG 13
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA KQ7AC
UT WOS:000517071000016
PM 31401762
DA 2020-09-29
ER

PT J
AU Santos, FRS
   Lima, WG
   Maia, EHB
   Assis, LC
   Davyt, D
   Taranto, AG
   Ferreira, JMS
AF Santos, Felipe R. S.
   Lima, William G.
   Maia, Eduardo H. B.
   Assis, Leticia C.
   Davyt, Danilo
   Taranto, Alex Gutterres
   Ferreira, Jaqueline M. S.
TI Identification of a Potential Zika Virus Inhibitor Targeting NS5
   Methyltransferase Using Virtual Screening and Molecular Dynamics
   Simulations
SO JOURNAL OF CHEMICAL INFORMATION AND MODELING
LA English
DT Article
ID DRUG DISCOVERY; ACCURATE DOCKING; FORCE-FIELD; IN-VITRO; DENGUE;
   PROTEASE; TRANSMISSION; PERMEABILITY; LIGAND; AGENTS
AB The NS5 methyltransferase (MTase) has been reported as an attractive molecular target for antivirals discovery against the Zika virus (ZIKV). Here, we report structure-based virtual screening of 42 390 structures from the Development Therapeutics Program (DTP) AIDS Antiviral Screen Database. Among the docked compounds, ZINC1652386 stood out due to its high affinity for MTase in comparison to the cocrystallized ligand MS2042, which interacts with the Asp146 residue in the MTase binding site by hydrogen bonding. Subsequent molecular dynamics simulations predicted that this compound forms a stable complex with MTase within 50 ns. Thus, ZINC1652386 may represent a promising ZIKV methyltransferase inhibitor.
C1 [Santos, Felipe R. S.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao Del Rei, Lab Microbiol Med, Divinopolis, MG, Brazil.
   [Lima, William G.] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Belo Horizonte, MG, Brazil.
   [Maia, Eduardo H. B.; Assis, Leticia C.; Taranto, Alex Gutterres] Univ Fed Sao Joao Del Rei, Lab Quim Farmaceut Med, Divinopolis, MG, Brazil.
   [Davyt, Danilo] Univ Republica, Dept Quim Organ, Montevideo, Uruguay.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao Del Rei, Lab Microbiol Med, Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
RI Santos, Felipe RS/J-3062-2017; DA SILVA SANTOS, FELIPE
   ROCHA/AAX-9240-2020; Gustavo de Lima, William/C-9258-2018
OI Santos, Felipe RS/0000-0002-8392-1467; DA SILVA SANTOS, FELIPE
   ROCHA/0000-0002-8392-1467; Gustavo de Lima, William/0000-0001-8946-9363
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Fundacao de Amparo a Pesquisa de Minas Gerais
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG) [APQ:02742-17];
   Federal University of Sao Joao del-Rei (UFSJ)/PPGBiotec and PPGCF
FX This work was supported by the Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior - Brasil (CAPES) [Finance Code 001]; Fundacao de
   Amparo a Pesquisa de Minas Gerais FAPEMIG [APQ:02742-17]; Federal
   University of Sao Joao del-Rei (UFSJ)/PPGBiotec and PPGCF.
CR Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905
   Almeida RD, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030062
   Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Chen CL, 2013, J IMMUNOL, V191, P1744, DOI 10.4049/jimmunol.1201976
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   da Cunha EFF, 2012, MED CHEM RES, V21, P590, DOI 10.1007/s00044-011-9554-z
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Devnarain N, 2018, CHEM BIOL DRUG DES, V92, P1838, DOI 10.1111/cbdd.13353
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Coelho IED, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-3078-x
   Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Dubankova A., 2019, ANTIVIR RES, V169, P169
   Elshahawi H, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040169
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hwu JR, 2017, ANTIVIR RES, V146, P96, DOI 10.1016/j.antiviral.2017.08.008
   Jain R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01756-7
   Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Khanfar MA, 2010, J MED CHEM, V53, P8534, DOI 10.1021/jm100941j
   Kuca K, 2018, BMC PHARMACOL TOXICO, V19, DOI 10.1186/s40360-018-0196-3
   Kukic P, 2010, FUTURE MED CHEM, V2, P647, DOI [10.4155/fmc.10.6, 10.4155/FMC.10.6]
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Leeson P, 2012, NATURE, V481, P455, DOI 10.1038/481455a
   Leonel CA, 2018, ARCH VIROL, V163, P575, DOI 10.1007/s00705-017-3641-5
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P
   MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e
   Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505
   Manvar D, 2016, BIOCHEM BIOPH RES CO, V469, P743, DOI 10.1016/j.bbrc.2015.12.042
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e
   Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u
   Nunes RR, 2016, MEM I OSWALDO CRUZ, V111, P721, DOI 10.1590/0074-02760160207
   Nutho B, 2019, J MOL GRAPH MODEL, V92, P227, DOI 10.1016/j.jmgm.2019.08.001
   Onawole AT, 2017, J MOL GRAPH MODEL, V73, P54, DOI 10.1016/j.jmgm.2017.01.018
   Othman R, 2008, J CHEM INF MODEL, V48, P1582, DOI 10.1021/ci700388k
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Rusanov T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35511-3
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j
   Sinigaglia A, 2018, EXPERT OPIN DRUG DIS, V13, P825, DOI 10.1080/17460441.2018.1515909
   Tao ZY, 2018, EUR J MED CHEM, V157, P994, DOI 10.1016/j.ejmech.2018.08.057
   Verma A, 2008, EUR J MED CHEM, V43, P897, DOI 10.1016/j.ejmech.2007.07.017
   Viswanathan U, 2014, J CHEM INF MODEL, V54, P2816, DOI 10.1021/ci500531r
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 60
TC 0
Z9 0
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9596
EI 1549-960X
J9 J CHEM INF MODEL
JI J. Chem Inf. Model.
PD FEB
PY 2020
VL 60
IS 2
BP 562
EP 568
DI 10.1021/acs.jcim.9b00809
PG 7
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science,
   Information Systems; Computer Science, Interdisciplinary Applications
SC Pharmacology & Pharmacy; Chemistry; Computer Science
GA KQ1BQ
UT WOS:000516665600015
PM 31985225
DA 2020-09-29
ER

PT J
AU Santos, FRS
   Nunes, DAF
   Lima, WG
   Davyt, D
   Santos, LL
   Taranto, AG
   Ferreira, JMS
AF Santos, Felipe R. S.
   Nunes, Damiana A. F.
   Lima, William G.
   Davyt, Danilo
   Santos, Luciana L.
   Taranto, Alex G.
   Ferreira, Jaqueline M. S.
TI Identification of Zika Virus NS2B-NS3 Protease Inhibitors by
   Structure-Based Virtual Screening and Drug Repurposing Approaches
SO JOURNAL OF CHEMICAL INFORMATION AND MODELING
LA English
DT Article
ID MOLECULAR-DYNAMICS; ANTIVIRAL ACTIVITY; APPROVED DRUGS; FORCE-FIELD;
   INFECTION; DOCKING; ANTIPSYCHOTICS; SERENDIPITY; DISCOVERY; DENGUE
AB The NS2B-NS3 protease has been identified as an attractive target for drug development against Zika virus (ZIKV) and combined drug repurposing and structure-based virtual screening has improved the development of antiviral drugs. In this study, we performed a structure based virtual screening of 1861 Food and Administration (FDA) approved drugs available in DrugBank by the selection and docking validation of crystal structure of ZIKV NS2B-NS3 protease (PDB ID 5H4I) using Glide and DOCK 6 software. The antihistaminic chlorcyclizine (Grid score -24.8 kcal/mol) exhibited the most promising interaction with NS2B-NS3 protease in comparison to crystallography ligand (Grid score -15.6 kcal/mol) by interaction to Tyr161 by hydrophobic interactions in the binding site of NS2B-NS3 which is recognized as an important amino acid in substrate molecular recognition. Cytotoxicity and global antiviral activity assay in Vero cells by MTT method showed that chlorcyclizine reduced the ZIKV induced cytopathic effect (EC50 of 69.0 +/- 7.3 mu M and SI = 1.9), and explicit molecular dynamics simulations implemented on a NAMD program indicated great stability of chlorcyclizine in protease binding site, suggesting the repurposing of chlorcyclizine as a promising finding in anti-ZIKV drug development.
C1 [Santos, Felipe R. S.; Nunes, Damiana A. F.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao Del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
   [Santos, Felipe R. S.; Taranto, Alex G.] Univ Fed Sao Joao Del Rei UFSJ, Lab Quim Farmaceut Med, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
   [Lima, William G.] Univ Fed Sao Joao Del Rei UFSJ, Dept Prod Farmaceut, Fac Farm, BR-31270901 Belo Horizonte, MG, Brazil.
   [Davyt, Danilo] Univ Republica, Dept Quim Organ, Fac Quim, Montevideo 11800, Uruguay.
   [Santos, Luciana L.] Univ Fed Sao Joao Del Rei UFSJ, Lab Biol Mol, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao Del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
RI DA SILVA SANTOS, FELIPE ROCHA/AAX-9240-2020; Santos, Felipe
   RS/J-3062-2017; Lima, William G/C-9258-2018; Santos, Luciana/C-9688-2013
OI DA SILVA SANTOS, FELIPE ROCHA/0000-0002-8392-1467; Santos, Felipe
   RS/0000-0002-8392-1467; Lima, William G/0000-0001-8946-9363; Santos,
   Luciana/0000-0001-6186-4062
FU Coordenacio de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Fundacio de Amparo a Pesquisa de Minas Gerais
   FAPEMIG [APQ-02742-17]; Federal University of Sao Joao del-Rei
   (UFSJ)/PPGBiotec; PPGCF
FX This work was supported by the Coordenacio de Aperfeicoamento de Pessoal
   de Nivel Superior - Brasil (CAPES) [Finance Code 001]; Fundacio de
   Amparo a Pesquisa de Minas Gerais FAPEMIG [APQ-02742-17]; Federal
   University of Sao Joao del-Rei (UFSJ)/PPGBiotec and PPGCF.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Aggarwal M, 2017, ANTIVIR RES, V146, P102, DOI 10.1016/j.antiviral.2017.08.015
   Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j
   Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Ban Thomas A, 2006, Dialogues Clin Neurosci, V8, P335
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Maia EHB, 2017, J MOL MODEL, V23, DOI 10.1007/s00894-016-3184-9
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x
   Bhargava S, 2019, NAT PROD RES, V33, P851, DOI 10.1080/14786419.2017.1413574
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bowen LR, 2019, J MOL MODEL, V25, DOI 10.1007/s00894-019-4076-6
   Campbell WC, 2005, ILAR J, V46, P352, DOI 10.1093/ilar.46.4.352
   Chakrabarty AN, 2000, INT J ANTIMICROB AG, V14, P215, DOI 10.1016/S0924-8579(99)00158-2
   Chance JP, 2018, BIOORG MED CHEM LETT, V28, P1846, DOI 10.1016/j.bmcl.2018.04.010
   Chen AT, 2019, SCHIZOPHR RES, V208, P1, DOI 10.1016/j.schres.2019.04.009
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Coelho IED, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-3078-x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Gentile S, 2004, ANN PHARMACOTHER, V38, P1265, DOI 10.1345/aph.1D485
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864
   Hart K, 2012, J CHEM THEORY COMPUT, V8, P348, DOI 10.1021/ct200723y
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Hippius H, 1999, J CLIN PSYCHIAT, V60, P22
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Imbernon B, 2018, INT J HIGH PERFORM C, V32, P789, DOI 10.1177/1094342017697471
   JonesBrando LV, 1997, SCHIZOPHR RES, V25, P63, DOI 10.1016/S0920-9964(97)00007-8
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068
   Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Macalino SJY, 2015, ARCH PHARM RES, V38, P1686, DOI 10.1007/s12272-015-0640-5
   MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P
   MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505
   Medigeshi GR, 2016, ANTIMICROB AGENTS CH, V60, P6709, DOI 10.1128/AAC.01367-16
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Micewicz ED, 2018, BIOORG MED CHEM LETT, V28, P452, DOI 10.1016/j.bmcl.2017.12.019
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Prasad S, 2016, TRENDS PHARMACOL SCI, V37, P435, DOI 10.1016/j.tips.2016.03.004
   Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168
   Rifaioglu AS, 2019, BRIEF BIOINFORM, V20, P1878, DOI 10.1093/bib/bby061
   Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   Sanchez-Linares I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S13
   Schafer A, 2018, ANTIVIR RES, V157, P47, DOI 10.1016/j.antiviral.2018.07.003
   Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197
   Song CM, 2009, BRIEF BIOINFORM, V10, P579, DOI 10.1093/bib/bbp023
   Trott O., 2009, J COMPUT CHEM
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037
   Xu HY, 2014, EUR ARCH PSY CLIN N, V264, P121, DOI 10.1007/s00406-013-0414-3
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
NR 68
TC 2
Z9 2
U1 4
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9596
EI 1549-960X
J9 J CHEM INF MODEL
JI J. Chem Inf. Model.
PD FEB
PY 2020
VL 60
IS 2
BP 731
EP 737
DI 10.1021/acs.jcim.9b00933
PG 7
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science,
   Information Systems; Computer Science, Interdisciplinary Applications
SC Pharmacology & Pharmacy; Chemistry; Computer Science
GA KQ1BQ
UT WOS:000516665600031
PM 31850756
DA 2020-09-29
ER

PT J
AU Pereira, LHS
   de Souza, TPP
   Camargos, VN
   Barbosa, LAD
   Taranto, AG
   Comar, M
   Santos, HD
   Lopes, DD
   Ferreira, JMS
   dos Santos, LL
AF Sales Pereira, Lailah Horacio
   Porto de Souza, Thais Paiva
   Camargos, Vidyleison Neves
   de Oliveira Barbosa, Leandro Augusto
   Taranto, Alex Guterres
   Comar Junior, Moacyr
   Santos, Herica de Lima
   Lopes, Debora de Oliveira
   Siqueira Ferreira, Jaqueline Maria
   dos Santos, Luciana Lara
TI Assays with recombinant soluble isoforms of DC-SIGN, a dengue virus
   ligand, show variation in their ability to bind to mannose residues
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID INFECTION; NONINTEGRIN; ENHANCEMENT
AB The DC-SIGN glycoprotein is responsible for the initial adhesion of dengue virus (DENV) to immune cells by the carbohydrate recognition domain (CRD). There are thirteen soluble and membrane-bound DC-SIGN isoforms, but the role of soluble isoforms in the DENV internalization process is not known. Five isoforms with an altered or absent CRD were identified, and three different soluble isoforms were used to confirm the interactions with mannose residues. The results show the loss of binding ability of one soluble isoform and binding ability of two of them. All of them will be used to verify their role in the DENV internalization process.
C1 [Sales Pereira, Lailah Horacio; Porto de Souza, Thais Paiva; Lopes, Debora de Oliveira; dos Santos, Luciana Lara] Univ Fed Sao Joao Rei UFSJ, Lab Mol Biol, Divinopolis, MG, Brazil.
   [Camargos, Vidyleison Neves] Univ Fed Minas Gerais, Lab Microorganism Host Interact, Belo Horizonte, MG, Brazil.
   [de Oliveira Barbosa, Leandro Augusto; Santos, Herica de Lima] Univ Fed Sao Joao Rei UFSJ, Lab Cell Biochem, Divinopolis, MG, Brazil.
   [Taranto, Alex Guterres; Comar Junior, Moacyr] Univ Fed Sao Joao Rei UFSJ, Lab Mol Modeling, Divinopolis, MG, Brazil.
   [Sales Pereira, Lailah Horacio; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao Rei UFSJ, Lab Virol, Divinopolis, MG, Brazil.
RP dos Santos, LL (corresponding author), Univ Fed Sao Joao Rei UFSJ, Lab Mol Biol, Divinopolis, MG, Brazil.
EM llaramg@hotmail.com
RI Barbosa, Leandro/K-1008-2013; Camargos, Vidyleison/AAN-2202-2020;
   Santos, Luciana/C-9688-2013; Lopes, Debora de Oliveira/L-3601-2016
OI Barbosa, Leandro/0000-0002-4631-0130; Camargos,
   Vidyleison/0000-0002-7926-0950; Santos, Luciana/0000-0001-6186-4062;
   Lopes, Debora de Oliveira/0000-0002-8559-8552
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG) [APQ-02179-10]; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)National
   Council for Scientific and Technological Development (CNPq)
   [475329/2013-9]
FX This work was supported by the Fundacao de Amparo a Pesquisa do Estado
   de Minas Gerais (FAPEMIG; grant number, APQ-02179-10) and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ; grant
   number, 475329/2013-9). The funders had no role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alen MMF, 2009, VIROLOGY, V387, P67, DOI 10.1016/j.virol.2009.01.043
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Broer BM, 2003, J COMPUT AID MOL DES, V17, P739, DOI 10.1023/B:JCAM.0000017491.97244.69
   Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200
   Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200
   Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200
   Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784
   Kim SY, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020044
   Liu P, 2017, TRAFFIC, V18, P218, DOI 10.1111/tra.12469
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Plazolles N, 2011, J LEUKOCYTE BIOL, V89, P329, DOI 10.1189/jlb.0710386
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Shah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059211
   Sutkeviciute I, 2014, ACS CHEM BIOL, V9, P1377, DOI 10.1021/cb500054h
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
NR 17
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD NOV
PY 2019
VL 164
IS 11
BP 2793
EP 2797
DI 10.1007/s00705-019-04377-9
PG 5
WC Virology
SC Virology
GA JB4FF
UT WOS:000488510500017
PM 31440811
DA 2020-09-29
ER

PT J
AU Andrade, JT
   de Figueiredo, GF
   Cruz, LF
   de Morais, SE
   Souza, CDF
   Pinto, FCH
   Ferreira, JMS
   Araujo, MGD
AF Andrade, Jessica Tauany
   de Figueiredo, Geisa Fantini
   Cruz, Luisa Ferreira
   de Morais, Sarah Eliza
   Ferreira Souza, Carla Daiane
   Horta Pinto, Flavia Carmo
   Siqueira Ferreira, Jaqueline Maria
   de Freitas Araujo, Marcelo Gonzaga
TI Efficacy of curcumin in the treatment of experimental vulvovaginal
   candidiasis
SO REVISTA IBEROAMERICANA DE MICOLOGIA
LA English
DT Article
DE Antifungal activity; Candida albicans; Curcumin; Ergosterol;
   Vulvovaginal candidiasis
ID ANTIFUNGAL ACTIVITY; DERIVATIVES; MECHANISM; ALBICANS; FUTURE; RISK
AB Background: Candida albicans is the main agent that causes vulvovaginal candidiasis. Resistance among isolates to azole antifungal agents has been reported.
   Aims: Due to the well-known antifungal potential of curcumin, the purpose of this work was to evaluate the in vitro anticandidal activity of curcumin and its effect in the treatment of experimental vulvovaginal candidiasis.
   Methods: The anticandidal activity of curcumin was investigated against eight Candida strains by the broth microdilution assay, and its mechanism of action was evaluated by testing the binding to ergosterol. Then, the effect of curcumin in the treatment of vulvovaginal candidiasis was evaluated in an immunosuppressed, estrogen treated rat model.
   Results: Curcumin showed minimum inhibitory concentration values of 125-1000 mu g/ml, and the best result was observed against Candida glabrata. The compound was shown to be able to bind to the ergosterol present in the membrane, event that may be the mechanism of action. In addition, in the in vivo model of vulvovaginal candidiasis with C. albicans, treatments reduced the vaginal fungal burden in infected rats after seven days of treatment with different doses.
   Conclusions: Curcumin could be considered a promising effective antifungal agent in the treatment of vulvovaginal candidiasis. (C) 2019 Asociacion Espanola de Micologia. Published by Elsevier Espana, S.L.U. All rights reserved.
C1 [Andrade, Jessica Tauany; Ferreira Souza, Carla Daiane; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Lab Med Microbiol, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [de Figueiredo, Geisa Fantini; Cruz, Luisa Ferreira; de Morais, Sarah Eliza; de Freitas Araujo, Marcelo Gonzaga] Univ Fed Sao Joao del Rei, Lab Pharmacol, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Horta Pinto, Flavia Carmo] Univ Fed Sao Joao del Rei, Nat Sci Dept, Campus Dom Bosco, Sao Joao Del Rei, MG, Brazil.
RP Araujo, MGD (corresponding author), Univ Fed Sao Joao del Rei, Lab Pharmacol, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
EM mgfaraujo@ufsj.edu.br
OI Araujo, Marcelo/0000-0002-6320-3185
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Coordenacdo de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Federal
   University of Sao Joao Del Rei
FX The authors are grateful to Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FAPEMIG) for the financial support which provided
   fellowships to S.E. Morais and G.F. Figueiredo, and Coordenacdo de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Federal
   University of Sao Joao Del Rei which provided a fellowship to J.T.
   Andrade.
CR Allochio JF, 2016, J BRAZIL CHEM SOC, V27, P2127, DOI 10.5935/0103-5053.20160104
   ArauJo MGF, 2003, MED MYCOL, V51, P673
   Badiee P, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2825-7
   Bahri R, 2010, J CELL PHYSIOL, V222, P209, DOI 10.1002/jcp.21939
   Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441
   Cao EY, 2011, BUS POLIT, V13, DOI 10.2202/1469-3569.1368
   Carrara MA, 2010, MYCOPATHOLOGIA, V170, P331, DOI 10.1007/s11046-010-9326-1
   Cassone A, 2016, INFECT IMMUN, V84, P1255, DOI 10.1128/IAI.01544-15
   Chew SY, 2016, MYCOSES, V59, P262, DOI 10.1111/myc.12455
   Cho JW, 2005, EXP MOL MED, V37, P186, DOI 10.1038/emm.2005.25
   Clinical and Laboratory Standards Institute, 2008, M27A3 CLSI
   Conti Heather R, 2014, Curr Protoc Immunol, V105, DOI 10.1002/0471142735.im1906s105
   Debata PR, 2013, GYNECOL ONCOL, V129, P145, DOI 10.1016/j.ygyno.2012.12.005
   Dhawan S, 2009, WORLD J MICROB BIOT, V25, P161, DOI 10.1007/s11274-008-9871-7
   Edwards RL, 2017, J BIOL CHEM, V292, P21243, DOI 10.1074/jbc.RA117.000123
   Escalante A, 2008, J NAT PROD, V71, P1720, DOI 10.1021/np070660i
   Fadus Matthew C, 2017, J Tradit Complement Med, V7, P339, DOI 10.1016/j.jtcme.2016.08.002
   Fidel PL, 2007, AM J REPROD IMMUNOL, V57, P2, DOI 10.1111/j.1600-0897.2006.00450.x
   Giavini E, 2010, TOXICOL LETT, V198, P106, DOI 10.1016/j.toxlet.2010.07.005
   Guo ZY, 2014, CARBOHYD POLYM, V99, P469, DOI 10.1016/j.carbpol.2013.08.044
   He X, 2017, LETT APPL MICROBIOL, V64, P350, DOI 10.1111/lam.12711
   Hewlings SJ, 2017, FOODS, V6, DOI 10.3390/foods6100092
   Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165
   Kyriakidis I, 2017, EXPERT OPIN DRUG SAF, V16, P149, DOI 10.1080/14740338.2017.1270264
   Lee W, 2014, IUBMB LIFE, V66, P780, DOI 10.1002/iub.1326
   Logan-Smith MJ, 2001, J BIOL CHEM, V276, P46905, DOI 10.1074/jbc.M108778200
   Martins CVB, 2009, J ANTIMICROB CHEMOTH, V63, P337, DOI 10.1093/jac/dkn488
   Miro MS, 2017, PATHOG DIS, V75
   Moghadamtousi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186864
   Musthafa KS, 2016, MICROB PATHOGENESIS, V99, P19, DOI 10.1016/j.micpath.2016.07.012
   Neelofar K, 2011, CAN J MICROBIOL, V57, P204, DOI 10.1139/W10-117
   Netea MG, 2010, CELL HOST MICROBE, V8, P219, DOI 10.1016/j.chom.2010.08.008
   Perfect JR, 2017, NAT REV DRUG DISCOV, V12, P1
   Peters BM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003965
   Ramos MAS, 2016, INT J MOL SCI, V17, P1
   Sharma M, 2010, BIOSCIENCE REP, V30, P391, DOI 10.1042/BSR20090151
   Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x
   Sobel JD, 2016, AM J OBSTET GYNECOL, V214, P15, DOI 10.1016/j.ajog.2015.06.067
   Tapia CV, 2017, MYCOPATHOLOGIA, V182, P339, DOI 10.1007/s11046-016-0095-3
   Teinkela JEM, 2017, S AFR J BOT, V111, P302, DOI 10.1016/j.sajb.2017.03.026
   Tverdek FP, 2016, EXPERT REV ANTI-INFE, V14, P765, DOI 10.1080/14787210.2016.1199272
   Udayalaxmi S., 2014, J CLIN DIAGN RES, V8, pDC15
   Wiederhold NP, 2017, INFECT DRUG RESIST, V10, P249, DOI 10.2147/IDR.S124918
   Wong SSW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085836
   Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160
   Zeng H, 2011, EVID-BASED COMPL ALT, P1, DOI 10.1155/2011/659704
   Zhang LY, 2017, MED CHEM RES, V26, P2468, DOI 10.1007/s00044-017-1946-2
NR 47
TC 0
Z9 0
U1 2
U2 2
PU ASOCIACION ESPANOLA MICOLOGIA-AEM
PI BILBAO
PA C/O DR GUILLERMO QUINDOS, EDITOR-IN-CHIEF, DEPT INMUNOLOGIA,
   MICROBIOLOGIA Y PARASITOLO, BILBAO, 00000, SPAIN
SN 1130-1406
J9 REV IBEROAM MICOL
JI Rev. Iberoam. Micol.
PD OCT 31
PY 2019
VL 36
IS 4
BP 192
EP 199
DI 10.1016/j.riam.2019.01.003
PG 8
WC Mycology
SC Mycology
GA JY0UZ
UT WOS:000504141000006
PM 31757595
DA 2020-09-29
ER

PT J
AU dos Santos, M
   Teixeira, TR
   Santos, FRD
   Lima, WG
   Ferraz, AC
   Silva, NL
   Leite, FJ
   Siqueira, JM
   Luyten, W
   de Castro, AHF
   de Magalhaes, JC
   Ferreira, JMS
AF dos Santos, Michelli
   Teixeira, Thaiz Rodrigues
   da Silva Santos, Felipe Rocha
   Lima, William Gustavo
   Ferraz, Ariane Coelho
   Silva, Nathalia Lucca
   Leite, Flavio Jose
   Siqueira, Joao Maximo
   Luyten, Walter
   Fonseca de Castro, Ana Hortencia
   de Magalhaes, Jose Carlos
   Siqueira Ferreira, Jaqueline Maria
TI Bauhinia holophylla (Bong.) Steud. leaves-derived extracts as potent
   anti-dengue serotype 2
SO NATURAL PRODUCT RESEARCH
LA English
DT Article; Early Access
DE Dengue virus; antiviral activity; cytotoxicity; Bauhinia holophylla;
   flavonoids
ID ANTIVIRAL ACTIVITIES; VIRUS; INHIBITORS; PROANTHOCYANIDIN; FLAVONOIDS;
   PLANTS
AB Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen and made the disease a major health concern worldwide. However, specific antiviral drugs against this arbovirose or vaccines are not yet available for treatment or prevention. Thus, here we aimed to study the antiviral activity of hydroethanolic extract, fraction ethyl acetate and subfractions of the leaves of Bauhinia holophylla (Fabaceae:Cercideae), a native plant of the Brazilian Cerrado, against DENV-2 by methylthiazolyldiphenyl-tetrazolium bromide (MTT) method in mammalian cells culture. As results, the hydroethanolic extract showed the most potent effect, with an inhibitory concentration (IC50) of 3.2 mu g mL(-1) and selectivity index (SI) of 27.6, approximately 16-times higher anti-DENV-2 activity than of the ribavirin (IC50 52.8 mu g mL(-1)). Our results showed in this study appointed that B. holophylla has a promising anti-dengue activity, which was associated mainly with the presence of flavonoids.
C1 [dos Santos, Michelli; da Silva Santos, Felipe Rocha; Ferraz, Ariane Coelho; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao Rei, Lab Microbiol Med, Divinopolis, Brazil.
   [Silva, Nathalia Lucca; Leite, Flavio Jose; Siqueira, Joao Maximo; Fonseca de Castro, Ana Hortencia] Univ Fed Sao Joao Del Rei, Lab Quim Prod Nat, Divinopolis, Brazil.
   [Teixeira, Thaiz Rodrigues] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Fis & Quim, Lab Quim Organ Ambiente Marinho, Ribeirao Preto, Brazil.
   [Lima, William Gustavo] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Lab Radioisotopos, Belo Horizonte, MG, Brazil.
   [Ferraz, Ariane Coelho; de Magalhaes, Jose Carlos] Univ Fed Sao Joao Del Rei, Dept Quim Biotecnol & Engn Bioproc, Lab Biol Mol & Celular, Ouro Branco, Brazil.
   [Luyten, Walter] Katholieke Univ Leuven, Dept Biol, Leuven, Belgium.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao Rei, Lab Microbiol Med, Divinopolis, Brazil.
EM jaque@ufsj.edu.br
RI Santos, Felipe RS/J-3062-2017; Lima, William G/C-9258-2018; DA SILVA
   SANTOS, FELIPE ROCHA/AAX-9240-2020
OI Santos, Felipe RS/0000-0002-8392-1467; Lima, William
   G/0000-0001-8946-9363; DA SILVA SANTOS, FELIPE
   ROCHA/0000-0002-8392-1467; dos Santos, Michelli/0000-0003-0257-6620;
   Rodrigues Teixeira, Thaiz/0000-0001-9514-3327
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil:
   CAPES [PNPD 2833-2011, 001]
FX "This study was financed in part by the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior - Brasil: CAPES (PNPD 2833-2011) and
   Finance Code 001."
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bicalho G. O. D., 2005, Caderno de Pesquisa Serie Biologia, V17, P13
   Cechinel V, 2009, PHYTOTHER RES, V23, P1347, DOI 10.1002/ptr.2756
   dos Santos AE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-130
   dos Santos M, 2018, J PHARM NEGAT RESULT, V9, P39, DOI 10.4103/jpnr.JPNR_2_18
   Farag MA, 2015, PHYTOCHEMISTRY, V119, P41, DOI 10.1016/j.phytochem.2015.09.004
   Feld JJ, 2017, LIVER INT, V37, P5, DOI 10.1111/liv.13212
   Ferraz AC, 2019, ANTIVIR RES, V168, P76, DOI 10.1016/j.antiviral.2019.05.008
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Godoi IP, 2017, J COMP EFFECT RES, V6, P165, DOI 10.2217/cer-2016-0045
   Gois RWS, 2017, REV BRAS FARMACOGN, V27, P711, DOI 10.1016/j.bjp.2017.09.002
   Jain R, 2008, ARCH PHARM RES, V31, P1525, DOI 10.1007/s12272-001-2145-7
   Kim M, 2013, ANTIVIR RES, V100, P460, DOI 10.1016/j.antiviral.2013.08.002
   Lani R, 2016, ANTIVIR RES, V133, P50, DOI 10.1016/j.antiviral.2016.07.009
   Leonel CA, 2018, ARCH VIROL, V163, P575, DOI 10.1007/s00705-017-3641-5
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lima WG, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2056
   Ma YH, 2017, VIRUS RES, V232, P34, DOI [10.1016/j.virusres.2017.01.021, 10.1016/j.virusres.2017.01.020]
   Markham K.R., 1982, TECHNIQUES FLAVONOID, P144
   Mohamed S., 2014, CURRSCI INT, V3, P172
   Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055
   Panda SK, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00658
   Pieroni LG., 2013, THESIS
   Schmidt MEP, 2018, REV BRAS FARMACOGN, V28, P21, DOI 10.1016/j.bjp.2017.11.005
   Pinheiro MS, 2017, AN ACAD BRAS CIENC, V89, P263, DOI 10.1590/0001-3765201720160050
   Silva ARA, 2011, J VENOM ANIM TOXINS, V17, P406, DOI [10.1590/S1678-91992011000400018, 10.1590/S1678-91992011000400007]
   Taylor RSL, 1996, J ETHNOPHARMACOL, V53, P97, DOI 10.1016/0378-8741(96)01430-4
   Teixeira, 2016, THESIS
   Tsukuda S, 2017, HEPATOLOGY, V65, P1104, DOI 10.1002/hep.28952
   Wankhar W, 2015, NAT PROD RES, V29, P1757, DOI 10.1080/14786419.2014.999060
   World Health Organization, 2019, DENG SEV DENG
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zhang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029774
NR 35
TC 0
Z9 0
U1 1
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
DI 10.1080/14786419.2019.1669030
EA SEP 2019
PG 6
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA JB0DX
UT WOS:000488222600001
PM 31554433
DA 2020-09-29
ER

PT J
AU de Oliveira, GT
   Amado, PA
   Ferreira, JMS
   Lima, LARD
AF de Oliveira, Graziela Teixeira
   Amado, Paula Avelar
   Siqueira Ferreira, Jaqueline Maria
   Rodrigues dos Santos Lima, Luciana Alves
TI Allelopathic effect of the ethanol extract and fractions of the aerial
   parts of Lippia alba (Verbenaceae)
SO NATURAL PRODUCT RESEARCH
LA English
DT Article
DE Lippia alba; herbal; allelopathic; biological activity
ID ESSENTIAL OIL
AB Lippia alba, belonging to the Verbenaceae family, is one of the most commonly utilized medicinal plants in folk medicine. The allelopathic activity was assessed using seeds of Lactuca sativa (lettuce) and Allium cepa (onion) by assessing the growth of the radicle and hypocotyl. The tests showed allelopathic efficiency in inhibiting the growth of lettuce and onion seeds. The best results for allelopathic activity were presented by the dichloromethane (DCM) fraction of the fresh plant, which inhibited radicle (23.04-100% lettuce and 64.17-66.36% onion) and hypocotyl (16.77-100% lettuce and 65.10-69.43% onion) formation, and as well as the DCM fraction of the dry plant, which also inhibited radicle (30.74-82.83% lettuce and 63.50-93.67% onion) and hypocotyl (24.12-70% lettuce and 69.07-79.95% onion) formation. Based on these results, it was found that the aerial parts of L. alba are rich in bioactive substances, suggesting the possibility of using of L. alba as a natural herbicide.
   [GRAPHICS]
   .
C1 [de Oliveira, Graziela Teixeira; Amado, Paula Avelar; Siqueira Ferreira, Jaqueline Maria; Rodrigues dos Santos Lima, Luciana Alves] Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, Brazil.
RP Lima, LARD (corresponding author), Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, Brazil.
EM luarsantos@ufsj.edu.br
OI Lima, Luciana/0000-0002-4130-0304
FU Federal University of Sao Joao Del Rei - UFSJ
FX This work was supported by the Federal University of Sao Joao Del Rei -
   UFSJ for a fellowship.
CR Beninger CW, 2005, BIOCHEM SYST ECOL, V33, P103, DOI 10.1016/j.bse.2004.06.016
   Benzarti S., 2016, MED AROMAT PLANTS, V5, P1
   Biasi Luiz Antônio, 2003, Cienc. Rural, V33, P455, DOI 10.1590/S0103-84782003000300010
   Blanco MA, 2013, J ETHNOPHARMACOL, V149, P803, DOI 10.1016/j.jep.2013.08.007
   Candido ACD, 2010, ACTA BOT BRAS, V24, P235, DOI 10.1590/S0102-33062010000100025
   de Oliveira GT, 2018, NAT PROD RES, V32, P723, DOI 10.1080/14786419.2017.1335727
   de Oliveira GT, 2014, REV SOC BRAS MED TRO, V47, P247, DOI 10.1590/0037-8682-0008-2013
   Duke SO, 2000, WEED RES, V40, P99, DOI 10.1046/j.1365-3180.2000.00161.x
   Glamoclija J, 2011, BRAZ J MICROBIOL, V42, P1537, DOI 10.1590/S1517-838220110004000041
   Gouda NAA, 2016, WEED SCI, V64, P191, DOI 10.1614/WS-D-15-00045.1
   Hachinohe M, 2007, J CHEM ECOL, V33, P1919, DOI 10.1007/s10886-007-9359-1
   Liu Y, 2011, WEED BIOL MANAG, V11, P160, DOI 10.1111/j.1445-6664.2011.00416.x
   MAIRESSE L.A.S., 2007, REV FZVA, V12, P1
   Matsumoto RS, 2010, ACTA BOT BRAS, V24, P631, DOI 10.1590/S0102-33062010000300005
   Maynard LG, 2011, INDIAN J PHARMACOL, V43, P694, DOI 10.4103/0253-7613.89828
   Pascual ME, 2001, J ETHNOPHARMACOL, V76, P201, DOI 10.1016/S0378-8741(01)00234-3
   Reichel T, 2013, J AGRON SCI, V2, P161
   Ribeiro P. G. F., 2008, Plantas aromaticas e medicinais: cultivo e utilizacao
   Rice EL, 1984, ALLELOPATHY, V2, P422
   Miranda CASF, 2015, SEMIN-CIENC AGRAR, V36, P1783, DOI 10.5433/1679-0359.2015v36n3Supl1p1783
   Santos S., 2011, Ecletica Quimica, V36, P51, DOI 10.1590/S0100-46702011000200003
   Shrivastava S, 2016, INT J INF RES REV, V3, P2612
   Smit JJ, 2004, AFRICON, P323
   Soares G. L. G., 2002, Floresta e Ambiente, V9, P119
   Sousa DG, 2015, BRAZ J MED BIOL RES, V48, P697, DOI 10.1590/1414-431X20154710
   Souza JRP, 2002, SEMIN-CIENC AGRAR, V23, P197
   Souza SAM, 2005, PUBLICACOES UEPG CIE, V11, P29
   Stupnicka-Rodzynkiewcz E, 2006, J PLANT DIS PROTECT, P479
   VAUGHN SF, 1993, WEED SCI, V41, P114, DOI 10.1017/S0043174500057672
   Weir TL, 2004, CURR OPIN PLANT BIOL, V7, P472, DOI 10.1016/j.pbi.2004.05.007
   Yamagushi MQ, 2011, SEMIN-CIENC AGRAR, V32, P1361, DOI 10.5433/1679-0359.2011v32n4p1361
   Yoneyama K, 2010, COMPREHENSIVE NATURA, P7388
NR 32
TC 0
Z9 0
U1 0
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
PD AUG 18
PY 2019
VL 33
IS 16
BP 2402
EP 2407
DI 10.1080/14786419.2018.1443090
PG 6
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA IE0KN
UT WOS:000472075600020
PM 29468885
DA 2020-09-29
ER

PT J
AU Ferraz, AC
   Moraes, TDS
   Nizer, WSD
   dos Santos, M
   Totola, AH
   Ferreira, JMS
   Vieira, SA
   Rodrigues, VG
   Duarte, LP
   Magalhaes, CLD
   de Magalhaes, JC
AF Ferraz, Ariane Coelho
   Silva Moraes, Thais de Fatima
   da Cruz Nizer, Waleska Stephanie
   dos Santos, Michelli
   Totola, Antonio Helvecio
   Siqueira Ferreira, Jaqueline Maria
   Vieira-Filho, Sidney Augusto
   Rodrigues, Vanessa Gonsalves
   Duarte, Lucienir Pains
   de Brito Magalhaes, Cintia Lopes
   de Magalhaes, Jose Carlos
TI Virucidal activity of proanthocyanidin against Mayaro virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Alphavirus; Antiviral effect; Maytenus imbricata; Proanthocyanidin;
   Epicatechin; Metilepigalocatechin; Celastraceae
ID ANTIVIRAL ACTIVITY; ARBOVIRUS; TRANSMISSION; INHIBITION; ANALOGS
AB Mayaro virus (MAYV) is a sublethal arbovirus transmitted by mosquitoes with possible installation of an urban cycle in the Americas. Its infection causes disabling arthralgia, and still, there is no vaccine or treatment to it. We recently investigated nearly 600 compounds by molecular docking and identified epicatechin as a potent antiviral against MAYV. The root extract of Maytenus imbricata showed anti-MAYV activity and two isolated compounds from this plant were also evaluated in vitro. Proanthocyanidin (PAC), a dimer containing epicatechin, showed an effective concentration for 50% of the cells infected by MAYV (EC50) of 37.9 +/- 2.4 mu M and a selectivity index (SI) above 40. PAC showed significant virucidal activity, inhibiting 100% of the virus proliferation (7 log units), and caused moderate effect during adsorption and virus internalization stage. However, PAC was unable to block the infection when only the cells were pretreated. It was observed a reduction in virus yields when adding PAC at different moments after infection. The set of results indicates that PAC binds to viral and non-cellular elements and may inactivate the MAYV. The inactivation occurs before infection or when the virus reaches the extracellular environment from the 2nd cycle of infection that could block its progression cell-to-cell or to tissues not yet infected.
C1 [Ferraz, Ariane Coelho; Silva Moraes, Thais de Fatima; da Cruz Nizer, Waleska Stephanie; Totola, Antonio Helvecio; de Magalhaes, Jose Carlos] Univ Fed Sao Joao del Rei, Dept Chem Biotechnol & Bioproc Engn, Campus Alto Paraopeba, BR-36420000 Ouro Branco, MG, Brazil.
   [Ferraz, Ariane Coelho; da Cruz Nizer, Waleska Stephanie; dos Santos, Michelli; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Vieira-Filho, Sidney Augusto] Univ Fed Ouro Preto, Pharm Sch, Dept Pharm, Campus Morro Cruzeiro, Ouro Preto, MG, Brazil.
   [Rodrigues, Vanessa Gonsalves; Duarte, Lucienir Pains] Univ Fed Minas Gerais, Dept Chem, Belo Horizonte, MG, Brazil.
   [de Brito Magalhaes, Cintia Lopes] Univ Fed Ouro Preto, Nucl Biol Sci Res, Dept Biol Sci, Campus Morro Cruzeiro, Ouro Preto, MG, Brazil.
   [Vieira-Filho, Sidney Augusto; Duarte, Lucienir Pains; de Magalhaes, Jose Carlos] Univ Fed Minas Gerais, Dept Chem, Nucl Studies Med Plants NEPLAM, Belo Horizonte, MG, Brazil.
RP de Magalhaes, JC (corresponding author), Univ Fed Sao Joao del Rei, Dept Chem Biotechnol & Bioproc Engn, Campus Alto Paraopeba, BR-36420000 Ouro Branco, MG, Brazil.
EM josecarlos@ufsj.edu.br
RI Duarte, Lucienir Pains P/J-6307-2012
OI Duarte, Lucienir Pains P/0000-0002-8885-6625; dos Santos,
   Michelli/0000-0003-0257-6620; Nizer, Waleska/0000-0002-5134-719X
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Universidade
   Federal de Sao Joao del-Rei
FX We thank Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG) and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) for Scientific Initiation grants. We thank the
   Universidade Federal de Sao Joao del-Rei for Master's degree grants and
   the facilities to carry out this work.
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   Aguiar ACC, 2018, INT J PARASITOL-DRUG, V8, P459, DOI 10.1016/j.ijpddr.2018.10.002
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Camini FC, 2018, ANTIVIR RES, V158, P8, DOI 10.1016/j.antiviral.2018.07.023
   Cecilio AB, 2012, J ETHNOPHARMACOL, V141, P975, DOI 10.1016/j.jep.2012.03.031
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   Devaux Christian A, 2012, World J Virol, V1, P11, DOI 10.5501/wjv.v1.i1.11
   DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747
   Epasinghe DJ, 2017, ARCH ORAL BIOL, V84, P29, DOI 10.1016/j.archoralbio.2017.09.012
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   Gallina L, 2011, ANTIVIR RES, V92, P447, DOI 10.1016/j.antiviral.2011.10.004
   Ganjhu Rajesh Kumar, 2015, VirusDisease, V26, P225, DOI 10.1007/s13337-015-0276-6
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Gescher K, 2011, ANTIVIR RES, V89, P9, DOI 10.1016/j.antiviral.2010.10.007
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   International Committee on Taxonomy of Viruses, 2019, VIR TAX 2019 REL
   Ishida Y, 2014, WORLD J HEPATOL, V6, P870, DOI 10.4254/wjh.v6.i12.870
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lee JW, 2017, J AGR FOOD CHEM, V65, P4472, DOI 10.1021/acs.jafc.7b00923
   Lipson SM, 2017, FOOD ENVIRON VIROL, V9, P434, DOI 10.1007/s12560-017-9299-z
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   Pujol CA, 2012, INT J BIOL MACROMOL, V51, P412, DOI 10.1016/j.ijbiomac.2012.05.028
   Spindola KCW, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0537-z
   Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945
   Terlizzi ME, 2016, ANTIVIR RES, V132, P154, DOI 10.1016/j.antiviral.2016.06.006
   Tsukuda S, 2017, HEPATOLOGY, V65, P1104, DOI 10.1002/hep.28952
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wiggins K, 2018, MED VET ENTOMOL, V32, P436, DOI 10.1111/mve.12322
   WU X, 2017, GASTROENTEROLOGY, V17, DOI DOI 10.1053/J.GASTRO.2017.10.041
NR 32
TC 2
Z9 2
U1 3
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD AUG
PY 2019
VL 168
BP 76
EP 81
DI 10.1016/j.antiviral.2019.05.008
PG 6
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA IR6PU
UT WOS:000481562000009
PM 31125633
DA 2020-09-29
ER

PT J
AU Herrera, KMS
   da Silva, FK
   de Oliveira, ME
   de Paiva, MC
   Soares, AC
   Ferreira, JMS
AF Silva Herrera, Karina Marjorie
   da Silva, Fernanda Kelen
   de Oliveira, Michael Eder
   de Paiva, Magna Cristina
   Soares, Adriana Cristina
   Siqueira Ferreira, Jaqueline Maria
TI First report of polymyxin B activity in Klebsiella pneumoniae biofilm
SO JOURNAL OF CHEMOTHERAPY
LA English
DT Article
DE Antibacterial; Biofilm; Klebsiella pneumoniae; Polymyxin B; Polysorbate
   80
ID SUSCEPTIBILITY; RESISTANT; DRUG; ENTEROBACTERIACEAE; POLYSORBATE-80;
   ANTIBACTERIAL; COLISTIN
AB Considering the clinical importance of biofilm in medical devices and chronic infections, this study aimed to investigate the action of polymyxin B on Klebsiella pneumoniae (K. pneumoniae) biofilm. The experiments were performed using a biofilm formation assay and the interaction of polysorbate 80 was explored. Both inhibition of biofilm formation and reduction of pre-formed biofilm occurred in a concentration-dependent manner with inhibition as high as 56 and 64%, and reduction of pre-formed biofilm as high as 70 and 66%, with and without polysorbate, respectively. The addition of polysorbate enhances the biofilm reduction, but more studies are needed to elucidate this mechanism. Our findings reveal, for the first time, polymyxin B as a potential agent for the treatment of K. pneumoniae biofilm, a current challenge for clinical practice.
C1 [Silva Herrera, Karina Marjorie; da Silva, Fernanda Kelen; de Oliveira, Michael Eder; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [de Paiva, Magna Cristina] Univ Fed Sao Joao del Rei UFSJ, Lab Diagnost Lab & Microbiol Clin, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Soares, Adriana Cristina] Univ Fed Sao Joao del Rei UFSJ, Lab Farmacol, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
RP Herrera, KMS (corresponding author), Univ Fed Sao Joao del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
EM kmsherrera@gmail.com
OI PAIVA, MAGNA/0000-0001-9375-7261; Herrera, Karina Marjorie
   Silva/0000-0002-1259-9087
FU Universidade Federal de Sao Joao del-Rei; Conselho Nacional de
   Desenvolvimento Cientifico and Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de
   Amparo a Pesquisa do estado deMinas Gerais (FAPEMIG)Minas Gerais State
   Research Foundation (FAPEMIG)
FX We would like to thank Universidade Federal de Sao Joao del-Rei,
   Conselho Nacional de Desenvolvimento Cientifico and Tecnologico (CNPq),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and
   Fundacao de Amparo a Pesquisa do estado deMinas Gerais (FAPEMIG).
CR Andrade LN, 2014, J CLIN MICROBIOL, V52, P2530, DOI 10.1128/JCM.00088-14
   Bhattacharya M, 2015, EXPERT REV ANTI-INFE, V13, P1499, DOI 10.1586/14787210.2015.1100533
   Boev C, 2017, CRIT CARE NURS CLIN, V29, P51, DOI 10.1016/j.cnc.2016.09.012
   Mendes CAC, 2009, REV ASSOC MED BRAS, V55, P752, DOI 10.1590/S0104-42302009000600023
   Dosler S, 2016, J CHEMOTHERAPY, V28, P95, DOI 10.1179/1973947815Y.0000000004
   Humphries RM, 2015, PHARMACOTHERAPY, V35, P22, DOI 10.1002/phar.1505
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Malinowski AM, 2017, DIAGN MICR INFEC DIS, V87, P154, DOI 10.1016/j.diagmicrobio.2016.11.008
   Naparstek L, 2014, J ANTIMICROB CHEMOTH, V69, P1027, DOI 10.1093/jac/dkt487
   O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437
   Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0
   Sader HS, 2012, DIAGN MICR INFEC DIS, V74, P412, DOI 10.1016/j.diagmicrobio.2012.08.025
   Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067
   Silva A, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw036
   Sloup RE, 2016, BIOFOULING, V32, P1131, DOI 10.1080/08927014.2016.1230849
   Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16407
   The European Committee on Antimicrobial Susceptibility Testing, 2018, BREAKPOINT TABLES IN
   van Duin D, 2013, DIAGN MICR INFEC DIS, V75, P115, DOI 10.1016/j.diagmicrobio.2012.11.009
   Vasoo S, 2017, J CLIN MICROBIOL, V55, P2573, DOI [10.1128/JCM.00888-17, 10.1128/jcm.00888-17]
NR 19
TC 2
Z9 3
U1 1
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1120-009X
EI 1973-9478
J9 J CHEMOTHERAPY
JI J. Chemother.
PD APR 3
PY 2019
VL 31
IS 3
BP 127
EP 131
DI 10.1080/1120009X.2018.1558751
PG 5
WC Oncology; Infectious Diseases; Pathology; Pharmacology & Pharmacy
SC Oncology; Infectious Diseases; Pathology; Pharmacology & Pharmacy
GA HZ4LQ
UT WOS:000468819700003
PM 30661470
DA 2020-09-29
ER

PT J
AU Lima, WG
   Alves-Nascimento, LA
   Andrade, JT
   Vieira, L
   Ribeiro, RIMD
   Thome, RG
   dos Santos, HB
   Ferreira, JMS
   Soares, AC
AF Lima, William Gustavo
   Alves-Nascimento, Lidia Anita
   Andrade, Jessica Tauany
   Vieira, Leticia
   Maciel de Azambuja Ribeiro, Rosy Iara
   Thome, Ralph Gruppi
   dos Santos, Helio Batista
   Siqueira Ferreira, Jaqueline Maria
   Soares, Adriana Cristina
TI Are the Statins promising antifungal agents against invasive
   candidiasis?
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Candida albicans; Biofilm; Yeast-to-hyphal transition; Synergism;
   Fluvastatin; Intra-abdominal candidiasis
ID INFECTIOUS-DISEASES-SOCIETY; SIMVASTATIN; DRUG; ANTIBACTERIAL;
   EPIDEMIOLOGY; MECHANISMS; SYNERGISM; ALBICANS; THERAPY; UPDATE
AB The medical importance of intra-abdominal candidiasis (IAC) contrasts with the limited number of pharmacological treatment options available and the increasing rate of resistance to antifungal drugs. Thus, the repositioning of compounds in clinical use can contribute to the broadening of treatment possibilities for this infection. Statins, a class of drugs used to reduce cardiovascular event risk, have shown antiparasitic, antibacterial, and antiviral activities; however, their antifungal effects remain poorly studied. In this context, the present study aimed to elucidate the antifungal potential of six statins in vitro, as well as to evaluate the therapeutic use of fluvastatin in a mouse model of IAC. The biological effects of statins were evaluated against Candida spp., through the determination of the minimum inhibitory concentration (MIC). For the statins that showed activity, the fungicidal concentration, toxicity/selectivity, synergism with azoles and polyenes, pheno-typic effects, and activity against virulence factors were also determined. Atorvastatin, rosuvastatin and fluvastatin were highly active, especially against C. albicans (MIC < 1-128 mu g.mL(-1)) and C. glabrata (MIC 32-64 mu g.mL(-1)). Fluvastatin and atorvastatin were selective for C. albicans in baby hamster kidney (BHK) cells. Moreover, all active statins in the antifungal assay showed high selectivity for fungal cells over bacteria. The combination of atorvastatin, rosuvastatin, and fluvastatin with azoles was associated with a synergistic effect. Active statins do not act on the fungal membrane or wall, but instead stimulate farnesol-dependent pathogenicity factors such as yeast-to-hyphal transition and biofilm generation. Fluvastatin treatment was evaluated in a mouse model of IAC, showing stimulation of the extra-hepatic dissemination of C. albicans but improvements in renal, splenic, and hepatic histological aspects. In conclusion, statins have potent antifungal activity in vitro, but the therapeutic effect in vivo is restricted to their anti-inflammatory activity.
C1 [Lima, William Gustavo; Alves-Nascimento, Lidia Anita; Andrade, Jessica Tauany; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Lima, William Gustavo; Vieira, Leticia; dos Santos, Helio Batista; Soares, Adriana Cristina] Univ Fed Sao Joao Rei UFSJ, Lab Farmacol Dor & Inflamacao, Campus Ctr Oeste Dona Lindu, BR-35501293 Divinopolis, MG, Brazil.
   [Maciel de Azambuja Ribeiro, Rosy Iara] Univ Fed Sao Joao Rei UFSJ, Lab Patol Expt, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Vieira, Leticia; Thome, Ralph Gruppi] Univ Fed Sao Joao Rei UFSJ, Lab Processamento Tecidos, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
RP Lima, WG (corresponding author), Univ Fed Sao Joao Rei UFSJ, Lab Farmacol Dor & Inflamacao, Campus Ctr Oeste Dona Lindu, BR-35501293 Divinopolis, MG, Brazil.
EM williamgustavofarmacia@hotmail.com
RI Thome, Ralph G/M-7997-2018; Lima, William G/C-9258-2018; Ribeiro,
   Rosy/O-8831-2019; Ribeiro, Rosy Iara Maciel Azambuja/C-6073-2014
OI Thome, Ralph G/0000-0002-1779-5036; Lima, William G/0000-0001-8946-9363;
   Ribeiro, Rosy/0000-0002-7374-4743; Ribeiro, Rosy Iara Maciel
   Azambuja/0000-0002-7374-4743
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
FX We thank the teachers Ph.D. Sussana Johann (Department of Microbiology,
   Federal University of Minas Gerais, Belo Horizonte, Brazil) and Ph.D.
   Magna Cristina Paiva (Laboratory of Diagnosis and Clinical Microbiology,
   Federal University of Sao Joao del-rei, Divinopolis, Brazil), as well as
   to the Laboratory Biocentro Analises Clinicas Ltda. (Divinopolis,
   Brazil) for kindly providing the clinical isolates used in this study.
   We also thank teacher Ph.D. Marcelo Gonzaga de Araujo (Laboratory of
   Pain and Inflammation Pharmacology, Federal University of Sao Joao
   Del-rei, Divinopolis, Brazil) for providing the Ergosterol used in
   phenotypic studies. W.G.L. is grateful to FAPEMIG for the M.Sc.
   scholarship.
CR Allen SC, 2017, J PHARMACOL EXP THER, V362, P319, DOI 10.1124/jpet.117.242081
   Andrade JT, 2018, J ANTIBIOT, V71, P702, DOI 10.1038/s41429-018-0048-9
   [Anonymous], 2009, 109935 ISO
   Arpaci OT, 2002, FARMACO, V57, P175, DOI 10.1016/S0014-827X(01)01143-0
   Barko PC, 2018, J VET INTERN MED, V32, P9, DOI 10.1111/jvim.14875
   Bassetti M, 2015, INTENS CARE MED, V41, P1601, DOI 10.1007/s00134-015-3866-2
   Bergman P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024394
   Bhandari N., 2014, INT SCH RES NOTICES, V2014
   Cabral ME, 2013, REV IBEROAM MICOL, V30, P31, DOI 10.1016/j.riam.2012.09.006
   Carvalho RS, 2018, S AFR J BOT, V114, P181, DOI 10.1016/j.sajb.2017.11.010
   Centers for Disease Control and Prevention (CDC), 2017, CAND
   Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A
   CLSI, 2012, METH DIL ANT SUSC TE
   de Ruiter J, 2009, INFECTION, V37, P522, DOI 10.1007/s15010-009-8249-6
   Dimopoulos G, 2017, MINERVA ANESTESIOL, V83, P1126, DOI 10.23736/S0375-9393.17.11528-2
   Dinesh N, 2015, PARASITOL RES, V114, P3873, DOI 10.1007/s00436-015-4618-5
   Dormoi J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-189
   Goncalves T. P. R., 2018, ANTIFUNGAL ANTIBACTE, V9, P1
   Heeney DD, 2018, CURR OPIN BIOTECH, V49, P140, DOI 10.1016/j.copbio.2017.08.004
   Jin YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073706
   Kaushik N, 2015, PRIMARY CARE, V42, P501, DOI 10.1016/j.pop.2015.08.004
   Klepser M, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.08.005
   Kollef M, 2012, CLIN INFECT DIS, V54, P1739, DOI 10.1093/cid/cis305
   Lange PT, 2016, J VIROL, V90, P3342, DOI 10.1128/JVI.02277-15
   Lima WG, 2018, J PHARM NEGAT RESULT, V9, P27, DOI 10.4103/jpnr.JPNR_11_17
   do Couto FMM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2130-8
   Maseda E, 2016, REV IBEROAM MICOL, V33, P196, DOI 10.1016/j.riam.2016.02.003
   Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913
   Mbaveng AT, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1645-8
   McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903
   Menezes EA, 2012, REV INST MED TROP SP, V54, P197, DOI 10.1590/S0036-46652012000400003
   Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00
   Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897
   Brilhante RSN, 2015, BRAZ J INFECT DIS, V19, P459, DOI 10.1016/j.bjid.2015.06.001
   Nyilasi I, 2010, FEMS MICROBIOL LETT, V307, P175, DOI 10.1111/j.1574-6968.2010.01972.x
   Pappas PC, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.26
   Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933
   Peman J, 2017, REV IBEROAM MICOL, V34, P130, DOI 10.1016/j.riam.2016.12.001
   Reddy CS, 2009, CHEM PHARM BULL, V57, P685, DOI 10.1248/cpb.57.685
   Revie NM, 2018, CURR OPIN MICROBIOL, V45, P70, DOI 10.1016/j.mib.2018.02.005
   Rosch JW, 2010, J CLIN INVEST, V120, P627, DOI 10.1172/JCI39843
   Shrivastava-Ranjan P, 2018, MBIO, V9, DOI [10.1128/mBio.00660-18, 10.1128/mbio.00660-18]
   Silva RR, 2012, MEM I OSWALDO CRUZ, V107, P513, DOI 10.1590/S0074-02762012000400012
   Stylianou M, 2014, ANTIMICROB AGENTS CH, V58, P1055, DOI 10.1128/AAC.01087-13
   Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819
   Tan SK, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00218
   Tashiro M, 2012, MED MYCOL, V50, P353, DOI 10.3109/13693786.2011.610037
   Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16407
   Theuretzbacher Ursula, 2009, Future Microbiol, V4, P1243, DOI 10.2217/fmb.09.97
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Vallabhaneni Snigdha, 2015, Open Forum Infect Dis, V2, pofv163, DOI 10.1093/ofid/ofv163
   Vergidis P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153247
NR 52
TC 7
Z9 7
U1 2
U2 3
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD MAR
PY 2019
VL 111
BP 270
EP 281
DI 10.1016/j.biopha.2018.12.076
PG 12
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA HL5AK
UT WOS:000458737800030
PM 30590315
OA Other Gold
DA 2020-09-29
ER

PT J
AU Lima, WG
   dos Santos, FJ
   Soares, AC
   Macias, FA
   Molinillo, JMG
   Ferreira, JMS
   de Siqueira, JM
AF Lima, William Gustavo
   dos Santos, Flavio Jose
   Soares, Adriana Cristina
   Macias, Francisco A.
   Molinillo, Jose M. G.
   Siqueira Ferreira, Jaqueline Maria
   de Siqueira, Joao Maximo
TI Synthesis and antimicrobial activity of some benzoxazinoids derivatives
   of 2-nitrophenol and 3-hydroxy-2-nitropyridine
SO SYNTHETIC COMMUNICATIONS
LA English
DT Article
DE Benzoxazinones; pyridoxazinones; antifungal activity; antibacterial
   activity; cytotoxicity; chemo-informatics
AB Benzoxazinoids (BXs), alkaloids frequently found in Gramineae species, are natural defensives that can potentially be exploited to the development of novel antimicrobial agents. Here, BXs analogs were synthesized from 2-nitrophenol (benzoxazinone series) and 3-hydroxy-2-nitropyridine (pyridoxazinone series) and tested against fungal and bacteria of medical interest. The starting materials were submitted to adequate nucleophilic substitution in order to functionalize of analogs, followed by a reductive cyclization catalyzed by palladium on carbon. Next, the biological assays showed that pyridoxazinone serie has a good antibacterial activity, especially against Enterococcus faecalis (Minimum inhibitory concentration-MIC: 7.8-15.6 mu g.mL(-1)) and Acinetobacter baumannii (MIC 31.25-125 mu g.mL(-1)). Antifungal activity, in turn, was related to compound 2e which showed a MIC of 62.5 mu g.mL(-1) against Candida albicans, Candida glabrata, and Candida tropicalis. All analogs complied with Lipinski's rules and were predicted to have a low toxicity.
   [GRAPHICS]
C1 [Lima, William Gustavo; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, Divinopolis, Brazil.
   [dos Santos, Flavio Jose; de Siqueira, Joao Maximo] Univ Fed Sao Joao del Rei, Lab Farmacognosia & Quim Prod Nat, Campus Ctr Oeste Dona Lindu, BR-35501293 Divinopolis, MG, Brazil.
   [Soares, Adriana Cristina] Univ Fed Sao Joao del Rei, Lab Farmacol Dor & Inflamacao, Campus Ctr Oeste Dona Lindu, Divinopolis, Brazil.
   [Macias, Francisco A.; Molinillo, Jose M. G.] Univ Cadiz, Sch Sci, Inst Biomol INBIO, Allelopathy Grp,Dept Organ Chem, Puerto Real, Spain.
RP Lima, WG (corresponding author), Univ Fed Sao Joao del Rei, Lab Farmacognosia & Quim Prod Nat, Campus Ctr Oeste Dona Lindu, BR-35501293 Divinopolis, MG, Brazil.
EM williamgustavofarmacia@hotmail.com
RI Lima, William G/C-9258-2018; Molinillo, Jose Maria Gonzalez/B-9373-2013
OI Lima, William G/0000-0001-8946-9363; Molinillo, Jose Maria
   Gonzalez/0000-0002-7844-9401; maximo de siqueira,
   joao/0000-0002-2854-9383
FU Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES)CAPES
   [2833-2011]
FX This work was supported by the Coordenacao de Aperfeicoamento de Pessoal
   do Nivel Superior (CAPES) under Grant 2833-2011.
CR Adhikari KB, 2015, MOL NUTR FOOD RES, V59, P1324, DOI 10.1002/mnfr.201400717
   Bakera B, 2015, J APPL GENET, V56, P287, DOI 10.1007/s13353-015-0271-z
   Carvalho RS, 2018, S AFR J BOT, V114, P181, DOI 10.1016/j.sajb.2017.11.010
   Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A
   CLSI, 2012, METH DIL ANT SUSC TE
   de Oliveira GT, 2018, NAT PROD RES, V32, P723, DOI 10.1080/14786419.2017.1335727
   Leeson P, 2012, NATURE, V481, P455, DOI 10.1038/481455a
   Lima WG, 2018, J PHARM NEGAT RESULT, V9, P27, DOI 10.4103/jpnr.JPNR_11_17
   Lima WG, 2018, EUR J CLIN MICROBIOL, V37, P1009, DOI 10.1007/s10096-018-3223-9
   Lyu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep27258
   Macias FA, 2006, J AGR FOOD CHEM, V54, P9843, DOI 10.1021/jf062709g
   Moloney MG, 2016, TRENDS PHARMACOL SCI, V37, P689, DOI 10.1016/j.tips.2016.05.001
   Oliveira LG, 2018, WATER SCI TECHNOL, P108, DOI 10.2166/wst.2018.091
   Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j
   Wong SSW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085836
   Wouters FC, 2016, J BRAZIL CHEM SOC, V27, P1379, DOI 10.5935/0103-5053.20160177
NR 16
TC 2
Z9 2
U1 1
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0039-7911
EI 1532-2432
J9 SYNTHETIC COMMUN
JI Synth. Commun.
PD JAN 17
PY 2019
VL 49
IS 2
BP 286
EP 296
DI 10.1080/00397911.2018.1554146
PG 11
WC Chemistry, Organic
SC Chemistry
GA HK2IL
UT WOS:000457733600011
DA 2020-09-29
ER

PT J
AU Herrera, KMS
   Ferreira, LS
   Braga, AV
   Souza, JP
   Andrade, JT
   Soares, AC
   Soares, LF
   Chagas, RCR
   Ferreira, JMS
AF Herrera, Karina M. S.
   Ferreira, Lorena S.
   Braga, Alysson, V
   Souza, Juliano P.
   Andrade, Jessica T.
   Soares, Adriana C.
   Soares, Luis F.
   Chagas, Rafael C. R.
   Ferreira, Jaqueline M. S.
TI Synthesis, characterization and antimicrobial activity of Cr (III), Co
   (II) and Ni (II) complexes with 2-thiazoline-2-tiol derivative ligands
   against bacteria and yeasts of clinical importance
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE 1,2-bis (2-thiazolin-2-isulfanyl) ethane; antimicrobial activity;
   hidrotris (2-mercaptothiazolyl) borate; complexes
ID THIOUREA DERIVATIVES; METAL-COMPLEXES; NICKEL; DFT
AB Four novel Cr (III), Co (II) and Ni (II) complexes with 2-thiazoline-2-tiol derivative ligands were synthesized and characterized using elemental, physiochemical, and spectroscopy analytical methods. The results showed the formation of ligands coordinated by sulfur atoms of the C = S bond to the L1 ligand and by the sulfur atom of the C-S bond and/or nitrogen of the intra C-ring bond of the L2 ligand. The activity of the complexes against Gram-negative, Grain-positive bacteria and yeasts of clinical importance was evaluated by broth microdilution method. The best result was obtained to L2-Ni compound against E. cloacae (Minimal Inhibitory Concentration (MIC) = 62.5 mu g/mL). Additionally, the compounds showed anti-Candida activity (MX values ranging from 250 to 500 mu g/mL), except the L1-Cr that was not active against any tested microorganism.
C1 [Herrera, Karina M. S.; Braga, Alysson, V; Souza, Juliano P.; Andrade, Jessica T.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao Del Rei, Lab Microbiol Med, UFSJ, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
   [Ferreira, Lorena S.; Soares, Luis F.; Chagas, Rafael C. R.] Univ Fed Sao Joao Del Rei, Lab Compostos Bioativos & Catalit, UFSJ, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
   [Soares, Adriana C.] Univ Fed Sao Joao Del Rei, Lab Farmacol Dor & Inflamacao, UFSJ, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
RP Herrera, KMS (corresponding author), Univ Fed Sao Joao Del Rei, Lab Microbiol Med, UFSJ, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
EM kmsherrera@gmail.com
OI Herrera, Karina Marjorie Silva/0000-0002-1259-9087
FU Conselho Nacional de Desenvolvimento Cientifico Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Universidade
   Federal de Sao Joao Del-Rei (UFSJ)
FX The authors are grateful to Conselho Nacional de Desenvolvimento
   Cientifico Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado
   de Minas Gerais (FAPEMIG) and Universidade Federal de Sao Joao Del-Rei
   (UFSJ) for financial support.
CR Alaghaz ANMA, 2013, J MOL STRUCT, V1035, P383, DOI 10.1016/j.molstruc.2012.11.030
   Allochio JF, 2016, J BRAZIL CHEM SOC, V27, P2127, DOI 10.5935/0103-5053.20160104
   ANDRADE JT, 2018, J ANTIBIOT, V1, P1
   Arslan H, 2009, MOLECULES, V14, P519, DOI 10.3390/molecules14010519
   Bernalte-Garcia A, 2006, POLYHEDRON, V25, P1399, DOI 10.1016/j.poly.2005.09.028
   Bouchoucha A, 2014, INORG CHIM ACTA, V418, P187, DOI 10.1016/j.ica.2014.04.016
   Cetin A, 2006, DALTON T, P1006, DOI 10.1039/b516558j
   Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A
   CLSI, 2012, METH DIL ANT SUSC TE
   Netto AVD, 2008, QUIM NOVA, V31, P1208
   Denny BJ, 2005, MED PRIN PRACT, V14, P377, DOI 10.1159/000088108
   Eweis M, 2006, INT J BIOL MACROMOL, V38, P1, DOI 10.1016/j.ijbiomac.2005.12.009
   FARIAS RF, 2009, QUIMICA COORDENACAO
   GEARY WJ, 1971, COORDIN CHEM REV, V7, P81, DOI 10.1016/S0010-8545(00)80009-0
   Gwaram NS, 2012, MOLECULES, V17, P5952, DOI 10.3390/molecules17055952
   Jungwirth U, 2011, ANTIOXID REDOX SIGN, V15, P1085, DOI 10.1089/ars.2010.3663
   Konstantinovic SS, 2003, J SERB CHEM SOC, V68, P641, DOI 10.2298/JSC0309641K
   Li Y, 2013, INORG CHEM COMMUN, V34, P4, DOI 10.1016/j.inoche.2013.04.028
   Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098
   Lyu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep27258
   Moellering RC, 2011, INT J ANTIMICROB AG, V37, P2, DOI 10.1016/j.ijantimicag.2010.08.018
   Muneera MS, 2016, J PHOTOCH PHOTOBIO B, V163, P57, DOI 10.1016/j.jphotobiol.2016.08.010
   Pahontu E, 2017, MOLECULES, V22, DOI 10.3390/molecules22040650
   Patel MN, 2014, SPECTROCHIM ACTA A, V127, P261, DOI 10.1016/j.saa.2014.02.053
   Rabie UM, 2011, SPECTROCHIM ACTA A, V78, P512, DOI 10.1016/j.saa.2010.11.019
   Ramos MAS, 2016, INT J MOL SCI, V17, P1
   ROMANHOLI LKS, 2005, THESIS
   Scorciapino MA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030542
   Shawish HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100933
   SILVERSTEIN RM, 1998, IDENTIFICACAO ESPECT, P460
   Soares LF, 2004, J BRAZIL CHEM SOC, V15, P695, DOI 10.1590/S0103-50532004000500014
   Sulekh Chandra, 2014, Journal of Chemical and Pharmaceutical Research, V6, P44
   Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16407
   Vinuelas-Zahinos E, 2011, EUR J MED CHEM, V46, P150, DOI 10.1016/j.ejmech.2010.10.030
   Wang W., 2012, INT J ORG CHEM, V2012, P117, DOI DOI 10.4236/ijoc.2012.22018
   Wong SSW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085836
   Zhang JA, 2011, INORG CHIM ACTA, V374, P269, DOI 10.1016/j.ica.2011.02.073
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PY 2019
VL 91
IS 4
AR e20181077
DI 10.1590/0001-376520181077
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KK8WI
UT WOS:000513016500001
OA DOAJ Gold
DA 2020-09-29
ER

PT J
AU Santos, FRS
   Andrade, JT
   Sousa, CDF
   Fernandes, JS
   Carmo, LF
   Araujo, MGF
   Ferreira, JMS
   Villar, JAFP
AF Santos, Felipe R. S.
   Andrade, Jessica T.
   Sousa, Carla D. F.
   Fernandes, Joice S.
   Carmo, Lucas F.
   Araujo, Marcelo G. F.
   Ferreira, Jaqueline M. S.
   Villar, Jose A. F. P.
TI Synthesis and Evaluation of the in vitro Antimicrobial Activity of
   Triazoles, Morpholines and Thiosemicarbazones
SO MEDICINAL CHEMISTRY
LA English
DT Article
DE Antifungal; antibacterial; Bacterial resistance; triazoles; morpholines;
   thiosemicarbazones
ID NOSOCOMIAL INFECTIONS; BIOLOGICAL EVALUATION; ANTIFUNGAL ACTIVITY;
   DERIVATIVES; COMPLEXES; DESIGN; RESISTANCE; ANTIBACTERIAL; CYTOTOXICITY;
   ANTIOXIDANT
AB Background: Microbial infections is a global public health problem. The aim of this work was to synthesize and evaluate the antimicrobial activity of novel triazoles, morpholines and thiosemicarbazones.
   Methods: Compounds were synthesized using 2,4-Dihydroxyacetophenone and 4-hydroxybenzaldehyde as starting materials. The antimicrobial activity of these compounds against bacteria and yeast was evaluated by the broth microdilution method.
   Results: The proposed route for synthesis gave high to moderate yields, moreover these compounds were successfully characterized by H-1 NMR, C-13 NMR and LC-MS. Antimicrobial testing indicated that the thiosemicarbazone and morphine derivatives had the best antimicrobial activity against the microorganisms tested with minimum inhibitory concentrations (MIC) between 0.29 and 5.30 mu M. Thiosemicarbazone derivative (12) was able to inhibit the growth of C. tropicalis, with minimum fungicidal concentration (MFC) of 0.55 mu M. In addition, this compound was active against E. coli, S. aureus and S. epidermidis, with MIC values ranging from 0.29 to 1.11 mu M. Moreover, the morpholine derivative (15) had an MIC value of 0.83 mu M against C. albicans and E. coli.
   Conclusion: We have efficiently synthesized a series of eleven novel triazoles, thiosemicarbazones and morpholine derivatives using 2,4-Dihydroxyacetophenone and 4-hydroxybenzaldehyde as starting materials. Thiosemicarbazone derivative (12) showed promising antifungal and antibacterial activity and these findings suggest that this compound can be used as scaffolds to design new antimicrobial drugs.
C1 [Santos, Felipe R. S.; Fernandes, Joice S.; Carmo, Lucas F.; Villar, Jose A. F. P.] Univ Fed Sao Joao del Rei, Lab Sintese Organ & Nanoestruturas, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, Brazil.
   [Andrade, Jessica T.; Sousa, Carla D. F.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao del Rei, Lab Microbiol, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, Brazil.
   [Araujo, Marcelo G. F.] Univ Fed Sao Joao del Rei, Lab Farmacol, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, Brazil.
RP Villar, JAFP (corresponding author), Univ Fed Sao Joao del Rei, Campus Ctr Oeste Dona Lindu,POB 35501-296, Divinopolis, Brazil.
EM zevillar@ufsj.edu.br
RI Villar, Jose Augusto Ferreira Perez/AAB-5849-2019; Santos, Felipe
   RS/J-3062-2017; DA SILVA SANTOS, FELIPE ROCHA/AAX-9240-2020; Villar,
   Jose Augusto F. P. Ferreira Perez/V-4142-2018
OI Villar, Jose Augusto Ferreira Perez/0000-0003-1580-0644; Santos, Felipe
   RS/0000-0002-8392-1467; DA SILVA SANTOS, FELIPE
   ROCHA/0000-0002-8392-1467; Villar, Jose Augusto F. P. Ferreira
   Perez/0000-0003-1580-0644
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior)CAPES
FX The authors thank the Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and CAPES (Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior) for financial support.
CR Andrade JT, 2018, J ANTIBIOT, V71, P702, DOI 10.1038/s41429-018-0048-9
   Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A
   CLSI, 2012, METH DIL ANT SUSC TE
   Cooper SR, 1941, ORG SYNTH, V21, P103
   da Silva GD, 2012, MOLECULES, V17, P10331, DOI 10.3390/molecules170910331
   Rosenthal VD, 2016, AM J INFECT CONTROL, V44, P1495, DOI 10.1016/j.ajic.2016.08.007
   Dhahagani K, 2014, SPECTROCHIM ACTA A, V117, P87, DOI 10.1016/j.saa.2013.07.101
   Duarte MCT, 2005, J ETHNOPHARMACOL, V97, P305, DOI 10.1016/j.jep.2004.11.016
   Ertan-Bolelli T, 2016, MED CHEM RES, V25, P553, DOI 10.1007/s00044-015-1499-1
   Gales AC, 2011, J ANTIMICROB CHEMOTH, V66, P2070, DOI 10.1093/jac/dkr239
   Golkar Z, 2014, J INFECT DEV COUNTR, V8, P129, DOI 10.3855/jidc.3573
   Gould IM, 2013, VIRULENCE, V4, P185, DOI 10.4161/viru.22507
   Guo ZY, 2014, CARBOHYD POLYM, V99, P469, DOI 10.1016/j.carbpol.2013.08.044
   Haribabu J, 2016, J MOL STRUCT, V1110, P185, DOI 10.1016/j.molstruc.2016.01.044
   Ilies DC, 2014, POLYHEDRON, V81, P123, DOI 10.1016/j.poly.2014.05.074
   Kant R, 2016, EUR J MED CHEM, V124, P218, DOI 10.1016/j.ejmech.2016.08.031
   Karad SC, 2016, EUR J MED CHEM, V112, P270, DOI 10.1016/j.ejmech.2016.02.016
   Karad SC, 2014, EUR J MED CHEM, V84, P51, DOI 10.1016/j.ejmech.2014.07.008
   Kaushik CP, 2014, MED CHEM RES, V23, P2995, DOI 10.1007/s00044-013-0882-z
   Khan HA, 2017, ASIAN PAC J TROP BIO, V7, P478, DOI 10.1016/j.apjtb.2017.01.019
   Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0
   Kumar K, 2014, EUR J MED CHEM, V86, P113, DOI 10.1016/j.ejmech.2014.08.053
   Kumbhare RM, 2014, MED CHEM RES, V23, P4404, DOI 10.1007/s00044-014-1006-0
   Ladopoulou EM, 2015, BIOORGAN MED CHEM, V23, P7015, DOI 10.1016/j.bmc.2015.09.034
   Lemke TL, 2008, FOYES PRINCIPLES MED
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Liu J, 2008, BIOORGAN MED CHEM, V16, P1096, DOI 10.1016/j.bmc.2007.10.102
   Marchi E, 2015, MICROBIOL RES, V170, P184, DOI 10.1016/j.micres.2014.07.001
   Marra AR, 2011, J CLIN MICROBIOL, V49, P1866, DOI 10.1128/JCM.00376-11
   Matesanz AI, 2016, INORG CHIM ACTA, V445, P62, DOI 10.1016/j.ica.2016.02.027
   Mbaveng AT, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1645-8
   Mir F, 2014, EUR J MED CHEM, V76, P274, DOI 10.1016/j.ejmech.2014.02.017
   Oliveira MTA, 2016, SAUDI J BIOL SCI, V23, P34, DOI 10.1016/j.sjbs.2015.02.001
   Pandiarajan D, 2013, INORG CHEM COMMUN, V33, P33, DOI 10.1016/j.inoche.2013.03.032
   Parrilha GL, 2011, EUR J MED CHEM, V46, P1473, DOI 10.1016/j.ejmech.2011.01.041
   Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10
   Ramdass A, 2013, INORG CHEM COMMUN, V35, P186, DOI 10.1016/j.inoche.2013.06.024
   Regiel-Futyra A, 2017, COORDIN CHEM REV, V351, P76, DOI 10.1016/j.ccr.2017.05.005
   Rodriguez-Arguelles MC, 2009, J INORG BIOCHEM, V103, P35, DOI 10.1016/j.jinorgbio.2008.08.015
   Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j
   Schelenz S, 2007, J ANTIMICROB CHEMOTH, V61, pI31, DOI 10.1093/jac/dkm430
   Senwar KR, 2015, EUR J MED CHEM, V102, P413, DOI 10.1016/j.ejmech.2015.08.017
   Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x
   Smelcerovic A, 2013, FOOD CHEM TOXICOL, V55, P493, DOI 10.1016/j.fct.2013.01.052
   Souza MA, 2013, MEM I OSWALDO CRUZ, V108, P342, DOI 10.1590/S0074-02762013000300013
   Stefani C, 2015, J INORG BIOCHEM, V152, P20, DOI 10.1016/j.jinorgbio.2015.08.010
   STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041
   Teinkela JEM, 2017, S AFR J BOT, V111, P302, DOI 10.1016/j.sajb.2017.03.026
   Tenorio RP, 2005, QUIM NOVA, V28, P1030, DOI 10.1590/S0100-40422005000600018
   Trubiano JA, 2015, ANAEST INTENS CARE M, V16, P598, DOI 10.1016/j.mpaic.2015.09.010
   World Health Organization, LIST BACT WHICH NEW
   World Health Organization, ANT RES GLOB REP SUR
   Zheng J, 2017, PROCESS BIOCHEM, V62, P91, DOI 10.1016/j.procbio.2017.07.004
NR 53
TC 1
Z9 1
U1 1
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4064
EI 1875-6638
J9 MED CHEM
JI Med. Chem.
PY 2019
VL 15
IS 1
BP 38
EP 50
DI 10.2174/1573406414666180730111954
PG 13
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HL0TW
UT WOS:000458408000006
PM 30058497
DA 2020-09-29
ER

PT J
AU Andrade, JT
   Santos, FRS
   Lima, WG
   Sousa, CDF
   Oliveira, LSFM
   Ribeiro, RIMA
   Gomes, AJPS
   Araujo, MGF
   Villar, JAFP
   Ferreira, JMS
AF Andrade, Jessica T.
   Santos, Felipe R. S.
   Lima, William G.
   Sousa, Carla D. F.
   Oliveira, Lohanna S. F. M.
   Ribeiro, Rosy I. M. A.
   Gomes, Ana J. P. S.
   Araujo, Marcelo G. F.
   Villar, Jose A. F. P.
   Ferreira, Jaqueline M. S.
TI Design, synthesis, biological activity and structure-activity
   relationship studies of chalcone derivatives as potential anti-Candida
   agents
SO JOURNAL OF ANTIBIOTICS
LA English
DT Article
ID ANTIFUNGAL EVALUATION; MECHANISM; ANTIBACTERIAL; DISCOVERY; ANALOGS;
   SERIES
AB Vulvovaginal candidiasis (VVC) affects millions of women around the world every year. Candida albicans is the most frequently isolated pathogen in women and its rapid ability to develop resistance to first and second line therapies has boosted the search for new and effective antifungal agents. In this study, we show the in vitro anti-Candida activity of fifteen synthetic chalcone analogs and their antifungal potential in an in vivo model of VVC. Chalcone 12 showed potent antifungal effects, being able to inhibit the growth of Candida spp. at a concentration of 15.6 mu g mL(-1). In addition, mechanism of action studies have indicated the ergosterol fungal membrane as the target of this compound. Despite a considerable antifungal activity, the chalcone 12 showed high cytotoxicity in kidney cells lineages. Moreover, this compound was able to reduce Candida-associated virulence, impairing yeast-hyphal transition in C. albicans. An in vivo model of VVC showed that chalcone 12 significantly reduces the fungal load. Taken together, these findings showed that the chalcone 12 is a potent anti-Candida agent in vitro beyond of contribute to improve the fungal infection in a model of CVV. However, it showed low selectivity and high toxicity, suggesting molecular modifications to minimize these proprieties.
C1 [Andrade, Jessica T.; Santos, Felipe R. S.; Lima, William G.; Sousa, Carla D. F.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Santos, Felipe R. S.; Villar, Jose A. F. P.] Univ Fed Sao Joao del Rei UFSJ, Lab Sintese Organ & Nanoestruturas, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Oliveira, Lohanna S. F. M.; Ribeiro, Rosy I. M. A.] Univ Fed Sao Joao del Rei UFSJ, Lab Patol Expt, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Gomes, Ana J. P. S.] Univ Fed Sao Joao del Rei UFSJ, Lab Desenvolvimento Farmacotecn, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Araujo, Marcelo G. F.] Univ Fed Sao Joao del Rei UFSJ, Lab Farmacol, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
RI Santos, Felipe RS/J-3062-2017; Ribeiro, Rosy Iara Maciel
   Azambuja/C-6073-2014; Lima, William G/C-9258-2018; Ribeiro,
   Rosy/O-8831-2019; Villar, Jose Augusto Ferreira Perez/AAB-5849-2019;
   Villar, Jose Augusto F. P. Ferreira Perez/V-4142-2018; DA SILVA SANTOS,
   FELIPE ROCHA/AAX-9240-2020
OI Santos, Felipe RS/0000-0002-8392-1467; Ribeiro, Rosy Iara Maciel
   Azambuja/0000-0002-7374-4743; Lima, William G/0000-0001-8946-9363;
   Ribeiro, Rosy/0000-0002-7374-4743; Villar, Jose Augusto Ferreira
   Perez/0000-0003-1580-0644; Villar, Jose Augusto F. P. Ferreira
   Perez/0000-0003-1580-0644; DA SILVA SANTOS, FELIPE
   ROCHA/0000-0002-8392-1467; GOMES, ANA/0000-0003-4563-2194
FU Universidade Federal de Sao Joao del-Rei; Conselho Nacional de
   Desenvolvimento Cientifico and Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de
   Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)Minas Gerais State
   Research Foundation (FAPEMIG); UFSJ; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG)
FX We would like to thank Universidade Federal de Sao Joao del-Rei,
   Conselho Nacional de Desenvolvimento Cientifico and Tecnologico (CNPq),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and
   Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG) by
   financial support. JTA and WGL are grateful to UFSJ and FAPEMIG for a
   fellowship, respectively.
CR Ahmad A, 2009, EUR J OBSTET GYN R B, V144, P68, DOI 10.1016/j.ejogrb.2008.12.020
   Allochio JF, 2016, J BRAZIL CHEM SOC, V27, P2127, DOI 10.5935/0103-5053.20160104
   [Anonymous], 2008, M27A3 CLSI
   Araujo MGF, 2013, MED MYCOL, V1, P1
   Batovska D, 2007, EUR J MED CHEM, V42, P87, DOI 10.1016/j.ejmech.2006.08.012
   Carrara M, 2010, MYCOPATHOLOGIA, V1, P1
   Cleveland AA, 2012, CLIN INFECT DIS, V55, P1352, DOI 10.1093/cid/cis697
   Diaz-Tielas C, 2016, PLANTA DANINHA, V34, P607, DOI 10.1590/S0100-83582016340300022
   Eccleston GM, 2002, ENCY PHARM TECHNOLOG, V2, P1060
   Escalante A, 2008, J NAT PROD, V71, P1720, DOI 10.1021/np070660i
   Evangelista FCG, 2017, MED CHEM RES, V26, P27, DOI 10.1007/s00044-016-1705-9
   Guo ZY, 2014, CARBOHYD POLYM, V99, P469, DOI 10.1016/j.carbpol.2013.08.044
   Hameed A, 2016, BIOORG CHEM, V65, P175, DOI 10.1016/j.bioorg.2016.02.008
   Hu YM, 2016, ANTIMICROB AGENTS CH, V60, P4820, DOI 10.1128/AAC.00800-16
   Kant R, 2016, EUR J MED CHEM, V113, P34, DOI 10.1016/j.ejmech.2016.02.041
   Karad SC, 2016, EUR J MED CHEM, V112, P270, DOI 10.1016/j.ejmech.2016.02.016
   Konduru NK, 2013, EUR J MED CHEM, V59, P23, DOI 10.1016/j.ejmech.2012.09.004
   Krcmery Vladimir, 2007, Recent Pat Antiinfect Drug Discov, V2, P182, DOI 10.2174/157489107782497317
   Lee YT, 2014, MOLECULES, V19, P641, DOI 10.3390/molecules19010641
   Leeson P, 2012, NATURE, V481, P455, DOI 10.1038/481455a
   Lima WG, 2017, J PHARM NEGAT RESULT, V8, P1
   Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098
   Lopez SN, 2001, BIOORGAN MED CHEM, V9, P1999, DOI 10.1016/S0968-0896(01)00116-X
   Maurya IK, 2013, BBA-GEN SUBJECTS, V1830, P5193, DOI 10.1016/j.bbagen.2013.07.016
   Messier C, 2011, PHYTOMEDICINE, V18, P380, DOI 10.1016/j.phymed.2011.01.013
   Nobrega HN, 2013, TIME KILL REV I A LU, V72, P226
   Olowe OA, 2014, EUR J MICROBIOL IMMU, V4, P193, DOI 10.1556/EUJMI-D-14-00027
   Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933
   Passalacqua TG, 2015, BIOORG MED CHEM LETT, V25, P3564, DOI 10.1016/j.bmcl.2015.06.085
   Perfect JR, 2017, NAT REV DRUG DISCOV, V12, P1
   Ramos MAS, 2016, INT J MOL SCI, V17, P1
   Sahu NK, 2012, CURR MED CHEM, V19, P209
   Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j
   Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x
   Sivakumar PM, 2009, CHEM BIOL DRUG DES, V74, P68, DOI 10.1111/j.1747-0285.2009.00828.x
   Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9
   Soper DE, 2007, BEREK NOVAKS GYNECOL, P1017
   Souza MA, 2013, MEM I OSWALDO CRUZ, V108, P342, DOI 10.1590/S0074-02762013000300013
   STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041
   Ventolini G, 2006, CLIN MICROBIOL NEWSL, V28, P15
   Wei ZY, 2016, BIOORG MED CHEM LETT, V26, P5920, DOI 10.1016/j.bmcl.2016.11.001
   Wong SSW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085836
   Yadav M, 2016, J APPL CHEM-USSR, V5, P136
   Yano J, 2011, JOVE-J VIS EXP, V58, P1
   Zenger K, 2015, TOXICOLOGY, V336, P26, DOI 10.1016/j.tox.2015.07.012
   Zore GB, 2011, PHYTOMEDICINE, V18, P1181, DOI 10.1016/j.phymed.2011.03.008
NR 46
TC 11
Z9 11
U1 0
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0021-8820
EI 1881-1469
J9 J ANTIBIOT
JI J. Antibiot.
PD AUG
PY 2018
VL 71
IS 8
BP 702
EP 712
DI 10.1038/s41429-018-0048-9
PG 11
WC Biotechnology & Applied Microbiology; Immunology; Microbiology;
   Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Immunology; Microbiology;
   Pharmacology & Pharmacy
GA GO4YW
UT WOS:000440025100003
PM 29674635
DA 2020-09-29
ER

PT J
AU Assis, IB
   da Rocha, EMM
   Guimaraes, DSM
   Pereira, GAD
   Pereira, FP
   Ferreira, JMS
   Barreto, EO
AF Assis, Isabela Bacelar
   Mauricio da Rocha, Eliana Maria
   Martins Guimaraes, Daniel Silqueira
   do Nascimento Pereira, Glaecia Aparecida
   Pereira, Fabiana Paula
   Siqueira Ferreira, Jaqueline Maria
   Barreto, Emiliano O.
TI Evaluation of Biological Activity, Toxicity, and Phytochemical Content
   of Bowdichia virgilioides (Fabaceae) Aqueous Extract
SO PHARMACOGNOSY MAGAZINE
LA English
DT Article
DE Antimalarial; antimicrobial; biological activity; Bowdichia virgilioides
ID RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMALARIAL-DRUG DISCOVERY;
   MEDICINAL-PLANTS; BOWDICHIA-VIRGILIOIDES; PLASMODIUM-FALCIPARUM;
   MALARIA; MICE; EPIDEMIOLOGY; CONSTITUENTS; DERIVATIVES
AB Background: Antibiotic resistance is a worldwide problem that poses a serious threat to human health, limiting the therapeutic options for bacterial infections. The spread of falciparum-resistant malaria is also concerning, making the patient treatment an extremely difficult task. Those facts have heightened the interest to find alternate options to treat infections caused by drug-resistant microorganisms. Objective: Considering the importance of the development of new substances with antibacterial and antimalarial properties, the present study aimed to investigate the activity of the aqueous extract of stem bark of Bowdichia virgilioides (AEBv). This plant is commonly used in Brazilian folk medicine to treat a wide range of illnesses, including signs and symptoms associated with malaria. Materials and Methods: The AEBv was assayed for toxicity against two cell lines and Artemia saline larvae. in vitro activity of the extract was screened against a panel of Gram-positive and Gram-negative bacteria, a chloroquine-resistant (W2) and a chloroquine-sensitive (3D7) Plasmodium falciparum strains. The extract was also tested as antimalarial in vivo against Plasmodium berghei. Results: The AEBv presented no significant toxicity and was found to exert in vitro growth inhibitory effect against the tested bacterial species. The lowest minimal inhibitory concentration was reported for Staphylococcus aureus (0.125 mg/ml) followed by Staphylococcus epidermidis and Staphylococcus saprophyticus (0.50 mg/ml). B. virgilioides extract showed weak in vitro antimalarial activity against P falciparum. A preliminary phytochemical analysis revealed the presence of flavonoids, phenolic groups, terpenoids, saponins, and tannins and the absence of alkaloids. Conclusion: The AEBv showed promising activity against Gram-positive microorganisms.
C1 [Assis, Isabela Bacelar; Mauricio da Rocha, Eliana Maria; Martins Guimaraes, Daniel Silqueira; Pereira, Fabiana Paula; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Cent West Campus, Divinopolis, MG, Brazil.
   [do Nascimento Pereira, Glaecia Aparecida] Oswaldo Cruz Fdn FIOCRUZ, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Barreto, Emiliano O.] Univ Fed Alagoas, Lab Cell Biol, Maceio, Brazil.
RP da Rocha, EMM (corresponding author), Univ Fed Sao Joao del Rei, Lab Parasitol, BR-35501296 Divinopolis, MG, Brazil.
EM eliana.rocha@pq.cnpq.br
RI Barreto, Emiliano/T-3671-2019; Alves, Claudio N/P-8973-2014; Barreto,
   Emiliano/J-2109-2012
OI Barreto, Emiliano/0000-0002-4956-5075; Alves, Claudio
   N/0000-0001-6576-4229; Barreto, Emiliano/0000-0002-4956-5075
CR Agra IKR, 2013, AN ACAD BRAS CIENC, V85, P945, DOI 10.1590/S0001-37652013005000049
   Aguiar ACC, 2012, MEM I OSWALDO CRUZ, V107, P831, DOI 10.1590/S0074-02762012000700001
   Ashvin Godghate, 2013, Rasayan Journal of Chemistry, V6, P107
   Barros WM, 2010, AN ACAD BRAS CIENC, V82, P609, DOI 10.1590/S0001-37652010000300008
   Bezivin C, 2003, PHYTOMEDICINE, V10, P499, DOI 10.1078/094471103322331458
   Borenfreund E., 1988, IN VITRO, V2, P1
   Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590
   Brandao GC, 2010, PHYTOMEDICINE, V17, P926, DOI 10.1016/j.phymed.2010.03.004
   Brandao HN, 2010, QUIM NOVA, V33, P1359, DOI 10.1590/S0100-40422010000600026
   Brandao LF, 2008, REV ELETRON FARM, V5, P8
   Brandao LF, 2008, REV ELETRON FARM, V5, P8
   BRANDAO MGL, 1992, J ETHNOPHARMACOL, V36, P175, DOI 10.1016/0378-8741(92)90018-M
   Carneiro MR, 2013, FRONTEIRAS, V2, p[28, 55]
   Carneiro MR, 2013, FRONTEIRAS, V2, P55
   CARVALHO LH, 1991, BRAZ J MED BIOL RES, V24, P1113
   Clinical and Laboratory Standards Institute (CLSI), 2012, M7A6 CLSI
   Deciga-Campos M, 2007, J ETHNOPHARMACOL, V110, P334, DOI 10.1016/j.jep.2006.10.001
   Deharo E, 2001, J ETHNOPHARMACOL, V77, P91, DOI 10.1016/S0378-8741(01)00270-7
   Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710
   Souza RKD, 2014, J ETHNOPHARMACOL, V157, P99, DOI 10.1016/j.jep.2014.09.001
   Falajiki YF, 2015, PARASITOLOGY, V142, P849, DOI 10.1017/S0031182015000062
   Ferro JN, 2016, J MED PLANTS RES, V10, P575
   Gales AC, 2009, BRAZ J INFECT DIS, V13, P90, DOI 10.1590/S1413-86702009000200004
   GESSLER MC, 1994, ACTA TROP, V56, P65, DOI 10.1016/0001-706X(94)90041-8
   Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3
   Hutzinger O, 1989, ECOINFORMA 1 REV P 1, P199
   Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367
   Krettli AU, 2009, EXPERT OPIN DRUG DIS, V4, P95, DOI 10.1517/17530050802678127
   Li Y, 2012, BIOORGAN MED CHEM, V20, P4316, DOI 10.1016/j.bmc.2012.05.050
   Lv ZH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00549
   Maciel Renata L., 2006, Rev. bras. farmacogn., V16, P99, DOI 10.1590/S0102-695X2006000100018
   MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236
   Napralert, 2012, BOWD VIRG
   Nguyen TH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00090
   Noedl H, 2002, EXP PARASITOL, V102, P157, DOI 10.1016/S0014-4894(03)00051-1
   Oliveira AB, 2009, AN ACAD BRAS CIENC, V81, P715, DOI 10.1590/S0001-37652009000400011
   Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]
   Pradel G, 2010, CURR MOL MED, V10, P335, DOI 10.2174/156652410791065273
   Rasoanaivo P, 1999, J ETHNOPHARMACOL, V64, P117, DOI 10.1016/S0378-8741(98)00114-7
   Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452
   Saraiva ME, 2015, J ETHNOPHARMACOL, V171, P141, DOI 10.1016/j.jep.2015.05.034
   Saxena S, 2003, CURR SCI INDIA, V85, P1314
   Secretaria de Atencao a Saude. Departamento de Atencao Basica, 2012, CAD AT BAS A, V31, P156
   Seo KA, 2008, CHEM-BIOL INTERACT, V174, P141, DOI 10.1016/j.cbi.2008.06.003
   Silva JP, 2010, J MED FOOD, V13, P348, DOI 10.1089/jmf.2009.0099
   Tan KR, 2011, AM J TROP MED HYG, V84, P517, DOI 10.4269/ajtmh.2011.10-0285
   Thomazzi SM, 2010, J ETHNOPHARMACOL, V127, P451, DOI 10.1016/j.jep.2009.10.014
   TORRENEGRA R, 1989, PHYTOCHEMISTRY, V28, P2219, DOI 10.1016/S0031-9422(00)97953-6
   TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840
   Vieira LFD, 2013, REV BRAS FARMACOGN, V23, P680, DOI 10.1590/S0102-695X2013005000044
   Wagner H., 1996, PLANT DRUG ANAL THIN, DOI 10.1007/978-3-642-00574-9
   World Health Organization, 2016, WHOHTMGMP201611
   World Health Organization, 2013, ANT RES CONS LIF SAV
   Zhang BC, 2011, BIOCHEMISTRY-US, V50, P3570, DOI 10.1021/bi200113y
NR 56
TC 0
Z9 0
U1 1
U2 4
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0973-1296
EI 0976-4062
J9 PHARMACOGN MAG
JI Pharmacogn. Mag.
PD JUL-SEP
PY 2018
VL 14
IS 57
SU 2
BP S403
EP S408
DI 10.4103/pm.pm_273_17
PG 6
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GT8FI
UT WOS:000444771700018
DA 2020-09-29
ER

PT J
AU Pereira, ACTD
   de Siqueira, TR
   Prado, AAD
   da Silva, CAV
   Moraes, TDS
   Aleixo, AA
   de Magalhaes, JC
   de Souza, GAP
   Drumond, BP
   Ferreira, GP
   Silva, BDM
   Magalhaes, CLD
   Santos, LL
   Ferreira, JMS
   Malaquias, LCC
   Coelho, LFL
AF Toledo da Cunha Pereira, Anna Carolina
   de Siqueira, Tatiane Ribeiro
   de Oliveira Prado, Andressa Anunciacao
   Veiga da Silva, Camila Almeida
   Silva Moraes, Thais de Fatima
   Aleixo, Alan Alex
   de Magalhaes, Jose Carlos
   Pires de Souza, Gabriel Augusto
   Drumond, Betania Paiva
   Ferreira, Gustavo Portela
   Silva, Breno de Mello
   de Brito Magalhaes, Cintia Lopes
   Santos, Luciana Lara
   Siqueira Ferreira, Jaqueline Maria
   Cotta Malaquias, Luiz Cosme
   Leomil Coelho, Luiz Felipe
TI High prevalence of dengue antibodies and the arginine variant of the Fc
   gamma RIIa polymorphism in asymptomatic individuals in a population of
   Minas Gerais State, Southeast Brazil
SO IMMUNOGENETICS
LA English
DT Article
DE Dengue; FcR gamma RIIa; Asymptomatic patients; SNPs
ID SINGLE AMINO-ACID; RECEPTOR-II; ASSOCIATION; INFECTION; PROMOTER;
   ADMIXTURE
AB Dengue is the most prevalent arthropod-borne viral illness in humans worldwide. Single-nucleotide polymorphisms (SNPs) in genes involved in the immune response, such as dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), IgG Fc receptor II-A (Fc gamma RIIa), vitamin D receptor (VDR), and tumor necrosis factor alpha (TNF-alpha), were previously reported to be associated with susceptibility to dengue disease in different human populations. Therefore, due to the relevant association of host immune and genetic status with disease susceptibility/severity of dengue, this work aims to verify the frequency of anti-dengue virus antibodies and some dengue-associated risk SNPs in a population in Minas Gerais State, Southeast Brazil. A total of 1560 individuals were genotyped for polymorphisms in DC-SIGN (rs4804803), Fc gamma RIIa (rs1801274), VDR (rs7975232), and TNF-alpha (rs1800629). The presence of anti-dengue antibodies (IgM and/or IgG) in these samples was also assayed. Anti-dengue antibodies were detected at an overall frequency of 16.86%, indicating a virus infection in asymptomatic individuals. The genotypic frequencies of all SNPs studied did not differ between the asymptomatic and control groups. Regarding the allelic frequencies of the four SNPs analyzed, a higher frequency was detected of the G allele of Fc gamma RIIa/rs1801274 in the asymptomatic individuals when compared to that in the control group (p = 0.03). Therefore, the results showed a high prevalence of asymptomatic individuals in Minas Gerais State, with a potential association between the presence of the G allele of Fc gamma RIIa/rs1801274 and protection against symptomatic disease.
C1 [Toledo da Cunha Pereira, Anna Carolina; Ferreira, Gustavo Portela] Univ Fed Piaui, Lab Bioquim & Biol Microrganismos & Plantas, Campus Minist Reis Velloso, Parnaiba, PI, Brazil.
   [de Siqueira, Tatiane Ribeiro; Drumond, Betania Paiva] Univ Fed Juiz de Fora, Lab Virol, Dept Parasitol Microbiol & Imunol, Juiz De Fora, Brazil.
   [de Oliveira Prado, Andressa Anunciacao; Veiga da Silva, Camila Almeida; Pires de Souza, Gabriel Augusto; Cotta Malaquias, Luiz Cosme; Leomil Coelho, Luiz Felipe] Univ Fed Alfenas, Lab Vacinas, Inst Ciencias Biomed, Rua Gabriel Monteiro,700 Ctr, BR-37130000 Alfenas, MG, Brazil.
   [Silva Moraes, Thais de Fatima; de Magalhaes, Jose Carlos] Univ Fed Sao Joao del Rei, Dept Quim Biotecnol & Engn Bioproc, Ouro Branco, MG, Brazil.
   [Aleixo, Alan Alex; Santos, Luciana Lara] Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, Brazil.
   [Drumond, Betania Paiva] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Silva, Breno de Mello; de Brito Magalhaes, Cintia Lopes] Univ Fed Ouro Preto, NUPEB, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil.
   [Silva, Breno de Mello; de Brito Magalhaes, Cintia Lopes] Univ Fed Ouro Preto, Dept Ciencias Biol, Ouro Preto, MG, Brazil.
RP Coelho, LFL (corresponding author), Univ Fed Alfenas, Lab Vacinas, Inst Ciencias Biomed, Rua Gabriel Monteiro,700 Ctr, BR-37130000 Alfenas, MG, Brazil.
EM coelho@unifal-mg.edu.br
RI Coelho, Luiz FL/G-5853-2012; silva, breno/W-5122-2018; Santos, Luciana
   L/C-9688-2013; DE SOUZA, GABRIEL/AAL-6131-2020
OI silva, breno/0000-0003-2472-8111; Santos, Luciana L/0000-0001-6186-4062;
   DE SOUZA, GABRIEL/0000-0002-2479-4429; Coelho, Luiz
   Felipe/0000-0003-4289-384X
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [404005/2012-8]; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [CBB APQ 01703/14]; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG); CAPESCAPES
FX The authors thank CNPq (grant number 404005/2012-8) and FAPEMIG (grant
   number CBB APQ 01703/14) for the financial support. A.A.O.P. received
   fellowships from CNPq. C.A.V.S., T.F.S.M., and A.A.A. received
   fellowships from FAPEMIG. T.R.S received fellowships from CAPES.
CR Alagarasu K, 2013, INFECT GENET EVOL, V17, P239, DOI 10.1016/j.meegid.2013.04.024
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carabali M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1058-x
   CLARK MR, 1991, EUR J IMMUNOL, V21, P1911, DOI 10.1002/eji.1830210820
   de Oliveira LF, 2014, VIRAL IMMUNOL, V27, P245, DOI 10.1089/vim.2013.0119
   Dettogni RS, 2015, HUM IMMUNOL, V76, P717, DOI 10.1016/j.humimm.2015.09.026
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   Gao XY, 2011, GENET EPIDEMIOL, V35, P154, DOI 10.1002/gepi.20563
   Garcia G, 2010, AM J TROP MED HYG, V82, P1153, DOI 10.4269/ajtmh.2010.09-0353
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2015, F1000RES, V4, pF1000, DOI DOI 10.12688/F1000RESEARCH.7024.1
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Jamjoom GA, 2016, SEROEPIDEMIOLOGY ASY, P5, DOI [10.4137/VRT.S34187, DOI 10.4137/VRT.S34187]
   Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102
   Malavige GN, 2013, J CLIN VIROL, V58, P605, DOI 10.1016/j.jcv.2013.10.023
   dos Santos ACM, 2017, IMMUNOL INVEST, V46, P201, DOI 10.1080/08820139.2016.1248560
   Mohsin SN, 2015, AM J TROP MED HYG, V93, P691, DOI 10.4269/ajtmh.15-0199
   Noecker CA, 2014, ACTA TROP, V138, P15, DOI 10.1016/j.actatropica.2014.05.021
   Ranjit S, 2011, PEDIATR CRIT CARE ME, V12, P90, DOI 10.1097/PCC.0b013e3181e911a7
   Garcia-Trejo AR, 2011, ACTA TROP, V120, P67, DOI 10.1016/j.actatropica.2011.06.002
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Santos HC, 2016, EUR J HUM GENET, V24, P725, DOI 10.1038/ejhg.2015.187
   Suarez-Kurtz G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00191
   Taioli E, 2004, MUTAT RES-REV MUTAT, V567, P63, DOI 10.1016/j.mrrev.2004.06.001
   Vikram K, 2016, ACTA TROP, V153, P21, DOI 10.1016/j.actatropica.2015.09.025
   Wang L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000934
   WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338
   Yacoub Sophie, 2016, F1000Res, V5, DOI 10.12688/f1000research.6233.1
   Yacoub S, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0147-9
NR 33
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0093-7711
EI 1432-1211
J9 IMMUNOGENETICS
JI Immunogenetics
PD JUN
PY 2018
VL 70
IS 6
BP 355
EP 362
DI 10.1007/s00251-017-1046-y
PG 8
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA GF4CY
UT WOS:000431909100002
PM 29164277
DA 2020-09-29
ER

PT J
AU De Assis, FV
   Siqueira, FL
   Goncalves, IE
   Lacerda, RP
   Nascimento, RA
   Araujo, SG
   Andrade, JT
   Herrera, KMS
   Lima, LARS
   Ferreira, JMS
AF De Assis, Felipe V.
   Siqueira, Flavia L.
   Goncalves, Isabela E.
   Lacerda, Rafael P.
   Nascimento, Rafaela A.
   Araujo, Sthefane G.
   Andrade, Jessica T.
   Herrera, Karina M. S.
   Lima, Luciana A. R. S.
   Ferreira, Jaqueline M. S.
TI Antibacterial activity of Lamiaceae plant extracts in clinical isolates
   of multidrug-resistant bacteria
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE antibacterial; clinical isolates; Lamiaceae extracts;
   multidrug-resistant
ID OLEIFERA PEEL EXTRACT; MEDICINAL-PLANTS; ANTIMICROBIAL ACTIVITY;
   ESSENTIAL OIL; NANOPARTICLES
AB The antibacterial activity of plant extracts of the Lamiaceae family was evaluated against clinical isolates of multi-resistant Gram-negative bacteria by broth microdilution technique. Promising results were obtained considering that all extracts were active for at least two bacterial species with MIC ranging from 0.5 to 2.0 mg/mL.
C1 [De Assis, Felipe V.; Siqueira, Flavia L.; Goncalves, Isabela E.; Lacerda, Rafael P.; Nascimento, Rafaela A.; Andrade, Jessica T.; Herrera, Karina M. S.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao del Rei UFSJ, Lab Microbiol, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
   [Araujo, Sthefane G.; Lima, Luciana A. R. S.] Univ Fed Sao Joao del Rei UFSJ, Lab Fitoquim, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao del Rei UFSJ, Lab Microbiol, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
RI , Luciana/T-8434-2019
OI , Luciana/0000-0002-4130-0304; Herrera, Karina Marjorie
   Silva/0000-0002-1259-9087
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Universidade
   Federal de Sao Joao del-Rei (UFSJ)
FX The authors are grateful to Prof. Dr. Alexandre Salino for his
   assistance in plant identification and to Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG) and Universidade Federal de
   Sao Joao del-Rei (UFSJ) for the financial support.
CR Araujo SG, 2014, BRAZ J MICROBIOL, V45, P1341, DOI 10.1590/S1517-83822014000400026
   CATANEO C., 2010, THESIS
   CLSI, 2012, M07A9 CLSI
   Dinesh M, 2017, J PHOTOCH PHOTOBIO B, V167, P64, DOI 10.1016/j.jphotobiol.2016.12.012
   Duarte MCT, 2005, J ETHNOPHARMACOL, V97, P305, DOI 10.1016/j.jep.2004.11.016
   Fabry W, 1998, J ETHNOPHARMACOL, V60, P79, DOI 10.1016/S0378-8741(97)00128-1
   GALVAO RFF, 2013, EVID-BASED COMPL ALT, V2013, P1
   Gemechu A, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-291
   Haida K. S., 2007, Arquivos de Ciencias da Saude da UNIPAR, V11, P185
   Holetz FB, 2002, MEM I OSWALDO CRUZ, V97, P1027, DOI 10.1590/S0074-02762002000700017
   KOWERO EE, 2016, EUR J MED PLANT, V12, P1
   Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2
   Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098
   Madhumitha G, 2015, J SOL-GEL SCI TECHN, V73, P476, DOI 10.1007/s10971-014-3591-2
   Manivel P, 2009, J CHIL CHEM SOC, V54, P183, DOI 10.4067/S0717-97072009000200020
   Novais T. S., 2003, REV BRASILEIRA FARMA, V14, P8
   Rakholiya Kalpna, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS876
   Rios JL, 2005, J ETHNOPHARMACOL, V100, P80, DOI 10.1016/j.jep.2005.04.025
   Santoyo S, 2005, J FOOD PROTECT, V68, P790, DOI 10.4315/0362-028X-68.4.790
   Surendra TV, 2016, J PHOTOCH PHOTOBIO B, V162, P550, DOI 10.1016/j.jphotobiol.2016.07.032
   Surendra TV, 2016, J PHOTOCH PHOTOBIO B, V161, P122, DOI 10.1016/j.jphotobiol.2016.05.019
   Tekwu EM, 2012, J ETHNOPHARMACOL, V142, P265, DOI 10.1016/j.jep.2012.05.005
   Valle Demetrio L. Jr., 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P532, DOI 10.1016/j.apjtb.2015.04.005
   Veiga JVF, 2008, REV BRAS FARMACOGN, V18, P308, DOI DOI 10.1590/S0102-695X2008000200027
   Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754
   Vukovic N, 2007, EVID-BASED COMPL ALT, V4, P17, DOI 10.1093/ecam/nem108
NR 26
TC 1
Z9 1
U1 1
U2 1
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD APR-JUN
PY 2018
VL 90
IS 2
BP 1665
EP 1670
DI 10.1590/0001-3765201820160870
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ1QE
UT WOS:000435032600032
PM 29668795
OA DOAJ Gold
DA 2020-09-29
ER

PT J
AU Leonel, CA
   Lima, WG
   dos Santos, M
   Ferraz, AC
   Taranto, AG
   de Magalhes, JC
   dos Santos, LL
   Ferreira, JMS
AF Leonel, Camyla Alves
   Lima, William Gustavo
   dos Santos, Michelli
   Ferraz, Ariane Coelho
   Taranto, Alex Gutterres
   de Magalhes, Jose Carlos
   dos Santos, Luciana Lara
   Siqueira Ferreira, Jaqueline Maria
TI Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a
   systematic review of the most promising compounds
SO ARCHIVES OF VIROLOGY
LA English
DT Review
ID VITRO ANTIMICROBIAL ACTIVITY; NS3 PROTEASE; ANTIVIRAL ACTIVITY;
   DISCOVERY; DERIVATIVES; FLAVIVIRUS; PEPTIDE; DOMAIN; DETERMINANTS;
   REPLICATION
AB Dengue virus (DENV) infection can lead to a wide range of clinical manifestations, including fatal hemorrhagic complications. There is a need to find effective pharmacotherapies to treat this disease due to the lack of specific immunotherapies and antiviral drugs. That said, the DENV NS2B/NS3pro protease complex is essential in both the viral multiplication cycle and in disease pathogenesis, and is considered a promising target for new antiviral therapies. Here, we performed a systematic review to evaluate the pharmacophoric characteristics of promising compounds against NS2B/NS3pro reported in the past 10 years. Online searches in the PUBMED/MEDLINE and SCOPUS databases resulted in 165 articles. Eight studies, which evaluated 3,384,268 molecules exhibiting protease inhibition activity, were included in this review. These studies evaluated anti-dengue activity in vitro and the IC50 and EC50 values were provided. Most compounds exhibited non-competitive inhibition. Cytotoxicity was evaluated in BHK-21, Vero, and LLC-MK2 cells, and the CC50 values obtained ranged from < 1.0 to 780.5 A mu M. Several groups were associated with biological activity against dengue, including nitro, catechol, halogen and ammonium quaternaries. Thus, these groups seem to be potential pharmacophores that can be further investigated to treat dengue infections.
C1 [Leonel, Camyla Alves; Lima, William Gustavo; dos Santos, Michelli; Ferraz, Ariane Coelho; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao Del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, BR-35501293 Divinopolis, MG, Brazil.
   [dos Santos, Luciana Lara] Univ Fed Sao Joao Del Rei UFSJ, Lab Biol Mol, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Taranto, Alex Gutterres] Univ Fed So Joo Rei UFSJ, Lab Quim Farmaceut Med, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Ferraz, Ariane Coelho; de Magalhes, Jose Carlos] Univ Fed So Joo Rei UFSJ, Lab Biol Mol & Celular, Dept Quim Biotecnol & Engn Bioproc DQBIO, Campus Alto Paraopeba, Ouro Branco, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao Del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, BR-35501293 Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
RI Santos, Luciana L/C-9688-2013; Ferreira, Jaqueline/E-4630-2018; Santos,
   Michelli dos/Q-2341-2019; Lima, William G/C-9258-2018; Taranto, Alex
   G/F-8618-2012
OI Santos, Luciana L/0000-0001-6186-4062; Ferreira,
   Jaqueline/0000-0002-1779-1975; Santos, Michelli dos/0000-0003-0257-6620;
   Lima, William G/0000-0001-8946-9363; Taranto, Alex G/0000-0002-6086-1043
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [UNIVERSAL 446997/2014-5, 449984/2014-1]; Fundacao de Amparo a
   Pesquisa de Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation
   (FAPEMIG) [EDITAL APQ-00557-14]
FX This study was funded by Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq) (UNIVERSAL 446997/2014-5 and 449984/2014-1) and
   Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) (EDITAL
   APQ-00557-14).
CR Abdel-Wahab BF, 2009, EUR J MED CHEM, V44, P2632, DOI 10.1016/j.ejmech.2008.09.029
   Aguilera-Pesantes D, 2017, BIOCH BIOPHYS RES CO
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Aljofan M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-187
   Altmann KH, 2011, MOL DIVERS, V15, P383, DOI 10.1007/s11030-010-9291-0
   Balasubramanian A, 2016, ANTIVIR RES, V134, P6, DOI 10.1016/j.antiviral.2016.08.014
   BARON S, 1989, J BIOL REG HOMEOS AG, V3, P67
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bozzini T, 2013, BIOORGAN MED CHEM, V21, P7699, DOI 10.1016/j.bmc.2013.10.026
   Brycki B, 2010, POL J MICROBIOL, V59, P49, DOI 10.33073/pjm-2010-007
   Carmona-Ribeiro AM, 2013, INT J MOL SCI, V14, P9906, DOI 10.3390/ijms14059906
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chung MC, 2011, CURR PHARM DESIGN, V17, P3515
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Corona A, 2016, CHEMMEDCHEM, V11, P1709, DOI 10.1002/cmdc.201600015
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   El Sahili A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040091
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Erwin ME, 1997, DIAGN MICR INFEC DIS, V28, P93, DOI 10.1016/S0732-8893(97)00004-7
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Fauquet CM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-64
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Frecer V, 2010, J COMPUT AID MOL DES, V24, P195, DOI 10.1007/s10822-010-9326-8
   Godoi IP, 2014, BBR BIOCH BIOTECHNOL, V3, P16
   Godoi IP, 2016, J BRAZ CHEM SOC
   Guerrero JL, 2017, BIOTECHNOL BIOENG, V114, P33, DOI 10.1002/bit.26066
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hoegy F, 2010, AMINO ACIDS, V38, P1627, DOI 10.1007/s00726-009-0353-5
   Ito A, 2016, J ANTIMICROB CHEMOTH, V71, P670, DOI 10.1093/jac/dkv402
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Ivanenkov YA, 2016, CURR TOP MED CHEM, V16, P1372, DOI 10.2174/1568026616666151120113040
   Janhg J, 1974, J PHARM PHARM
   JONKMAN JHG, 1977, CLIN PHARMACOL THER, V21, P457
   Kratky M, 2013, CURR PHARM DESIGN, V19, P1343
   Kumar D, 2010, EUR J MED CHEM, V45, P2806, DOI 10.1016/j.ejmech.2010.03.002
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Li Y, 2016, J CHROMATOGR B, V1029, P95, DOI 10.1016/j.jchromb.2016.07.006
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Martin J, 2016, ACTA VIROL, V60, P3, DOI 10.4149/av_2016_01_3
   Maurin C, 2006, BIOORGAN MED CHEM, V14, P2978, DOI 10.1016/j.bmc.2005.12.039
   McDowell M, 2010, ANTIVIR RES, V87, P78, DOI 10.1016/j.antiviral.2010.04.007
   Midde NM, 2016, EXPERT OPIN INV DRUG, V25, P1189, DOI 10.1080/13543784.2016.1212837
   Muhamad M, 2010, INT J BIOL SCI, V6, P294
   Munoz-Camargo C, 2016, J ANTIBIOT, V69, P783, DOI 10.1038/ja.2016.16
   Natarajan S, 2010, GENET MOL BIOL, V33, P214, DOI 10.1590/S1415-47572010000200002
   Olivares CI, 2016, ENVIRON TOXICOL CHEM, V35, P2774, DOI 10.1002/etc.3446
   Pambudi S, 2013, BIOCHEM BIOPH RES CO, V440, P393, DOI 10.1016/j.bbrc.2013.09.078
   Pillaiyar T, 2016, CURR MED CHEM, V23, P3404, DOI 10.2174/0929867323666160510122525
   Podvinec M, 2010, J MED CHEM, V53, P1483, DOI 10.1021/jm900776m
   Purohit AK, 2012, BIOORG MED CHEM LETT, V22, P5308, DOI 10.1016/j.bmcl.2012.06.031
   Rao ZG, 2016, CHEM BIOL DRUG DES, V87, P773, DOI 10.1111/cbdd.12711
   Rodpothong P, 2012, VIRUS GENES, V44, P408, DOI 10.1007/s11262-011-0709-2
   Rothan HA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-140
   Shannon AE, 2016, PROTEIN EXPRES PURIF, V119, P124, DOI 10.1016/j.pep.2015.11.022
   Sharmin N, 2006, BANGLADESH J MICROBI, V23, P107
   Sokolova AS, 2013, BIOORGAN MED CHEM, V21, P6690, DOI 10.1016/j.bmc.2013.08.014
   Soukup O, 2016, BIOORGAN MED CHEM, V24, P841, DOI 10.1016/j.bmc.2016.01.006
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Takagi Y, 2017, BIOORG MED CHEM LETT, V27, P3586, DOI 10.1016/j.bmcl.2017.05.027
   TAYLOR DB, 1965, PHYSIOL REV, V45, P523
   Tomlinson S. M., 2009, Infectious Disorders - Drug Targets, V9, P327
   Torresi J, 2017, HUM VACC IMMUNOTHER, V13, P1059, DOI 10.1080/21645515.2016.1261770
   Tuladhar E, 2012, APPL ENVIRON MICROB, V78, P2456, DOI 10.1128/AEM.07738-11
   Vaillant A, 2016, ANTIVIR RES, V133, P32, DOI 10.1016/j.antiviral.2016.07.004
   Valle RPC, 1998, J VIROL, V72, P624, DOI 10.1128/JVI.72.1.624-632.1998
   Woestenenk E, 2017, PROTEIN EXPRES PURIF, V140, P16, DOI 10.1016/j.pep.2017.07.002
   World Health Organization (WHO), 2012, GLOB ACT PLAN CONTR, P1, DOI DOI 10.1016/S0968-8080(12)40660-7
   Wu DW, 2015, ACTA PHARMACOL SIN, V36, P1126, DOI 10.1038/aps.2015.56
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   ZHANG YM, 1988, J VIROL, V62, P3027, DOI 10.1128/JVI.62.8.3027-3031.1988
   Zu XY, 2014, ANTIVIR RES, V104, P7, DOI 10.1016/j.antiviral.2014.01.011
NR 75
TC 4
Z9 5
U1 1
U2 9
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD MAR
PY 2018
VL 163
IS 3
BP 575
EP 586
DI 10.1007/s00705-017-3641-5
PG 12
WC Virology
SC Virology
GA FW4NB
UT WOS:000425289200001
PM 29147793
DA 2020-09-29
ER

PT J
AU Cruz, WS
   Ferraz, AC
   Lima, WG
   Moraes, TFS
   Ferreira, FL
   Ferreira, JMS
   Magalhaes, CLD
   Duarte, LP
   Vieira, SA
   De Magalhaes, JC
AF Cruz, Waleska Stephanie
   Ferraz, Ariane Coelho
   Lima, William Gustavo
   Silva Moraes, Thais Fatima
   Ferreira, Fernanda Lopes
   Siqueira Ferreira, Jaqueline Maria
   De Brito Magalhaes, Cintia Lopes
   Duarte, Lucienir Pains
   Vieira Filho, Sidney Augusto
   De Magalhaes, Jose Carlos
TI Evaluation of the Activity of Tontelea micrantha Extracts against
   Bacteria, Candida and Mayaro virus
SO JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS
LA English
DT Article
DE Antimicrobial activity; branch extracts; leaf extracts
ID ANTIMICROBIAL ACTIVITY; CELASTRACEAE; ETHANOL; PLANTS; BARK
AB Objectives: This work aimed to evaluate the antibacterial, antifungal, and anti-Mayaro virus (MAYV) activity of leaf and branch extracts from Tontelea micrantha. Materials and Methods: T. micrantha extracts were prepared through the partition of the leaf and branch samples in different solvents. Then, the antibacterial and antifungal activity was assessed against bacterial pathogens and Candida sp. by the determination of the minimum inhibitory concentration (MIC) by the broth microdilution method. The activity against anti-MAYV was evaluated through the quantification of the extract concentration that promoted the protection of 50% of the cells after the viral infection. Results: The extracts of T. micrantha were inactive (MIC >500 mu g/mL) against Gram-positive, Gram-negative and Candida species at the highest concentration tested (500 mu g/mL). Anti-MAYV activity was also not detected, with SI <10, ranging from 1.2 to 3.6. Conclusion: Although it is used in traditional medicine, Leaf and branch extracts from T. micrantha did not present antimicrobial activity, which could be caused by the antagonistic effect of the compounds present in the extract.
C1 [Cruz, Waleska Stephanie; Lima, William Gustavo; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Ferraz, Ariane Coelho; De Brito Magalhaes, Cintia Lopes] Univ Fed Ouro Preto, Dept Biol Sci, Ouro Preto, MG, Brazil.
   [Silva Moraes, Thais Fatima; De Magalhaes, Jose Carlos] Univ Fed Sao Joao del Rei, Dept Chem Biotechnol & Bioproc Engn, Campus Alto Paraopeba, Ouro Branco, MG, Brazil.
   [Ferreira, Fernanda Lopes; Duarte, Lucienir Pains] Univ Fed Minas Gerais, Inst Exact Sci, Dept Chem, Belo Horizonte, MG, Brazil.
   [Vieira Filho, Sidney Augusto] Univ Fed Ouro Preto, Dept Pharm, Ouro Preto, MG, Brazil.
RP De Magalhaes, JC (corresponding author), Univ Fed Sao Joao del Rei, Rodovia Mg 443,Km 7,Campus Alto Paraopeba, Ouro Branco, MG, Brazil.
EM josecarlos@ufsj.edu.br
RI Duarte, Lucienir Pains P/J-6307-2012; vieira, Sabrina n/X-1702-2018;
   Lima, William G/C-9258-2018
OI Duarte, Lucienir Pains P/0000-0002-8885-6625; Lima, William
   G/0000-0001-8946-9363; Nizer, Waleska/0000-0002-5134-719X
FU Council for Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq);
   Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; Research Support Foundation of Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG)
FX Council for Scientific and Technological Development (CNPq),
   Coordination for the Improvement of Higher Education Personnel (CAPES),
   Research Support Foundation of Minas Gerais (FAPEMIG).
CR Abreu OA, 2017, J PHARM NEGAT RESULT, V8, P11, DOI 10.4103/0976-9234.204910
   Alvan G, 2011, DRUG RESIST UPDATE, V14, P70, DOI 10.1016/j.drup.2011.01.007
   Aminov RI, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00134
   Awouafack MD, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-289
   Bereksi M. S., 2018, Pharmacognosy Journal, V10, P507, DOI 10.5530/pj.2018.3.83
   Bezivin C, 2003, PHYTOMEDICINE, V10, P499, DOI 10.1078/094471103322331458
   Biswas D, 2016, J PHARM NEGAT RESULT, V7, P29, DOI 10.4103/0976-9234.177059
   Chen Y, 2017, FITOTERAPIA, V119, P64, DOI 10.1016/j.fitote.2017.04.003
   Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A, V28, pM27
   Clinical And Laboratory Standards Institute C, 2012, METH DIL ANT SUSC TE, V32, P1
   Dhayalan A, 2018, J PHARM BIOALLIED SC, V10, P15, DOI 10.4103/jpbs.JPBS_95_17
   Dias J.F.G., 2005, Rev. bras. farmacogn., V15, P220, DOI 10.1590/S0102-695X2005000300011
   dos Santos AE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-130
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   Kloucek P, 2007, J ETHNOPHARMACOL, V111, P427, DOI 10.1016/j.jep.2006.11.010
   Latilha SG, 2016, J PHARM NEGAT RESULT, V7, P16
   Littler Eddy, 2005, Antiviral Chemistry & Chemotherapy, V16, P155
   Mbaveng AT, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1645-8
   Mercadante-Simoes MO, 2014, AN ACAD BRAS CIENC, V86, P1167, DOI 10.1590/0001-3765201420130105
   Mercadante-Simoes MO, 2009, P 60 C NAC BOT BRAZ
   Mokoka TA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-111
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Odak JA, 2018, J ASIAN NAT PROD RES, V20, P510, DOI 10.1080/10286020.2017.1420648
   Pauw E, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-317
   Roemer T, 2014, COLD SPRING HARB PER
   Setzer MC, 2003, REV BIOL TROP, V51, P647
   Spindola KCW, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0537-z
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
NR 28
TC 2
Z9 2
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0976-9234
EI 2229-7723
J9 J PHARM NEGAT RESULT
JI J. Pharm. Negat. Results
PD JAN-DEC
PY 2018
VL 9
IS 1
BP 21
EP 26
DI 10.4103/jpnr.JPNR_8_18
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GR6RD
UT WOS:000442785300004
DA 2020-09-29
ER

PT J
AU Lima, WG
   Parreira, AG
   Nascimento, LAA
   Leonel, CA
   Andrade, JT
   Palumbo, JMC
   Soares, AC
   Granjeiro, PA
   Ferreira, JMS
AF Lima, William Gustavo
   Parreira, Adriano Guimaraes
   Alves Nascimento, Lidia Anitta
   Leonel, Camyla Alves
   Andrade, Jessica Tauany
   Campos Palumbo, Juliana Maria
   Soares, Adriana Cristina
   Granjeiro, Paulo Afonso
   Siqueira Ferreira, Jaqueline Maria
TI Absence of Antibacterial, Anti-candida, and Anti-dengue Activities of a
   Surfactin Isolated from Bacillus subtilis
SO JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS
LA English
DT Article
DE Antimicrobial activity; broth microdilution assay; cellular viability;
   surfactin; synergic effect
ID DRUG-RESISTANCE; MECHANISM; BIOSURFACTANT; FUNGAL; GROWTH; VIRUS; OIL
AB Background: Biosurfactants are biological compounds that possess many pharmacological proprieties. Among them, surfactin is one of the most active against pathogens of medical interest, such as fungi, bacteria, and enveloped viruses. Objectives: In this study, we aim to evaluate the antibacterial anti-Candida, and anti-dengue potential of a surfactin biosynthesized by Bacillus subtilis ATCC 6633. In addition, the fractional inhibitory concentration (FIC) was calculated to determine the behavior of this biosurfactant in association with antibacterial and antifungal drugs of clinical use. Materials and Methods: B. subtilis ATCC 6633 culture was maintained on nutrient agar plates, and biosurfactant production was carried out in mineral salt medium with 2% glucose. The isolated and purified surfactin was used for determination of antibacterial and antifungal effects by the broth microdilution method. A checkerboard assay was performed to determine the potential synergic effect of surfactin with gentamicin, penicillin, and nystatin. Finally, the activity against Dengue virus (DENV) was evaluated through quantification of cell viability after viral infection. Results: Although it had low cytotoxicity (CC50 > 400 mu g/mL), surfactin was inactive against Gram-negative and Gram-positive bacteria, Candida species, and DENV at the highest concentration tested (500 mu g/mL). According to FIC values, none of the antimicrobials tested showed a synergistic association with surfactin. Conclusions: Surfactin produced by B. subtilis ATCC 6633 is not a promising antimicrobial agent, and its combination with clinically available antibiotics does not lead to a synergic effect.
C1 [Lima, William Gustavo; Alves Nascimento, Lidia Anitta; Leonel, Camyla Alves; Andrade, Jessica Tauany; Campos Palumbo, Juliana Maria; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Lab Med Microbiol, Cent West Campus Dona Lindu, Divinopolis, MG, Brazil.
   [Parreira, Adriano Guimaraes; Granjeiro, Paulo Afonso] Univ Fed Sao Joao del Rei, Lab Biotechnol Proc & Macromol Purificat, Cent West Campus Dona Lindu, Divinopolis, MG, Brazil.
   [Soares, Adriana Cristina] Univ Fed Sao Joao del Rei, Lab Pharmacol Pain & Inflammat, Cent West Campus Dona Lindu, Divinopolis, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao del Rei, Lab Med Microbiol, Cent West Campus Dona Lindu, Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
RI Lima, William G/C-9258-2018; Granjeiro, Paulo Afonso/AAS-6392-2020
OI Lima, William G/0000-0001-8946-9363; Granjeiro, Paulo
   Afonso/0000-0003-0322-0861
FU Brazilian Council for Development of Science and Technology
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Minas Gerais Foundation for the Support of Science (FAPEMIG);
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
FX This study was financially supported by Brazilian Council for
   Development of Science and Technology (CNPq) and Minas Gerais Foundation
   for the Support of Science (FAPEMIG). W.G.L. thank FAPEMIG for having
   received a postgraduate scholarship.
CR Aleixo A. A., 2015, Journal of Medicinal Plants Research, V9, P741
   Budiman A., 2017, Pharmacognosy Journal, V9, P611, DOI 10.5530/pj.2017.5.97
   Bush K, 2012, REV SCI TECH OIE, V31, P43
   Carrillo C, 2003, BBA-BIOMEMBRANES, V1611, P91, DOI 10.1016/S0005-2736(03)00029-4
   Chandankere R, 2014, FUEL, V122, P140, DOI 10.1016/j.fuel.2014.01.023
   Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A, V28
   Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT
   Dugasani S, 2010, PHARMACOGN MAG, V6, P204, DOI 10.4103/0973-1296.66937
   Etchegaray A, 2008, ARCH MICROBIOL, V190, P611, DOI 10.1007/s00203-008-0409-z
   Farzaneh M, 2016, PLANT PATHOLOGY J, V32, P209, DOI 10.5423/PPJ.OA.11.2015.0250
   Hidari KIPJ, 2012, BIOCHEM BIOPH RES CO, V424, P573, DOI 10.1016/j.bbrc.2012.07.002
   Jasim B, 2016, APPL BIOCHEM BIOTECH, V179, P830, DOI 10.1007/s12010-016-2034-7
   Khan RA, 2017, INDIAN J PHARM EDUC, V51, P144, DOI 10.5530/ijper.51.1.19
   Kracht M, 1999, J ANTIBIOT, V52, P613, DOI 10.7164/antibiotics.52.613
   Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034430
   Loiseau C, 2015, APPL MICROBIOL BIOT, V99, P5083, DOI 10.1007/s00253-014-6317-z
   Ma W, 2017, J PROTEOMICS, V150, P242, DOI 10.1016/j.jprot.2016.09.014
   Mogi T, 2009, CELL MOL LIFE SCI, V66, P3821, DOI 10.1007/s00018-009-0129-9
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Roy S, 2015, PHARMACOGN RES, V7, P263, DOI 10.4103/0974-8490.157977
   Samarghandian S, 2010, PHARMACOGN MAG, V6, P309, DOI 10.4103/0973-1296.71799
   Sanguinetti M, 2015, MYCOSES, V58, P2, DOI 10.1111/myc.12330
   Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010
   Suleyman G, 2016, INFECT DIS CLIN N AM, V30, P1023, DOI 10.1016/j.idc.2016.07.008
   Theuretzbacher U, 2009, INT J ANTIMICROB AG, V34, P15, DOI 10.1016/j.ijantimicag.2009.02.005
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Uttlova P, 2016, BBA-BIOMEMBRANES, V1858, P2965, DOI 10.1016/j.bbamem.2016.09.006
   Vedaraman N, 2011, BRAZ J CHEM ENG, V28, P175, DOI 10.1590/S0104-66322011000200001
   Vollenbroich D, 1997, BIOLOGICALS, V25, P289, DOI 10.1006/biol.1997.0099
   Waclaw B, 2016, ADV EXP MED BIOL, V915, P49, DOI 10.1007/978-3-319-32189-9_5
NR 30
TC 4
Z9 4
U1 1
U2 3
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0976-9234
EI 2229-7723
J9 J PHARM NEGAT RESULT
JI J. Pharm. Negat. Results
PD JAN-DEC
PY 2018
VL 9
IS 1
BP 27
EP 32
DI 10.4103/jpnr.JPNR_11_17
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GR6RD
UT WOS:000442785300005
DA 2020-09-29
ER

PT J
AU dos Santos, M
   Santos, FRD
   Ferraz, AC
   Andrade, JT
   Herrera, KMS
   Lima, WG
   Pereira, LHS
   da Silva, MG
   Villar, JAFP
   de Magalhaes, JC
   Taranto, AG
   Santos, LLD
   Soares-Martins, JAP
   Ferreira, JMS
AF dos Santos, Michelli
   da Silva Santos, Felipe Rocha
   Ferraz, Ariane Coelho
   Andrade, Jessica Tauany
   Silva Herrera, Karina Marjorie
   Lima, William Gustavo
   Sales Pereira, Lailah Horacio
   da Silva, Marina Goulart
   Ferreira Perez Villar, Jose Augusto
   de Magalhaes, Jose Carlos
   Taranto, Alex Gutterres
   Santos, Luciana Lara dds
   Pinheiro Soares-Martins, Jamaria Adriana
   Siqueira Ferreira, Jaqueline Maria
TI Triazole-chalcones: Lack of Antibacterial, Anti-candida, and Anti-dengue
   Virus Activities
SO JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS
LA English
DT Article
DE Antibacterial; antifungal; antiviral; chalcones; cytotoxicity
ID BIOLOGICAL EVALUATION; DERIVATIVES; AGENTS; CELLS; CYTOTOXICITY; DNA
AB Background: The need to identify new antimicrobial drugs that present different mechanisms of action is urgent. The variety of biological properties of chalcones give them a potential therapeutic compounds. Chalcones' synthetic manipulations are investigated worldwide in search of more powerful and efficient drugs to several infectious diseases' treatment. Objective: The purpose of this work was to evaluate the potential antibacterial, antifungal, and anti-dengue virus (DENV) of new ten triazole chalcones. Materials and Methods: Triazole chalcones were used to determine its antibacterial activity against Gram-positive bacteria (Staphylococcus aureus and Staphylococcus epidermidis), Gram-negative bacteria (Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii, and Pseudomonas aeruginosa) species, and anti-Candida activity (Candida albicans) by the broth microdilution assay. The anti-DENV activity was evaluated by cell viability quantification after viral infection by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide colorimetric assay. Results: Although Triazole chalcones have shown a low cytotoxicity concentration (with CC50 of 47.21-192.51 mu g/mL), these compounds did not exhibit antimicrobial activity against Gram-negative and Gram-positive bacteria, C. albicans neither DENV, even in the highest concentration tested. Triazole chalcones had no activity against all tested microorganisms, except for Gram-positive S. epidermidis bacteria when a poor antimicrobial effect was observed (125 mu g/mL). Conclusion: The results suggest that triazole chalcones investigated in this study are not promising antimicrobial agents.
C1 [dos Santos, Michelli; da Silva Santos, Felipe Rocha; Andrade, Jessica Tauany; Silva Herrera, Karina Marjorie; Lima, William Gustavo; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Lab Med Microbiol, Cent West Campus Dona Lindu, Divinopolis, MG, Brazil.
   [Ferraz, Ariane Coelho; de Magalhaes, Jose Carlos] Univ Fed Sao Joao del Rei, Dept Bioproc Engn, Lab Mol & Cellular Biol, Alto Paraopeba Campus, Ouro Branco, MG, Brazil.
   [Sales Pereira, Lailah Horacio; Santos, Luciana Lara dds] Univ Fed Sao Joao del Rei, Lab Mol Biol, Cent West Campus Dona Lindu, Divinopolis, MG, Brazil.
   [da Silva, Marina Goulart; Ferreira Perez Villar, Jose Augusto] Univ Fed Sao Joao del Rei, Lab Organ Synth & Nanostruct, Cent West Campus Dona Lindu, Divinopolis, MG, Brazil.
   [Taranto, Alex Gutterres] Univ Fed Sao Joao del Rei, Lab Pharmaceut Chem, Cent West Campus Dona Lindu, Divinopolis, MG, Brazil.
   [Pinheiro Soares-Martins, Jamaria Adriana] Milwaukee Area Tech Coll, Milwaukee, WI USA.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao del Rei, Lab Med Microbiol, Cent West Campus Dona Lindu, Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
RI Lima, William G/C-9258-2018; DA SILVA SANTOS, FELIPE
   ROCHA/AAX-9240-2020; Taranto, Alex G/F-8618-2012; Santos, Michelli
   dos/Q-2341-2019; Santos, Felipe RS/J-3062-2017; Villar, Jose Augusto F.
   P. Ferreira Perez/V-4142-2018; Santos, Luciana/C-9688-2013
OI Lima, William G/0000-0001-8946-9363; DA SILVA SANTOS, FELIPE
   ROCHA/0000-0002-8392-1467; Taranto, Alex G/0000-0002-6086-1043; Santos,
   Michelli dos/0000-0003-0257-6620; Santos, Felipe RS/0000-0002-8392-1467;
   Villar, Jose Augusto F. P. Ferreira Perez/0000-0003-1580-0644; Santos,
   Luciana/0000-0001-6186-4062; Herrera, Karina Marjorie
   Silva/0000-0002-1259-9087
FU Brazilian Council for Development of Science and Technology
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Minas Gerais Foundation for the Support of Science (FAPEMIG)
FX Brazilian Council for Development of Science and Technology (CNPq) and
   Minas Gerais Foundation for the Support of Science (FAPEMIG).
CR Allochio JF, 2016, J BRAZIL CHEM SOC, V27, P2127, DOI 10.5935/0103-5053.20160104
   Aoki N, 2008, J NAT PROD, V71, P1308, DOI 10.1021/np800187f
   Ayati A, 2018, EUR J MED CHEM, V145, P404, DOI 10.1016/j.ejmech.2018.01.015
   Chu WC, 2018, EUR J MED CHEM, V143, P905, DOI 10.1016/j.ejmech.2017.12.009
   Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A, V28, pM27
   Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT
   da Silva GD, 2012, MOLECULES, V17, P10331, DOI 10.3390/molecules170910331
   Dalvie DK, 2002, CHEM RES TOXICOL, V15, P269, DOI 10.1021/tx015574b
   Evangelista FCG, 2017, MED CHEM RES, V26, P27, DOI 10.1007/s00044-016-1705-9
   Faidallah HM, 2018, EUR J MED CHEM, V143, P1524, DOI 10.1016/j.ejmech.2017.10.042
   Flechas MC, 2017, PHARMACOGN J, V10, P55
   Fong HY, 2017, PHARMACOGN MAG, V13, P607, DOI 10.4103/pm.pm_53_17
   Hidari KIPJ, 2012, BIOCHEM BIOPH RES CO, V424, P573, DOI 10.1016/j.bbrc.2012.07.002
   Israf DA, 2007, MOL IMMUNOL, V44, P673, DOI 10.1016/j.molimm.2006.04.025
   Kunthalert D, 2014, MICROBIOL IMMUNOL, V58, P581, DOI 10.1111/1348-0421.12194
   Lahtchev KL, 2008, EUR J MED CHEM, V43, P2220, DOI 10.1016/j.ejmech.2007.12.027
   Mahapatra DK, 2016, LIFE SCI, V148, P154, DOI 10.1016/j.lfs.2016.02.048
   Mahapatra DM, 2015, EUR J MED CHEM, V98, P69, DOI 10.1016/j.ejmech.2015.05.004
   Mateeva N, 2017, BIOORG MED CHEM LETT, V27, P2350, DOI 10.1016/j.bmcl.2017.04.034
   Mbaveng AT, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1645-8
   Rizvi SUF, 2012, MED CHEM RES, V21, P3741, DOI 10.1007/s00044-011-9912-x
   Roy S, 2015, PHARMACOGN RES, V7, P263, DOI 10.4103/0974-8490.157977
   Samarghandian S, 2010, PHARMACOGN MAG, V6, P309, DOI 10.4103/0973-1296.71799
   Srivarangkul P, 2018, ANTIVIR RES, V151, P27, DOI 10.1016/j.antiviral.2018.01.010
   Tajuddeen N, 2017, INT J ANTIMICROB AG, V17, P30220
   Ugur AR, 2016, PHARMACOGN MAG, V12, pS471, DOI 10.4103/0973-1296.191459
   Wei ZY, 2016, BIOORG MED CHEM LETT, V26, P5920, DOI 10.1016/j.bmcl.2016.11.001
   Yin BT, 2014, EUR J MED CHEM, V71, P148, DOI 10.1016/j.ejmech.2013.11.003
NR 28
TC 3
Z9 3
U1 0
U2 3
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0976-9234
EI 2229-7723
J9 J PHARM NEGAT RESULT
JI J. Pharm. Negat. Results
PD JAN-DEC
PY 2018
VL 9
IS 1
BP 39
EP 43
DI 10.4103/jpnr.JPNR_2_18
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GR6RD
UT WOS:000442785300007
DA 2020-09-29
ER

PT J
AU de Oliveira, GT
   Ferreira, JMS
   Lima, WG
   Alves, LF
   Duarte-Almeida, JM
   Lima, LARD
AF de Oliveira, Graziela Teixeira
   Siqueira Ferreira, Jaqueline Maria
   Lima, William Gustavo
   Alves, Lucas Ferreira
   Duarte-Almeida, Joaquim Mauricio
   Rodrigues dos Santos Lima, Luciana Alves
TI Phytochemical characterisation and bioprospection for antibacterial and
   antioxidant activities of Lippia alba Brown ex Britton & Wilson
   (Verbenaceae)
SO NATURAL PRODUCT RESEARCH
LA English
DT Article
DE Lippia alba; antibacterial activity; multidrug-resistant bacteria;
   antioxidant; flavonoid
ID ANTIMICROBIAL ACTIVITY; ESSENTIAL OIL; HERBAL TEAS; CHEMOTYPES
AB Ethanol extract and fractions obtained from fresh and dry aerial parts of Lippia alba were examined in order to determine their phytochemical composition, antioxidant capacity and antibacterial activities. The ethanol extracts and fractions exhibited an antioxidant effect by the DPPH assay, especially samples of fresh plant. HPLC analysis of the ethyl acetate fractions identified the presence of phenolic acids and flavonoids. The ethanol extract and fractions showed activity against reference and multidrug-resistant strains of Staphylococcus aureus and Enterococcus faecalis (MIC range 2000-250 mu g/mL). The hexane and dichloromethane fractions of fresh plant showed better activity against reference strains of Escherichia coli (MIC of 250 and 125 mu g/mL, respectively), but all extracts and fractions were less active against multidrug-resistant strains of all the Gram-negative species evaluated. The results showed that the extract and fractions of L alba aerial parts showed antibacterial activity, even against multidrug-resistant Gram-positive bacteria, and antioxidant effect (DPPH assay).
   [GRAPHICS]
   .
C1 [de Oliveira, Graziela Teixeira; Siqueira Ferreira, Jaqueline Maria; Lima, William Gustavo; Alves, Lucas Ferreira] Univ Fed Sao Joao Del Rei, Lab Microbiol Med, Divinopolis, Brazil.
   [de Oliveira, Graziela Teixeira; Duarte-Almeida, Joaquim Mauricio; Rodrigues dos Santos Lima, Luciana Alves] Univ Fed Sao Joao Del Rei, Lab Fitoquim, Divinopolis, Brazil.
RP Lima, LARD (corresponding author), Univ Fed Sao Joao Del Rei, Lab Fitoquim, Divinopolis, Brazil.
EM luarsantos@ufsj.edu.br
RI , Luciana/T-8434-2019; Lima, William G/C-9258-2018
OI , Luciana/0000-0002-4130-0304; Lima, William G/0000-0001-8946-9363;
   Duarte-Almeida, Joaquim/0000-0001-5737-6963
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG) [CEX APQ 01671-12];
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX This work was supported by the Fundacao de Amparo a Pesquisa do Estado
   de Minas Gerais (FAPEMIG) [grant number CEX APQ 01671-12]; CNPq.
CR Aguiar JS, 2008, REV BRAS FARMACOGN, V18, P436, DOI 10.1590/S0102-695X2008000300018
   Alfadda AA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/936486
   Ara N, 2009, Pak J Biol Sci, V12, P87, DOI 10.3923/pjbs.2009.87.90
   Barbosa FG, 2005, MAGN RESON CHEM, V43, P334, DOI 10.1002/mrc.1546
   Blanco MA, 2013, J ETHNOPHARMACOL, V149, P803, DOI 10.1016/j.jep.2013.08.007
   Chies CE, 2013, ANTIOXIDANTS-BASEL, V2, P194, DOI 10.3390/antiox2040194
   Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002
   de Oliveira GT, 2014, REV SOC BRAS MED TRO, V47, P247, DOI 10.1590/0037-8682-0008-2013
   Di Stasi LC, 2002, FITOTERAPIA, V73, P69, DOI 10.1016/S0367-326X(01)00362-8
   Figueroa-Valvere L, 2011, ELIXIR BIO TECH, V40, P5452
   GIRON LM, 1991, J ETHNOPHARMACOL, V34, P173, DOI 10.1016/0378-8741(91)90035-C
   Gomes S.V.F., 2011, ECLET QUIM, V36, P64, DOI DOI 10.1590/S0100-
   Hennebelle T, 2008, J ETHNOPHARMACOL, V116, P211, DOI 10.1016/j.jep.2007.11.044
   Hennebelle T, 2006, NAT PROD COMMUN, V1, P727
   Kapepula PM, 2017, NAT PROD RES, V31, P1940, DOI 10.1080/14786419.2016.1263844
   Karamac M, 2009, INT J MOL SCI, V10, P5485, DOI 10.3390/ijms10125485
   Loguercio Andrea Pinto, 2005, Cienc. Rural, V35, P371, DOI 10.1590/S0103-84782005000200019
   Costa DCM, 2014, J ENZYM INHIB MED CH, V29, P12, DOI 10.3109/14756366.2012.743537
   Manimozhi D. M., 2012, International Journal of Pharmaceutical and Biological Research (IJPBR), V3, P7
   Mantovani D, 2009, REV TECNOLOGICA, V18, P69
   Maynard LG, 2011, INDIAN J PHARMACOL, V43, P694, DOI 10.4103/0253-7613.89828
   O'Leary N, 2012, AM J BOT, V99, P1778, DOI 10.3732/ajb.1200123
   Ozcelik B, 2008, TROP J PHARM RES, V7, P1151
   Pandelo D, 2012, REV BRAS FARMACOGN, V22, P497, DOI 10.1590/S0102-695X2012005000013
   Pascual ME, 2001, FARMACO, V56, P501, DOI 10.1016/S0014-827X(01)01086-2
   Reis AC, 2014, AM J BOT, V101, P1002, DOI 10.3732/ajb.1400149
   Rouffet M, 2011, DALTON T, V40, P3445, DOI 10.1039/c0dt01743d
   Savage PB, 2002, FEMS MICROBIOL LETT, V217, P1
   Sousa DG, 2015, BRAZ J MED BIOL RES, V48, P697, DOI 10.1590/1414-431X20154710
   Timoteo P, 2015, FOOD CHEM, V175, P366, DOI 10.1016/j.foodchem.2014.11.129
   Vera JR, 2007, SCI TECHNICA, V33, P345
   Wagner H., 2001, PLANT DRUG ANAL THIN
NR 32
TC 6
Z9 6
U1 0
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
PY 2018
VL 32
IS 6
BP 723
EP 731
DI 10.1080/14786419.2017.1335727
PG 9
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA FY6GT
UT WOS:000426942800017
PM 28571495
DA 2020-09-29
ER

PT J
AU Carvalho, RS
   Carollo, CA
   de Magalhaes, JC
   Palumbo, JMC
   Boaretto, AG
   Sa, ICNE
   Ferraz, AC
   Lima, WG
   de Siqueira, JM
   Ferreira, JMS
AF Carvalho, R. S.
   Carollo, C. A.
   de Magalhaes, J. C.
   Palumbo, J. M. C.
   Boaretto, A. G.
   Nunes e Sa, I. C.
   Ferraz, A. C.
   Lima, W. G.
   de Siqueira, J. M.
   Ferreira, J. M. S.
TI Antibacterial and antifungal activities of phenolic compound-enriched
   ethyl acetate fraction from Cochlospermum regium (mart. Et. Schr.)
   Pilger roots: Mechanisms of action and synergism with tannin and gallic
   acid
SO SOUTH AFRICAN JOURNAL OF BOTANY
LA English
DT Article
DE Cochlospermum regium (Mart. Et. Schr.) Pilger; Antimicrobial activity;
   Catalase inhibition; Ergosterol binding; Checkerboard assay;
   Tannin-enriched fraction
ID EXTRACTS; PRODUCTS; BACTERIA; LEAVES; PLANTS
AB Cochlospermum regium is a shrub used in folk medicine to treat infection diseases. However, limited information are available regarding the antimicrobial mechanism of action, synergic effect of major phytochemical components this specie, and it antimicrobial spectrum of activity. Here, we aimed to investigate the antimicrobial activity of its ethyl acetate fraction (EtOAc) from roots together with some constituents previously isolated and commercially available, to understand the possible pharmacological interactions between these components. The EtOAc fraction of C. regium, tannin and gallic acid commercially available, alone or in combination, were assessed for antimicrobial activity against eight bacteria and five yeasts. EtOAc fraction showed a broad spectrum of antimicrobial activity and gallic acid had better antifungal activity, while tannin was active against all microorganisms tested. Antibacterial effect was induced to catalase activity inhibition. For yeast, results indicated that the EtOAc fraction and compounds gallic acid and tannic acid bind to the ergosterol of the fungal membrane. Checkerboard assay showed that the combination of EtOAc fraction with tannin result in synergic effect against six microorganisms. Thus, highlight the pharmacological use of C. regium as a tannin-enriched extract for the treatment of infectious diseases. Together, data reveals the antimicrobial potential of C. regium, proving it used in the folk medicine of Brazilian southwestern. (C) 2017 SAAB. Published by Elsevier B.V. All rights reserved.
C1 [Carvalho, R. S.; Palumbo, J. M. C.; Lima, W. G.; Ferreira, J. M. S.] Univ Fed Sao Joao Del Rei, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, 400 Sebastiao Goncalves Coelho St, BR-35501293 Divinopolis, MG, Brazil.
   [Carvalho, R. S.; de Magalhaes, J. C.; Ferraz, A. C.] Univ Fed Sao Joao Del Rei, Lab Biol Mol & Celular, Dept Quim Biotecnol & Engn Bioproc, Campus Alto Paraopeba, Ouro Branco, MG, Brazil.
   [Carollo, C. A.; Boaretto, A. G.] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Campo Grande, MS, Brazil.
   [Nunes e Sa, I. C.; de Siqueira, J. M.] Univ Fed Sao Joao Dei Rei, Lab Quim Prod Nat, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao Del Rei, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, 400 Sebastiao Goncalves Coelho St, BR-35501293 Divinopolis, MG, Brazil.
EM jaque@ufsj.edu.br
RI Ferreira, Jaqueline/E-4630-2018; Lima, William G/C-9258-2018
OI Ferreira, Jaqueline/0000-0002-1779-1975; Lima, William
   G/0000-0001-8946-9363
FU CAPES-PNPDCAPES [2833/2011]; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG)
FX The authors thank CAPES-PNPD (2833/2011), CNPq and FAPEMIG for financial
   support. JMS and CAC acknowledge CNPq for an awarded research grant.
   This work research has the Certificado de Registro no Cadastro Nacional
   de biodiversidade-20110106526.
CR Ahmad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145053
   Aleixo A. A., 2015, Journal of Medicinal Plants Research, V9, P741
   Allochio JF, 2016, J BRAZIL CHEM SOC, V27, P2127, DOI 10.5935/0103-5053.20160104
   Borges A, 2013, MICROB DRUG RESIST, V19, P256, DOI 10.1089/mdr.2012.0244
   Breda CA, 2016, NAT PRODUCT BIOPROSP, V6, P195, DOI 10.1007/s13659-016-0101-y
   Ferreira PRB, 2012, CIENC RURAL, V42, P1861, DOI 10.1590/S0103-84782012005000080
   Campoy S, 2017, BIOCHEM PHARMACOL, V133, P86, DOI 10.1016/j.bcp.2016.11.019
   Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A
   CLSI, 2012, METH DIL ANT SUSC TE
   Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564
   Da Costa G.A.F., 2015, EVID-BASED COMPL ALT, V2015, P1
   Nguyen DMC, 2013, MICROB PATHOGENESIS, V56, P8, DOI 10.1016/j.micpath.2013.01.001
   Escalante A, 2008, J NAT PROD, V71, P1720, DOI 10.1021/np070660i
   Fiori G. M. L., 2013, American Journal of Plant Sciences, V4, P2193, DOI 10.4236/ajps.2013.411272
   Fu L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4287461
   Godstime O. C., 2014, J PHARM CHEM BIOL SC, V2, P77
   Hayashi MA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00195
   Herald TJ, 2012, J SCI FOOD AGR, V92, P2326, DOI 10.1002/jsfa.5633
   Hong SB, 2016, ANN LAB MED, V36, P111, DOI 10.3343/alm.2016.36.2.111
   Inacio MC, 2016, ACTA SCI-AGRON, V38, P467, DOI 10.4025/actasciagron.v38i4.30567
   Khan A, 2011, FEMS YEAST RES, V11, P114, DOI 10.1111/j.1567-1364.2010.00697.x
   KOBAYASHI A, 1995, Z NATURFORSCH C, V50, P398
   Kunle O. F., 2012, International Journal of Biodiversity and Conservation, V4, P101, DOI 10.5897/IJBC11.163
   Li ZhongWu, 2017, Soil & Tillage Research, V166, P1, DOI 10.1016/j.still.2016.10.004
   Linhares L.D.A., 2011, 19 C IN CIENT UFPE
   Lopes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072203
   Lu J, 2016, CURR PHARM BIOTECHNO, V17, P1153, DOI 10.2174/1389201017666161022235759
   Lyu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep27258
   Masoko P, 2007, S AFR J BOT, V73, P173, DOI 10.1016/j.sajb.2006.09.010
   Megeressa M, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0803-4
   Morey AT, 2016, CURR PHARM BIOTECHNO, V17, P365, DOI 10.2174/1389201017666151223123712
   Nader T. T., 2010, Arquivos do Instituto Biologico Sao Paulo, V77, P429
   Nakbi A, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-89
   Nathan C, 2010, CELL, V140, DOI 10.1016/j.cell.2010.03.008
   Ncube B, 2012, J ETHNOPHARMACOL, V139, P81, DOI 10.1016/j.jep.2011.10.025
   Oliveira C. C. de, 1996, Fitoterapia, V67, P176
   Oroojalian F, 2010, FOOD CHEM, V120, P765, DOI 10.1016/j.foodchem.2009.11.008
   Paiva CN, 2014, ANTIOXID REDOX SIGN, V20, P1000, DOI 10.1089/ars.2013.5447
   Petrovska Biljana Bauer, 2012, Pharmacogn Rev, V6, P1, DOI 10.4103/0973-7847.95849
   Rather MA, 2013, PHYTOMEDICINE, V21, P1, DOI 10.1016/j.phymed.2013.07.015
   Rattanata N, 2016, INT J NANOMED, V11, P3347, DOI 10.2147/IJN.S109795
   Sakakibara H, 2003, J AGR FOOD CHEM, V51, P571, DOI 10.1021/jf020926l
   Sanches Andréia Cristina Conegero, 2005, Rev. Bras. Cienc. Farm., V41, P101, DOI 10.1590/S1516-93322005000100012
   Sanchez-Salgado JC, 2007, J ETHNOPHARMACOL, V109, P400, DOI 10.1016/j.jep.2006.08.008
   SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L
   Silva J.L.S.C., 2014, BMC P, V8, P1
   Solon S., 2009, REV ELETRONICA FARMA, V6, P1
   Solon S, 2012, QUIM NOVA, V35, P1169, DOI 10.1590/S0100-40422012000600019
   Teixeira OG, 2017, NAT PROD RES, V1, P1
   Trolezi R, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0183-3
   Wagner H., 2001, PLANT DRUG ANAL THIN
   Widsten P, 2014, J AGR FOOD CHEM, V62, P11146, DOI 10.1021/jf503819t
   Wong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087778
   Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046
   Zhao XL, 2014, CURR OPIN MICROBIOL, V21, P1, DOI 10.1016/j.mib.2014.06.008
NR 55
TC 19
Z9 20
U1 0
U2 34
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0254-6299
EI 1727-9321
J9 S AFR J BOT
JI S. Afr. J. Bot.
PD JAN
PY 2018
VL 114
BP 181
EP 187
DI 10.1016/j.sajb.2017.11.010
PG 7
WC Plant Sciences
SC Plant Sciences
GA FS3UU
UT WOS:000419710000024
OA Other Gold
DA 2020-09-29
ER

PT J
AU Dutra, KR
   Drumond, BP
   de Rezende, IM
   Nogueira, ML
   Lopes, DD
   Silva, CEC
   Ferreira, JMS
   dos Santos, LL
AF Dutra, Karina Rocha
   Drumond, Betania Paiva
   de Rezende, Izabela Mauricio
   Nogueira, Mauricio Lacerda
   Lopes, Debora de Oliveira
   Calzavara Silva, Carlos Eduardo
   Siqueira Ferreira, Jaqueline Maria
   dos Santos, Luciana Lara
TI Molecular surveillance of dengue in Minas Gerais provides insights on
   dengue virus 1 and 4 circulation in Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE phylogenetic analysis; dengue virus; evolution; dynamics; genotype;
   lineage
ID POPULATION-DYNAMICS; CO-CIRCULATION; PHYLOGENETIC ANALYSIS; GENOTYPE-I;
   EVOLUTION; REPLACEMENT; DIVERSITY; SEROTYPES; LINEAGES; REVEALS
AB Dengue, caused by any of the four types of Dengue virus (DENV) is the most important arbovirus in the world. In this study we performed a molecular surveillance of dengue during the greatest dengue outbreak that took place in Divinopolis, Minas Gerais state, Southeast Brazil, in 2013. Samples from 100 patients with clinical symptoms of dengue were studied and 26 were positive. The capsid/premembrane (CprM) and envelope gene sequences of some samples were amplified and sequenced. Molecular analyses demonstrated that two DENV-1 lineages, belonging to genotype V were introduced and co-circulated in Divinopolis. When compared to each other, those lineages presented high genetic diversity and showed unique amino acids substitutions in the envelope protein, including in domains I, II, and III. DENV-4 strains from Divinopolis clustered within genotype IIb and the most recent common ancestor was probably introduced into the city three years before the 2013 epidemic. Here we demonstrated for the first time the circulation of DENV-4 and the co-circulation of two DENV-1 lineages in Midwest region of Minas Gerais, Brazil. Moreover our analysis indicated the introduction of five DENV-1 lineages, genotype V into Brazil, in different times. J. Med. Virol. 89:966-973, 2017. (c) 2016 Wiley Periodicals, Inc.
C1 [Dutra, Karina Rocha; Lopes, Debora de Oliveira; Siqueira Ferreira, Jaqueline Maria; dos Santos, Luciana Lara] Univ Fed Sao Joao Del Rei UFSJ, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Drumond, Betania Paiva; de Rezende, Izabela Mauricio] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Drumond, Betania Paiva; de Rezende, Izabela Mauricio] Univ Fed Juiz de Fora UFJF, Inst Ciencias Biol, Juiz De Fora, MG, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Sao Paulo, Brazil.
   [Calzavara Silva, Carlos Eduardo] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
RP dos Santos, LL (corresponding author), Univ Fed Sao Joao del Rei, Lab Biol Mol, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
EM llaramg@hotmail.com
RI lopes, debora/L-3601-2016; Rezende, Izabela Mauricio/AAL-5766-2020;
   Nogueira, Mauricio L/B-7599-2012; Ferreira, Jaqueline/E-4630-2018;
   Santos, Luciana L/C-9688-2013
OI lopes, debora/0000-0002-8559-8552; Rezende, Izabela
   Mauricio/0000-0003-2616-6300; Nogueira, Mauricio L/0000-0003-1102-2419;
   Ferreira, Jaqueline/0000-0002-1779-1975; Santos, Luciana
   L/0000-0001-6186-4062; CALZAVARA-SILVA, CARLOS/0000-0002-1406-6401
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [475329/2013-9]; Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
   [APQ-01703-14]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/21719-3]
FX Grant sponsor: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq); Grant number: 475329/2013-9; Grant sponsor: Fundacao
   de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Grant number:
   APQ-01703-14; Grant sponsor: Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP); Grant number: 2013/21719-3
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Martins VDA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100535
   Amancio FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129046
   Andrade EHP, 2016, AM J TROP MED HYG, V94, P1080, DOI 10.4269/ajtmh.15-0892
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga Jcd, 2014, J TROP MED, V2014, P1
   Campos RD, 2013, J CLIN VIROL, V56, P86, DOI 10.1016/j.jcv.2012.10.006
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   Center for Disease Control and Prevention, 2016, ENT EC
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013
   Cunha MD, 2016, INFECT GENET EVOL, V43, P130, DOI 10.1016/j.meegid.2016.05.021
   Taranto MFD, 2015, TROP MED INT HEALTH, V20, P77, DOI 10.1111/tmi.12402
   de Bruycker-Nogueira F, 2015, INFECT GENET EVOL, V34, P126, DOI 10.1016/j.meegid.2015.07.007
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Drumond BP, 2016, BRAZ J MICROBIOL, V47, P251, DOI 10.1016/j.bjm.2015.11.016
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   Figueiredo LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104516
   Figueiredo Luiz Tadeu Moraes, 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P613, DOI 10.1590/S0037-86821999000600002
   Foster JE, 2003, VIROLOGY, V306, P126, DOI 10.1016/S0042-6822(02)00033-8
   de Araujo JMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001784
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Ministerio Da Saude, 2010, 1182010 CGPNCDDEVEPS
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Rambaut A, 2015, TREEANNOTATOR VERSIO
   Rambaut A., 2014, FIGTREE VERSION 1 4
   Rambaut A., 2014, TRACER VERSION 1 6
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Ross TM, 2010, CLIN LAB MED, V30, P149, DOI 10.1016/j.cll.2009.10.007
   Rossi SL, 2012, VIROLOGY, V423, P58, DOI 10.1016/j.virol.2011.11.018
   Secretaria de Vigilancia em SaudeMinisterio da Saude, 2016, SEMANA EPIDEMIOLOGIC, V7
   Secretaria de Vigilancia em SaudeMinisterio da Saude, 2015, SEMANA EPIDEMIOLOGIC, V52
   Secretaria de Vigilancia em SaudeMinisterio da Saude, 2014, SEMANA EPIDEMIOLOGIC, V53
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Teoh BT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-213
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007
   World Health Organization [WHO], 2016, DENG GUID DIAGN TREA
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
NR 54
TC 2
Z9 2
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUN
PY 2017
VL 89
IS 6
BP 966
EP 973
DI 10.1002/jmv.24729
PG 8
WC Virology
SC Virology
GA ER6DA
UT WOS:000398893900005
PM 27926790
DA 2020-09-29
ER

PT J
AU Godoi, IP
   Lima, WG
   Comar, M
   Alves, RJ
   Ferreira, JMS
   Kong, DX
   Taranto, AG
AF Godoi, Isabella P.
   Lima, William Gustavo
   Comar Junior, Moacyr
   Alves, Ricardo Jose
   Ferreira, Jaqueline Maria S.
   Kong, De-Xin
   Taranto, Alex G.
TI Docking and QM/MM Studies of NS2B-NS3pro Inhibitors: a Molecular Target
   against the Dengue Virus
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE dengue; inhibitors; NS2B-NS3pro; molecular modeling
ID PROTEIN-LIGAND DOCKING; NS3 PROTEASE; PEPTIDE INHIBITORS; DIELECTRIC
   MEDIUM; SERINE-PROTEASE; WATER-MOLECULES; DRUG DISCOVERY; NS2B COFACTOR;
   SIMULATIONS; DESIGN
AB Dengue virus (DENV) has been characterized as having great clinical importance in the world, as there is no specific treatment against this virus. The NS2B-NS3pro complex is essential for the replication and maturation of DENV and is a potential pharmacological target. The present study aims to evaluate and understand the interactions and affinities (via molecular docking/AutoDock Vina) of 16 peptidomimetic derivatives applied to a NS2B-NS3pro DENV-2 complex constructed by homology modeling (via SWISS-MODEL). Two compounds were selected as potential inhibitors of this protein complex. In addition, these compounds possess important interactions involving Ser135, Gly169 and Tyr161, which have been described previously to be fundamental to the recognition of inhibitors directed to this receptor. Thus, the involvement of these residues is significant pharmacologically because they may contribute to the inhibitory action of this molecular target against DENV.
C1 [Godoi, Isabella P.; Lima, William Gustavo; Comar Junior, Moacyr; Taranto, Alex G.] Univ Fed Sao Joao Del Rei, Lab Quim Farmaceut Med, BR-35501296 Divinopolis, MG, Brazil.
   [Lima, William Gustavo; Ferreira, Jaqueline Maria S.] Univ Fed Sao Joao Del Rei, Microbiol Lab, BR-35501296 Divinopolis, MG, Brazil.
   [Alves, Ricardo Jose] Univ Fed Minas Gerais, Quim Farmaceut Lab, Dept Prod Farmaceut, Fac Farm, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kong, De-Xin] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Bioinformat, Wuhan 430070, Peoples R China.
RP Godoi, IP (corresponding author), Univ Fed Sao Joao Del Rei, Lab Quim Farmaceut Med, BR-35501296 Divinopolis, MG, Brazil.
EM labqf_ufsj@ufsj.edu.br
RI Godoi, Isabella P/G-3544-2019; Lima, William G/C-9258-2018; Kong,
   De-Xin/E-5630-2012; Alves, Ricardo J/I-7978-2015; Taranto, Alex
   G/F-8618-2012; Ferreira, Jaqueline/E-4630-2018
OI Godoi, Isabella P/0000-0002-0568-6625; Lima, William
   G/0000-0001-8946-9363; Kong, De-Xin/0000-0003-0744-116X; Taranto, Alex
   G/0000-0002-6086-1043; Ferreira, Jaqueline/0000-0002-1779-1975
FU UFSJ/PPGBiotec; CNPqNational Council for Scientific and Technological
   Development (CNPq) [449984/2014-1]; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG) [APQ-00557-14, CDS-APQ-02337-12, CBB-APQ-01301-11];
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
FX UFSJ/PPGBiotec, CNPq (449984/2014-1) and FAPEMIG (APQ-00557-14,
   CDS-APQ-02337-12, CBB-APQ-01301-11) are gratefully acknowledged for
   financial support, and I. P. G. is grateful to FAPEMIG for a fellowship.
CR Accelrys Software Solutions Pvt. Ltd, 2011, DISC STUD VIS VERS 3
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Breda A, 2008, CURR COMPUT-AID DRUG, V4, P265, DOI 10.2174/157340908786786047
   Carregal A. P., 2011, REV ELECT FARMACIA, V8, P71
   Case D.A., 2010, AMBER VERSION 11
   da Fonseca AL, 2016, J MOL GRAPH MODEL, V66, P174, DOI 10.1016/j.jmgm.2016.03.015
   de Lima WEA, 2016, LETT DRUG DES DISCOV, V13, P360, DOI 10.2174/1570180812666150918191550
   Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349
   Dubey KD, 2012, MED CHEM RES, V21, P1030, DOI 10.1007/s00044-011-9617-1
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605
   Forshey BM, 2013, FUTURE VIROL, V8, P1145, DOI 10.2217/fvl.13.95
   Frecer V, 2010, J COMPUT AID MOL DES, V24, P195, DOI 10.1007/s10822-010-9326-8
   Frisch MJ, 2009, GAUSSIAN VERSION 09
   Giese TJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2778428
   Godoi I. P., 2013, BIOCH BIOTECHNOL REP, V2, P48
   de Andrade DVG, 2012, INT J QUANTUM CHEM, V112, P3164, DOI 10.1002/qua.24102
   Groenhof G., 2013, BIOMOLECULAR SIMULAT
   Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n
   HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K
   Jaghoori M. M., 2016, J COMPUT AID MOL DES, V30, P49
   Johansson MU, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-173
   JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9
   Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549
   Kleinjung J, 2014, CURR OPIN STRUC BIOL, V25, P126, DOI 10.1016/j.sbi.2014.04.003
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LAU YK, 1981, J AM CHEM SOC, V103, P6291, DOI 10.1021/ja00411a004
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Lin H, 2007, THEOR CHEM ACC, V117, P185, DOI 10.1007/s00214-006-0143-z
   Natarajan S, 2010, GENET MOL BIOL, V33, P214, DOI 10.1590/S1415-47572010000200002
   Nemukhin AV, 2004, THEOR CHEM ACC, V111, P36, DOI 10.1007/s00214-003-0556-x
   Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Rossm J. M. V., 2011, J PHARM PHARMACOL, V15, P285
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   Santos MC, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-48
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082
   Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4
   STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038
   Taranto AG, 2008, J MOL GRAPH MODEL, V27, P275, DOI 10.1016/j.jmgm.2008.05.002
   Thilagavathi R, 2010, J CHEM INF MODEL, V50, P415, DOI 10.1021/ci900345h
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tomlinson S. M., 2009, Infectious Disorders - Drug Targets, V9, P327
   Tripathi SK, 2015, CHEM BIOL DRUG DES, V85, P107, DOI 10.1111/cbdd.12376
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E
   Vaque M, 2008, CURR PHARM ANAL, V4, P1
   Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p
   WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9
   WEINER SJ, 1986, P NATL ACAD SCI USA, V83, P649, DOI 10.1073/pnas.83.3.649
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Yotmanee P, 2015, J MOL GRAPH MODEL, V60, P24, DOI 10.1016/j.jmgm.2015.05.008
   Zhao HY, 2009, DRUG DISCOV TODAY, V14, P516, DOI 10.1016/j.drudis.2009.02.008
NR 61
TC 3
Z9 3
U1 1
U2 14
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD MAY
PY 2017
VL 28
IS 5
BP 895
EP 906
DI 10.21577/0103-5053.20160242
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA ET3DP
UT WOS:000400157800022
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Andrade, ACDP
   Lima, MT
   Oliveira, GP
   Calixto, RS
   Souza, ELDE
   de Souza, DD
   Leite, CMD
   Ferreira, JMS
   Kroon, EG
   de Oliveira, DB
   Martins, FD
   Abrahao, JS
AF dos Santos Pereira Andrade, A. C.
   Teixeira Lima, M.
   Pereira Oliveira, G.
   Silva Calixto, R.
   Lorenna de Sales e Souza, E.
   da Gloria de Souza, D.
   de Almeida Leite, C. M.
   Siqueira Ferreira, J. M.
   Kroon, E. G.
   Bretas de Oliveira, D.
   dos Santos Martins, F.
   Abrahao, J. S.
TI Daily ingestion of the probiotic Lactobacillus paracasei ST11 decreases
   Vaccinia virus dissemination and lethality in a mouse model
SO BENEFICIAL MICROBES
LA English
DT Article
DE probiotics; virus; inflammation; Orthopoxvirus
ID SKIN INFLAMMATION; IMMUNE-RESPONSES; INFECTION; PROTECTION; STRAINS;
   SPREAD; CASEI
AB Vaccinia virus (VACV) is an important pathogen. Although studies have shown relationships between probiotics and viruses, the effect of probiotics on VACV infection is unknown. Therefore, this work aims to investigate the probiotics effects on VACV infection. Mice were divided into four groups, two non-infected groups, one receiving the probiotic, the other one not receiving it, and two groups infected intranasally with VACV Western Reserve (VACV-WR) receiving or not receiving the probiotic. Viral titres in organs and cytokine production in the lungs were analysed. Lung samples were also subjected to histological analysis. The intake of probiotic results in reduction in viral spread with a significant decrease of VACV titer on lung, liver and brain of treated group. In addition, treatment with the probiotic results in attenuated mice lung inflammation showing fewer lesions on histological findings and decreased lethality in mice infected with VACV. The ingestion of Lactobacillus paracasei ST11 (LPST11) after VACV infection resulted in 2/9 animal lethality compared with 4/9 in the VACV group. This is the first study on probiotics and VACV interactions, providing not only information about this interaction, but also proposing a model for future studies involving probiotics and other poxvirus.
C1 [dos Santos Pereira Andrade, A. C.; Teixeira Lima, M.; Pereira Oliveira, G.; Silva Calixto, R.; Lorenna de Sales e Souza, E.; da Gloria de Souza, D.; Kroon, E. G.; Bretas de Oliveira, D.; dos Santos Martins, F.; Abrahao, J. S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Almeida Leite, C. M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Siqueira Ferreira, J. M.] Univ Fed Sao Joao Rei, Lab Microbiol, Ave Sebastiao Goncalves Coelho 400, BR-35501296 Divinopolis, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Ferreira,
   Jaqueline/E-4630-2018
OI Kroon, Erna Geessien/0000-0003-2721-3826; Ferreira,
   Jaqueline/0000-0002-1779-1975; Martins, Flaviano/0000-0003-0741-3062;
   Teixeira Lima, Mauricio/0000-0002-0830-3909
CR Abrahao J.S., EQUINE VET IN PRESS
   Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324
   Al Kassaa I, 2014, PROBIOTICS ANTIMICRO, V6, P177, DOI 10.1007/s12602-014-9162-6
   Barbosa RPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098685
   Campos M.A.S., 1993, REV MICROBIOL, V28, P474
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Chiu C, 2015, NAT IMMUNOL, V16, P18, DOI 10.1038/ni.3056
   Damon I.K., 2013, FIELDS VIROLOGY, V2, P2947
   Duniho SM, 2002, TOXICOL PATHOL, V30, P339, DOI 10.1080/01926230252929918
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002, GUID EV PROB FOOD
   Gueniche A, 2010, EUR J DERMATOL, V20, P731, DOI 10.1684/ejd.2010.1108
   Hori T, 2001, CLIN DIAGN LAB IMMUN, V8, P593, DOI 10.1128/CDLI.8.3.593-597.2001
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kalthoff D, 2014, VECTOR-BORNE ZOONOT, V14, P303, DOI 10.1089/vbz.2013.1442
   Kiso M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01563
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Lee YN, 2013, ANTIVIR RES, V98, P284, DOI 10.1016/j.antiviral.2013.03.013
   Lehtoranta L, 2014, EUR J CLIN MICROBIOL, V33, P1289, DOI 10.1007/s10096-014-2086-y
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Galan NNO, 2016, J APPL MICROBIOL, V120, P1041, DOI 10.1111/jam.13069
   Oliveira GP, 2014, AM J TROP MED HYG, V90, P1021, DOI 10.4269/ajtmh.13-0621
   Oliveira M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/807483
   Oyoshi MK, 2009, P NATL ACAD SCI USA, V106, P14954, DOI 10.1073/pnas.0904021106
   Perrin Y, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-1
   Reynolds MG, 2012, CURR OPIN VIROL, V2, P335, DOI 10.1016/j.coviro.2012.02.004
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Wassenberg J, 2011, CLIN EXP ALLERGY, V41, P565, DOI 10.1111/j.1365-2222.2011.03695.x
   Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265
NR 35
TC 1
Z9 1
U1 0
U2 5
PU WAGENINGEN ACADEMIC PUBLISHERS
PI WAGENINGEN
PA PO BOX 220, WAGENINGEN, 6700 AE, NETHERLANDS
SN 1876-2883
EI 1876-2891
J9 BENEF MICROBES
JI Benef. Mirbobes
PY 2017
VL 8
IS 1
BP 73
EP 80
DI 10.3920/BM2016.0074
PG 8
WC Microbiology; Nutrition & Dietetics
SC Microbiology; Nutrition & Dietetics
GA EM8HD
UT WOS:000395551200008
PM 27873547
DA 2020-09-29
ER

PT J
AU Allochio, JF
   Roldi, LL
   Delarmelina, M
   Fiorot, RG
   Andrade, JT
   Aleixo, AA
   Carvalho, RS
   Araujo, MGF
   Ferreira, JMS
   Taranto, AG
   Romao, W
   Greco, SJ
AF Allochio Filho, Joao F.
   Roldi, Larissa L.
   Delarmelina, Maicon
   Fiorot, Rodolfo G.
   Andrade, Jessica T.
   Aleixo, Alan A.
   Carvalho, Rafaella S.
   Araujo, Marcelo G. F.
   Ferreira, Jaqueline M. S.
   Taranto, Alex G.
   Romao, Wanderson
   Greco, Sandro J.
TI Synthesis, in vitro Antifungal Activity and Molecular Modeling Studies
   of New Mannich Bases Derived from Lawsone
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE lawsone; Mannich bases; antifungal activity; docking
ID BIOLOGICAL EVALUATION; CANDIDA-ALBICANS; DRUG DESIGN; DERIVATIVES;
   ANTIBACTERIAL; DOCKING; AMINONAPHTHOQUINONES; NAPHTHOQUINONES;
   EPIDEMIOLOGY; OPTIMIZATION
AB Hydroxynaphthoquinones such as lawsone (2-hydroxy-1,4-naphthoquinone) have proven to be effective antifungal agents. These compounds were tested for antifungal activity against yeast standard and clinical strains by the broth microdilution method. Among the synthetic lawsone derivatives, 2-hydroxy-3-((2-hydroxyphenyl)(pyrrolidin-1-yl) methyl) naphthalene-1,4-dione, 2-hydroxy-3-(((4-nitrophenyl) amino)(phenyl) methyl) naphthalene-1,4-dione and 2-hydroxy-3(( 2-hydroxyphenyl)((4-nitrophenyl) amino) methyl) naphthalene-1,4-dione showed high activity against Candida albicans ATCC 10231, with minimal inhibitory concentrations (MICs) and minimal fungicidal concentrations (MFCs) ranging from 20 to 330 and from 80 to 330 mu g mL(-1), respectively. Moreover, they also showed a mechanism of action on exogenous ergosterol. Therapeutic concentrations (CC50) of 2-hydroxy-3-((2-hydroxyphenyl)(pyrrolidin-1-yl) methyl) naphthalene-1,4-dione, 2-hydroxy-3-(((4-nitrophenyl) amino)(phenyl) methyl) naphthalene-1,4-dione and 2-hydroxy-3-((2-hydroxyphenyl)((4-nitrophenyl) amino) methyl) naphthalene-1,4-dione were 52.81, 52.58 and 85.94 mu g mL(-1), respectively, which can be considered moderate or low. In addition, docking studies showed that these compounds had similar binding energy to standard ketoconazole, which are recognized as the molecular target by van der Waals interactions. Furthermore, they are under Lipinski's rule of 5 with a druglikeness score better than ketoconazole and nystatin. These findings suggest that 2-hydroxy-3-((2-hydroxyphenyl)(pyrrolidin-1-yl) methyl) naphthalene-1,4-dione, 2-hydroxy-3-(((4-nitrophenyl) amino)(phenyl) methyl) naphthalene-1,4dione and 2-hydroxy-3-((2-hydroxyphenyl)((4-nitrophenyl) amino) methyl) naphthalene-1,4-dione have potential as leading compounds against human fungal infections.
C1 [Allochio Filho, Joao F.; Roldi, Larissa L.; Delarmelina, Maicon; Fiorot, Rodolfo G.; Greco, Sandro J.] Univ Fed Espirito Santo, Dept Quim, Lab Sintese Organ & Med, Ave Ferrari 514, BR-29075910 Vitoria, ES, Brazil.
   [Andrade, Jessica T.; Aleixo, Alan A.; Carvalho, Rafaella S.; Araujo, Marcelo G. F.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao Del Rei, Microbiol Lab, Campus Ctr Oeste, BR-35501296 Divinopolis, MG, Brazil.
   [Taranto, Alex G.] Univ Fed Sao Joao Del Rei, Lab Quim Farmaceut Med, Campus Ctr Oeste, BR-35501296 Divinopolis, MG, Brazil.
   [Romao, Wanderson] Univ Fed Espirito Santo, Dept Quim, Lab Petr, Ave Ferrari 514, BR-29075910 Vitoria, ES, Brazil.
RP Greco, SJ (corresponding author), Univ Fed Espirito Santo, Dept Quim, Lab Sintese Organ & Med, Ave Ferrari 514, BR-29075910 Vitoria, ES, Brazil.
EM sandro.greco@ufes.br
RI Filho, Joao Francisco Allochio/F-6619-2019; Taranto, Alex G/F-8618-2012;
   Delarmelina, Maicon/P-5636-2018; Fiorot, Rodolfo/AAL-6886-2020; Greco,
   Sandro/Q-5514-2019; Ferreira, Jaqueline/E-4630-2018
OI Filho, Joao Francisco Allochio/0000-0002-9520-5804; Taranto, Alex
   G/0000-0002-6086-1043; Delarmelina, Maicon/0000-0002-6414-552X; Fiorot,
   Rodolfo/0000-0002-4311-5989; Greco, Sandro/0000-0003-2382-9295;
   Ferreira, Jaqueline/0000-0002-1779-1975; Romao,
   Wanderson/0000-0002-2254-6683
FU FAPES [54684722/2012]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [449984/2014-1]; FAPEMIGMinas Gerais
   State Research Foundation (FAPEMIG) [APQ-00557-14]
FX The authors thank FAPES (process 54684722/2012), CNPq (process
   449984/2014-1) and FAPEMIG (APQ-00557-14) for financial support.
CR Accelrys Software Inc, 2014, DISC STUD MOD ENV RE
   Allochio JF, 2015, COLLOID INTERFAC SCI, V4, P14, DOI 10.1016/j.colcom.2015.03.002
   Amarante-Mendes GP, 1999, BRAZ J MED BIOL RES, V32, P1053, DOI 10.1590/S0100-879X1999000900001
   [Anonymous], 2008, M27A3 CLSI
   Asche C, 2005, MINI-REV MED CHEM, V5, P449, DOI 10.2174/1389557053765556
   Bala BD, 2014, EUR J MED CHEM, V85, P737, DOI 10.1016/j.ejmech.2014.08.009
   Baramee A, 2006, BIOORGAN MED CHEM, V14, P1294, DOI 10.1016/j.bmc.2005.09.054
   Barbosa TP, 2005, BIOORGAN MED CHEM, V13, P6464, DOI 10.1016/j.bmc.2005.06.068
   Brandao GC, 2010, PHYTOMEDICINE, V17, P926, DOI 10.1016/j.phymed.2010.03.004
   Bringmann G, 2004, TETRAHEDRON, V60, P3539, DOI 10.1016/j.tet.2004.02.060
   Clayton Y. M., 1977, P ROY SOC MED, V70, P359
   da Cruz EHG, 2014, NEW J CHEM, V38, P2569, DOI 10.1039/c3nj01499a
   da Silva EN, 2012, EUR J MED CHEM, V52, P304, DOI 10.1016/j.ejmech.2012.03.039
   De Moura KCG, 2001, J BRAZIL CHEM SOC, V12, P325
   de Oliveira ME, 2013, MOLECULES, V18, P15276, DOI 10.3390/molecules181215276
   DEALMEIDA ER, 1990, J ETHNOPHARMACOL, V29, P239, DOI 10.1016/0378-8741(90)90061-W
   Delarmelina M, 2015, J BRAZIL CHEM SOC, V26, P1804, DOI 10.5935/0103-5053.20150157
   dos Santos AF, 2000, INT J PARASITOL, V30, P1199, DOI 10.1016/S0020-7519(00)00114-4
   Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6
   El Hammi E, 2011, BIOCHEMISTRY-US, V50, P1255, DOI 10.1021/bi101650q
   Elavarasan S, 2014, SPECTROCHIM ACTA A, V133, P1, DOI 10.1016/j.saa.2014.05.037
   Elokely KM, 2013, J CHEM INF MODEL, V53, P1934, DOI 10.1021/ci400040d
   Escalante A, 2008, J NAT PROD, V71, P1720, DOI 10.1021/np070660i
   Fiorot RG, 2014, TETRAHEDRON LETT, V55, P4373, DOI 10.1016/j.tetlet.2014.06.031
   Fisher JF, 2011, CLIN INFECT DIS, V52, pS437, DOI 10.1093/cid/cir110
   GARNIER S, 1996, PHYTOCHEMISTRY, V42, P1315
   GraphPad, GRAPHPAD QUICKCALCS
   Ibis C, 2013, MED CHEM RES, V22, P2879, DOI 10.1007/s00044-012-0300-y
   Ibis C, 2011, EUR J MED CHEM, V46, P5861, DOI 10.1016/j.ejmech.2011.09.048
   Jardim GAM, 2015, RSC ADV, V5, P78047, DOI 10.1039/c5ra16213k
   Jardim GAM, 2015, MEDCHEMCOMM, V6, P120, DOI 10.1039/c4md00371c
   Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045
   Keseru GM, 2009, NAT REV DRUG DISCOV, V8, P203, DOI 10.1038/nrd2796
   LAGROTA MHD, 1988, REV MICROBIOL, V19, P338
   LEFFLER MT, 1948, J AM CHEM SOC, V70, P3222, DOI 10.1021/ja01190a006
   Lima NMF, 2002, J BRAZIL CHEM SOC, V13, P822, DOI 10.1590/S0103-50532002000600015
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Liu KKC, 2004, MINI-REV MED CHEM, V4, P1105
   Guimaraes DSM, 2015, MEM I OSWALDO CRUZ, V110, P255, DOI 10.1590/0074-02760140415
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Motulsky HJ, 2003, FITTING MODELS BIOL, P351
   National Committee for Clinical Laboratory Standards (NCCLS), 2002, M27A2 CLSI NCCLS
   Neves AP, 2009, J BRAZIL CHEM SOC, V20, P712, DOI 10.1590/S0103-50532009000400015
   Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003
   Ortega M, 2011, J HOSP INFECT, V77, P157, DOI 10.1016/j.jhin.2010.09.026
   Portillo A, 2005, J ETHNOPHARMACOL, V97, P49, DOI 10.1016/j.jep.2004.09.052
   Rahmoun NM, 2012, MED MALADIES INFECT, V42, P270, DOI 10.1016/j.medmal.2012.05.002
   Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j
   Santos MC, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-48
   Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0
   Silva Milton N. da, 2003, Quím. Nova, V26, P407, DOI 10.1590/S0100-40422003000300019
   Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x
   Sobel JD, 2003, ANTIMICROB AGENTS CH, V47, P34, DOI 10.1128/AAC.47.1.34-38.2003
   Stagliano KW, 2006, BIOORGAN MED CHEM, V14, P5651, DOI 10.1016/j.bmc.2006.04.034
   Stewart JJP, 2013, J MOL MODEL, V19, P1, DOI 10.1007/s00894-012-1667-x
   Stewart JJP, 2012, STEWART COMPUTATIONA
   Teixeira M.J., 2001, BIOORGAN MED CHEM, V15, P44
   ten Brink T, 2010, J COMPUT AID MOL DES, V24, P935, DOI 10.1007/s10822-010-9385-x
   Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Tuyun AF, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/645902
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Vale-Silva LA, 2012, ANTIMICROB AGENTS CH, V56, P1960, DOI 10.1128/AAC.05720-11
   Verdonk ML, 2011, J MED CHEM, V54, P5422, DOI 10.1021/jm200558u
   Wong SSW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085836
   Zani C.L., 1997, J BIOORG MED CHEM, V5, P2185
NR 66
TC 9
Z9 9
U1 0
U2 12
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD NOV
PY 2016
VL 27
IS 11
BP 2127
EP 2140
DI 10.5935/0103-5053.20160104
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA EC9DR
UT WOS:000388444900023
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Gomes, AVBT
   Morais, SMDS
   Menezes, SL
   de Almeida, LGN
   Rocha, RP
   Ferreira, JMS
   dos Santos, LL
   Malaquias, LCC
   Coelho, LFL
AF Boas Terra Gomes, Alessandra Vilas
   de Souza Morais, Stella Maria
   Menezes-Filho, Sergio Luiz
   Nogueira de Almeida, Luiz Gustavo
   Rocha, Raissa Prado
   Siqueira Ferreira, Jaqueline Maria
   dos Santos, Luciana Lara
   Cotta Malaquias, Luiz Cosme
   Leomil Coelho, Luiz Felipe
TI Demethylation Profile of the TNF-alpha Promoter Gene Is Associated With
   High Expression of This Cytokine in Dengue virus Patients
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Dengue virus; DNA methylation; promoter; IFN-gamma; TNF-alpha
ID EPIGENETIC REGULATION; DNA METHYLATION; IFN-GAMMA; T-CELLS; DISEASE;
   INFECTION; TH1
AB Dengue is the most prevalent arthropod-borne viral illness in humans. The overexpression of cytokines by Dengue virus (DENV) infected cells is associated with the most severe forms of the disease. Unmethylated CpG islands are related to a transcriptionally active structure, whereas methylated DNA recruits methyl-binding proteins that inhibit gene expression. Several studies have described the importance of epigenetic events in the regulation and expression of many cytokines. The purpose of the present study was to evaluate the methylation status of the IFN-gamma and TNF-alpha promoters in DNA extracted from dengue infected patients using methylation-specific polymerase chain reaction. A high frequency of demethylation was observed in the TNF-alpha promoter of DENV infected patients when compared to non-infected controls. The patients with an unmethylated profile showed higher expression of TNF-alpha mRNA than patients with the methylated status. No difference was found in the methylation frequency between the two analyzed groups regarding the IFN-gamma promoter or in the expression of IFN-gamma transcripts. The present study provides the first association of TNF-alpha promoter demethylation in DENV infected individuals and demonstrates a correlation between the methylation status of the region analyzed and the expression of TNF-alpha transcripts in DENV infected patients. (C) 2016 Wiley Periodicals, Inc.
C1 [Boas Terra Gomes, Alessandra Vilas; de Souza Morais, Stella Maria; Menezes-Filho, Sergio Luiz; Nogueira de Almeida, Luiz Gustavo; Rocha, Raissa Prado; Cotta Malaquias, Luiz Cosme; Leomil Coelho, Luiz Felipe] Univ Fed Alfenas, Inst Ciencias Biomed, Lab Vacinas, Rua Gabriel Monteiro,700 Ctr, BR-37130000 Alfenas, MG, Brazil.
   [Siqueira Ferreira, Jaqueline Maria; dos Santos, Luciana Lara] Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, Brazil.
RP Coelho, LFL (corresponding author), Univ Fed Alfenas, Inst Ciencias Biomed, Lab Vacinas, Rua Gabriel Monteiro,700 Ctr, BR-37130000 Alfenas, MG, Brazil.
EM coelho@unifal-mg.edu.br
RI Coelho, Luiz FL/G-5853-2012; Santos, Luciana L/C-9688-2013; Ferreira,
   Jaqueline/E-4630-2018
OI Santos, Luciana L/0000-0001-6186-4062; Ferreira,
   Jaqueline/0000-0002-1779-1975; Coelho, Luiz Felipe/0000-0003-4289-384X
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [475940/2011-3, 404005/2012-8]
FX Grant sponsor: CNPq; Grant numbers: 475940/2011-3; 404005/2012-8
CR Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Butthep P, 2012, PEDIATR INFECT DIS J, V31, pE232, DOI 10.1097/INF.0b013e31826fd456
   Chakravarti A, 2006, INDIAN J MED RES, V123, P25
   Chunhakan S, 2015, INT J VASC MED, V2015, DOI 10.1155/2015/917143
   Cohen CJ, 2011, J IMMUNOL, V187, P5615, DOI 10.4049/jimmunol.1101058
   Cordero P, 2011, J PHYSIOL BIOCHEM, V67, P463, DOI 10.1007/s13105-011-0084-4
   D'Addario C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039186
   Espada-Murao Lyre Anni, 2011, Trop Med Health, V39, P53, DOI 10.2149/tmh.2011-S06
   Friberg H, 2011, IMMUNOL CELL BIOL, V89, P122, DOI 10.1038/icb.2010.61
   Gowers IR, 2011, CYTOKINE, V56, P792, DOI 10.1016/j.cyto.2011.09.009
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Harb H, 2015, J ALLERGY CLIN IMMUN, V135, P15, DOI 10.1016/j.jaci.2014.11.009
   He D, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0525-y
   Karatzas PS, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000309
   Klein K, 2015, CURR OPIN RHEUMATOL, V27, P76, DOI 10.1097/BOR.0000000000000128
   Larsson L, 2014, J PERIODONTOL, V21, P1, DOI DOI 10.1902/J0P.2014.140559
   Ma D, 2014, SCI REP-UK, V4, DOI 10.1038/srep06331
   Malavige GN, 2013, J CLIN VIROL, V58, P605, DOI 10.1016/j.jcv.2013.10.023
   Mangione Julia N A, 2014, Trop Med Health, V42, P137, DOI 10.2149/tmh.2014-09
   Martina Byron E. E., 2014, Science Progress, V97, P197, DOI 10.3184/003685014X14049173153889
   McErlean P, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-37
   Nakayama-Hosoya K, 2015, J INFECT DIS, V211, P28, DOI 10.1093/infdis/jiu376
   Nimmo ER, 2012, INFLAMM BOWEL DIS, V18, P889, DOI 10.1002/ibd.21912
   Ranjit S, 2011, PEDIATR CRIT CARE ME, V12, P90, DOI 10.1097/PCC.0b013e3181e911a7
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Sanders VM, 2006, BRAIN BEHAV IMMUN, V20, P317, DOI 10.1016/j.bbi.2005.08.005
   Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192
   Silva EF, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-13
   Soundravally R, 2014, INT J INFECT DIS, V18, P68, DOI 10.1016/j.ijid.2013.09.022
   Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06
   Tempera I, 2014, SEMIN CANCER BIOL, V26, P22, DOI 10.1016/j.semcancer.2014.01.003
   van de Weg CAM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002236
   Watanabe Y, 2015, GENOME RES, V25, P328, DOI 10.1101/gr.175240.114
   Zhang SP, 2013, J PERIODONTOL, V84, P1606, DOI 10.1902/jop.2013.120294
NR 35
TC 6
Z9 6
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2016
VL 88
IS 8
BP 1297
EP 1302
DI 10.1002/jmv.24478
PG 6
WC Virology
SC Virology
GA DW5FU
UT WOS:000383669500003
PM 26792115
DA 2020-09-29
ER

PT J
AU Cecilio, SG
   Silva, WF
   Totola, AH
   Magalhaes, CLD
   Ferreira, JMS
   de Magalhaes, JC
AF Cecilio, Samyra Giarola
   Silva Junior, Willer Ferreira
   Totola, Antonio Helvecio
   de Brito Magalhaes, Cintia Lopes
   Siqueira Ferreira, Jaqueline Maria
   de Magalhaes, Jose Carlos
TI Dengue virus detection in Aedes aegypti larvae from southeastern Brazil
SO JOURNAL OF VECTOR ECOLOGY
LA English
DT Article
DE Aedes; dengue virus; ovitraps; transovarial transmission; oviposition;
   mosquitoes
ID CLIMATE-CHANGE; CULICIDAE; DIPTERA; TRANSMISSION; STATE; L.
AB The transmission of dengue, the most important arthropod-borne viral disease in Brazil, has been intensified over the past decades, along with the accompanying expansion and adaptation of its Aedes vectors. In the present study, we mapped dengue vectors in Ouro Preto and Ouro Branco, Minas Gerais, by installing ovitraps in 32 public schools. The traps were examined monthly between September, 2011 through July, 2012 and November, 2012 to April, 2013. The larvae were reared until the fourth stadium and identified according to species. The presence of dengue virus was detected by real time PCR and agarose gel electrophoresis. A total of 1,945 eggs was collected during the 17 months of the study. The Ovitrap Positivity Index (OPI) ranged from 0 to 28.13% and the Eggs Density Index (EDI) ranged from 0 to 59.9. The predominant species was Aedes aegypti, with 84.9% of the hatched larvae. Although the collection was low when compared to other ovitraps studies, vertical transmission could be detected. Of the 54 pools, dengue virus was detected in four Ae. aegypti pools.
C1 [Cecilio, Samyra Giarola; Silva Junior, Willer Ferreira; de Magalhaes, Jose Carlos] UFSJ, Dept Quim Biotecnol & Engn Bioproc DQBIO, Lab Microbiol Geral & Enzimol, Ouro Branco, MG, Brazil.
   [Totola, Antonio Helvecio] UFSJ, Dept Quim Biotecnol & Engn Bioproc DQBIO, Lab Bioquim & Imunol Celular & Mol, Ouro Branco, MG, Brazil.
   [de Brito Magalhaes, Cintia Lopes] Univ Fed Ouro Preto, Lab Biol & Tecnol Microorganismos, DCB, Ouro Preto, MG, Brazil.
   [Siqueira Ferreira, Jaqueline Maria] UFSJ, Lab Microbiol, Divinopolis, MG, Brazil.
RP Cecilio, SG (corresponding author), UFSJ, Dept Quim Biotecnol & Engn Bioproc DQBIO, Lab Microbiol Geral & Enzimol, Campus Alto Paraopeba, Ouro Branco, MG, Brazil.
EM samyracecilio@gmail.com
RI Ferreira, Jaqueline/E-4630-2018
OI Ferreira, Jaqueline/0000-0002-1779-1975
CR Anez G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/678645
   Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Bhattacharya M K, 2013, Int J Biomed Sci, V9, P61
   Braga Ima Aparecida, 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P347, DOI 10.1590/S0037-86822000000400003
   Cardoso Junior R P, 1997, Rev Soc Bras Med Trop, V30, P37, DOI 10.1590/S0037-86821997000100007
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Cecilio AB, 2009, BRAZ J BIOL, V69, P123, DOI 10.1590/S1519-69842009000100015
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Costa FS, 2008, REV SOC BRAS MED TRO, V41, P309, DOI 10.1590/S0037-86822008000300018
   de Almeida PS, 2006, REV SAUDE PUBL, V40, P1094, DOI 10.1590/S0034-89102006000700019
   de Carvalho-Leandro D, 2010, REV BRAS ENTOMOL, V54, P701, DOI 10.1590/S0085-56262010000400025
   de Resende MC, 2013, MEM I OSWALDO CRUZ, V108, P1024, DOI 10.1590/0074-0276130128
   de Resende MC, 2012, MEM I OSWALDO CRUZ, V107, P294, DOI 10.1590/S0074-02762012000300002
   Fantinatti ECS, 2007, NEOTROP ENTOMOL, V36, P960, DOI 10.1590/S1519-566X2007000600020
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   Khan MIH, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.014
   Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475
   Miyazaki RD, 2009, REV SOC BRAS MED TRO, V42, P392, DOI 10.1590/S0037-86822009000400007
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Nunes LS, 2011, BIOTA AMAZONIA, V1, P26
   Pessanha José Eduardo Marques, 2011, Rev. Soc. Bras. Med. Trop., V44, P103, DOI 10.1590/S0037-86822011000100023
   Primavesi R, 2013, CAN FAM PHYSICIAN, V59, P742
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Regis LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067682
   REITER P, 1991, J AM MOSQUITO CONTR, V7, P52
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Restrepo BN, 2014, J TROP MED-US, V2014, DOI 10.1155/2014/872608
   Russell RC, 1998, INT J PARASITOL, V28, P955, DOI 10.1016/S0020-7519(98)00053-8
   Santos S. R. A., 2003, Dengue Bulletin, V27, P156
   Velez I. D., 1998, Biomedica, V18, P192
   Zeidler Julianna Dias, 2008, Rev. Saúde Pública, V42, P986, DOI 10.1590/s0034-89102008000600002
   Zell R, 2004, INT J MED MICROBIOL, V293, P16, DOI 10.1016/S1433-1128(04)80005-6
NR 36
TC 10
Z9 10
U1 0
U2 9
PU SOC VECTOR ECOLOGY
PI CORONA
PA 1966 COMPTON AVE, CORONA, CA 92881 USA
SN 1081-1710
EI 1948-7134
J9 J VECTOR ECOL
JI J. Vector Ecol.
PD JUN
PY 2015
VL 40
IS 1
BP 71
EP 74
DI 10.1111/jvec.12134
PG 4
WC Entomology
SC Entomology
GA CJ9VN
UT WOS:000355851400009
PM 26047186
DA 2020-09-29
ER

PT J
AU Morais, MG
   da Costa, GAF
   Aleixo, AA
   de Oliveira, GT
   Alves, LF
   Duarte-Almeida, JM
   Ferreira, JMS
   Lima, LARD
AF Morais, Melissa Grazielle
   Ferreira da Costa, Guilherme Augusto
   Aleixo, Alan Alex
   de Oliveira, Graziela Teixeira
   Alves, Lucas Ferreira
   Duarte-Almeida, Joaquim Mauricio
   Siqueira Ferreira, Jaqueline Maria
   Rodrigues dos Santos Lima, Luciana Alves
TI Antioxidant, antibacterial and cytotoxic potential of the ripe fruits of
   Solanum lycocarpum A. St. Hil. (Solanaceae)
SO NATURAL PRODUCT RESEARCH
LA English
DT Article
DE cytotoxic; Solanum lycocarpum; ripe fruits; phenolic; antibacterial;
   antioxidant
AB Ethanol extract (EE) and fractions obtained from the ripe fruits of Solanum lycocarpum were examined in order to determine their phenolic composition, antioxidant capacity, antibacterial activities and cytotoxic potential. High-performance liquid chromatography coupled with DAD analysis indicated that caffeic and chlorogenic acids were the main phenolic compounds present in the EE, dichloromethane (DCM) and ethyl acetate (Ac) fractions. The antioxidant activity assessed by the scavenging ability on 1,1-diphenyl-2-picrylhydrazyl radical was significantly more pronounced for DCM and Ac fractions than that of the commercial antioxidant 2,6-di-tert-butyl-4-methylphenol (BHT). EE and fractions exhibited selective antibacterial activity against Gram-positive bacteria, especially the hexane (Hex) and DCM fractions. EE and fractions exhibited low toxicity towards the LLC-MK2 cell line, especially the Hex, DCM and Ac fractions. This work provides the knowledge of phenolic composition in the extract and fractions from the ripe fruits of S. lycocarpum and their antioxidant, antibacterial and cytotoxic activities.
C1 [Morais, Melissa Grazielle; Ferreira da Costa, Guilherme Augusto; Aleixo, Alan Alex; de Oliveira, Graziela Teixeira; Alves, Lucas Ferreira; Duarte-Almeida, Joaquim Mauricio; Siqueira Ferreira, Jaqueline Maria; Rodrigues dos Santos Lima, Luciana Alves] Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
RP Lima, LARD (corresponding author), Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, Rua Sebastiao Goncalves Coelho 400, BR-35501296 Divinopolis, MG, Brazil.
EM luarsantos@ufsj.edu.br
RI Ferreira, Jaqueline/E-4630-2018; , Luciana/T-8434-2019
OI Ferreira, Jaqueline/0000-0002-1779-1975; , Luciana/0000-0002-4130-0304;
   Morais, Melissa/0000-0002-5825-9897
FU Universidade Federal de Sao Joao Del Rei (UFSJ); Fundacao deAmparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research
   Foundation (FAPEMIG)
FX The authors are grateful to the Universidade Federal de Sao Joao Del Rei
   (UFSJ) and Fundacao deAmparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG) for their fellowships, Laboratory for Reference Materials of
   the Oswaldo Cruz Foundation, FIOCRUZ, for the donation of bacteria
   strains, and to Prof. Dr Alexandre Salino for the botanical
   identification this plant.
CR Al-Fatimi M, 2007, J ETHNOPHARMACOL, V111, P657, DOI 10.1016/j.jep.2007.01.018
   Bontempo P, 2013, FOOD CHEM TOXICOL, V55, P304, DOI 10.1016/j.fct.2012.12.048
   Clerici MTPS, 2011, FOOD RES INT, V44, P1658, DOI 10.1016/j.foodres.2011.04.020
   Duarte-Almeida JM, 2011, FOOD CHEM, V125, P660, DOI 10.1016/j.foodchem.2010.09.059
   Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793
   Jimoh FO, 2010, FOOD CHEM TOXICOL, V48, P964, DOI 10.1016/j.fct.2010.01.007
   Martins G. Z., 2013, Journal of Applied Sciences, V13, P147, DOI 10.3923/jas.2013.147.153
   Miranda MA, 2013, CHEM BIODIVERS, V10, P642, DOI 10.1002/cbdv.201200063
   Munari CC, 2012, FOOD CHEM TOXICOL, V50, P3696, DOI 10.1016/j.fct.2012.07.028
   Sakakibara H, 2003, J AGR FOOD CHEM, V51, P571, DOI 10.1021/jf020926l
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   SOUZA VC, 2005, BOT SISTEMATICA
   Vieira G, 2003, PHYTOTHER RES, V17, P892, DOI 10.1002/ptr.1247
NR 13
TC 12
Z9 13
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
PD MAR 4
PY 2015
VL 29
IS 5
BP 480
EP 483
DI 10.1080/14786419.2014.951930
PG 4
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA AY4FT
UT WOS:000347534400018
PM 25159821
DA 2020-09-29
ER

PT J
AU da Costa, GAF
   Morais, MG
   Saldanha, AA
   Silva, ICA
   Aleixo, AA
   Ferreira, JMS
   Soares, AC
   Duarte-Almeida, JM
   Lima, LARD
AF Ferreira da Costa, Guilherme Augusto
   Morais, Melissa Grazielle
   Saldanha, Aline Aparecida
   Assis Silva, Izabela Caputo
   Aleixo, Alan Alex
   Siqueira Ferreira, Jaqueline Maria
   Soares, Adriana Cristina
   Duarte-Almeida, Joaquim Mauricio
   Rodrigues dos Santos Lima, Luciana Alves
TI Antioxidant, Antibacterial, Cytotoxic, and Anti-Inflammatory Potential
   of the Leaves of Solanum lycocarpum A. St. Hil. (Solanaceae)
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID OXIDATIVE STRESS; IN-VITRO; FLAVONOIDS; EXTRACT; FRUITS; TEA;
   POLYPHENOLS; KAEMPFEROL; FRACTIONS; HEALTH
AB Ethanol extract and fractions obtained from leaves of Solanum lycocarpum were examined in order to determine their phenolic composition, antioxidant, antibacterial, anti-inflammatory, and cytotoxic potential. High performance liquid chromatography coupled with DAD analysis indicated that the flavonoids apigenin and kaempferol were the main phenolic compounds present in dichloromethane and ethyl acetate fractions, respectively. The antioxidant activity was significantly more pronounced for dichloromethane, ethyl acetate, and hydroethanol fractions than that of the commercial antioxidant 2,6-di-tert-butyl-4-methylphenol. The hexane and dichloromethane fractions were more active against the tested bacteria. The hydroethanol fraction exhibited significant anti-inflammatory activity at the dose of 75 and 150mg/kg in the later phase of inflammation. However, the antiedematogenic effect of the higher dose of the ethyl acetate fraction (150mg/kg) was more pronounced. The ethyl acetate fraction also presented a less cytotoxic effect than the ethanol extract and other fractions. These activities found in S. lycocarpum leaves can be attributed, at least in part, to the presence of phenolic constituents such as flavonoids. This work provided the knowledge of phenolic composition in the extract and fractions and the antioxidant, antibacterial, anti-inflammatory, and cytotoxic activities of leaves of S. lycocarpum.
C1 [Ferreira da Costa, Guilherme Augusto; Morais, Melissa Grazielle; Saldanha, Aline Aparecida; Assis Silva, Izabela Caputo; Aleixo, Alan Alex; Siqueira Ferreira, Jaqueline Maria; Soares, Adriana Cristina; Duarte-Almeida, Joaquim Mauricio; Rodrigues dos Santos Lima, Luciana Alves] Univ Fed Sao Joao Del Rei, BR-35501296 Divinopolis, MG, Brazil.
RP Lima, LARD (corresponding author), Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
EM luarsantos@ufsj.edu.br
RI , Luciana/T-8434-2019; Ferreira, Jaqueline/E-4630-2018
OI , Luciana/0000-0002-4130-0304; Ferreira, Jaqueline/0000-0002-1779-1975;
   Morais, Melissa/0000-0002-5825-9897
FU Universidade Federal de Sao Joao Del-Rei (UFSJ); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas Gerais State
   Research Foundation (FAPEMIG)
FX The authors thank the Campus Centro-Oeste Dona Lindu of Universidade
   Federal de Sao Joao Del-Rei (CCO/UFSJ) for the infrastructure. The
   authors are grateful to the Universidade Federal de Sao Joao Del-Rei
   (UFSJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG) for their fellowships, to Laboratory for Reference Materials
   of the Oswaldo Cruz Foundation, FIOCRUZ, by the donation of bacteria
   strains, and to Professor Dr. Alexandre Salino for botanical
   identification of this plant. They are grateful to Centro de Pesquisa
   Rene Rachou of the Oswaldo Cruz Foundation (CPqRR/FIOCRUZ) and
   Universidade Federal de Sao Joao Del-Rei (UFSJ) by the donation of Swiss
   mice.
CR Al-Fatimi M, 2007, J ETHNOPHARMACOL, V111, P657, DOI 10.1016/j.jep.2007.01.018
   [Anonymous], 2006, M7A7 CLSI
   Araujo S.G., 2013, BIOCH BIOTECHNOLOGY, V2, P35
   Bontempo P, 2013, FOOD CHEM TOXICOL, V55, P304, DOI 10.1016/j.fct.2012.12.048
   Bovy A, 2007, METABOLOMICS, V3, P399, DOI 10.1007/s11306-007-0074-2
   Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m
   Burke A, 2006, GOODMAN GILMANS PHAR, P671
   Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8
   Cornelius M. T. F., 2004, REV BRASILEIRA FARMA, V85, P57
   Torres AFC, 2010, TOXICON, V55, P795, DOI 10.1016/j.toxicon.2009.11.013
   Di Rosa M., 1974, FUTURE TRENDS INFLAM, P143
   Doll VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061404
   Duarte-Almeida JM, 2011, FOOD CHEM, V125, P660, DOI 10.1016/j.foodchem.2010.09.059
   Finney D.J., 1980, PROBIT ANAL STAT TRE
   Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793
   Graf BA, 2005, J MED FOOD, V8, P281, DOI 10.1089/jmf.2005.8.281
   Hollman PCH, 1999, FREE RADICAL RES, V31, pS75, DOI 10.1080/10715769900301351
   Huang HC, 2010, J AGR FOOD CHEM, V58, P8699, DOI 10.1021/jf101003v
   Ichikawa D, 2004, BIOL PHARM BULL, V27, P1353, DOI 10.1248/bpb.27.1353
   Jeyabal PVS, 2005, MOL CARCINOGEN, V44, P11, DOI 10.1002/mc.20115
   Jimoh FO, 2010, FOOD CHEM TOXICOL, V48, P964, DOI 10.1016/j.fct.2010.01.007
   Khan S, 2011, J ETHNOPHARMACOL, V135, P654, DOI 10.1016/j.jep.2011.03.064
   LEVY L, 1969, LIFE SCI PT 1 PHYSI, V8, P601, DOI 10.1016/0024-3205(69)90021-6
   Loganayaki N, 2012, J ETHNOPHARMACOL, V140, P230, DOI 10.1016/j.jep.2012.01.001
   Miranda MA, 2013, CHEM BIODIVERS, V10, P642, DOI 10.1002/cbdv.201200063
   Morais M. G., 2013, BIOCH BIOTECHNOLOGY, V2, P37, DOI [10.5433/2316-5200.2013v2n2p37, DOI 10.5433/2316-5200.2013V2N2P37]
   Morais MI, 2014, NAT PROD RES, V28, P1275, DOI 10.1080/14786419.2014.895728
   Morais MG, 2015, NAT PROD RES, V29, P480, DOI 10.1080/14786419.2014.951930
   Munari CC, 2012, FOOD CHEM TOXICOL, V50, P3696, DOI 10.1016/j.fct.2012.07.028
   Nielsen SE, 1999, BRIT J NUTR, V81, P447, DOI 10.1017/S000711459900080X
   Pan MH, 2000, BIOCHEM PHARMACOL, V59, P357, DOI 10.1016/S0006-2952(99)00335-4
   Pereira TM, 2014, REV SOC BRAS MED TRO, V47, P646, DOI 10.1590/0037-8682-0010-2014
   Rho HS, 2011, MOLECULES, V16, P3338, DOI 10.3390/molecules16043338
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Souza V. C., 2008, BOT SISTEMATICA GUIA
   Tatsimo Simplice Joel Ndendoung, 2012, BMC Res Notes, V5, P158, DOI 10.1186/1756-0500-5-158
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Vieira G, 2003, PHYTOTHER RES, V17, P892, DOI 10.1002/ptr.1247
   VINSON JA, 1995, J AGR FOOD CHEM, V43, P2800, DOI 10.1021/jf00059a005
   Wiseman SA, 1997, CRIT REV FOOD SCI, V37, P705, DOI 10.1080/10408399709527798
   Yang FJ, 1998, J NUTR, V128, P2334
NR 41
TC 1
Z9 1
U1 0
U2 8
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2015
AR 315987
DI 10.1155/2015/315987
PG 8
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CJ9DX
UT WOS:000355803800001
PM 26064159
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Taranto, MFD
   Pessanha, JEM
   dos Santos, M
   Andrade, ACDP
   Camargos, VN
   Alves, SN
   Oliveira, CD
   Taranto, AG
   dos Santos, LL
   de Magalhaes, JC
   Kroon, EG
   Figueiredo, LB
   Drumond, BP
   Ferreira, JMS
AF da Rocha Taranto, Martinelle Ferreira
   Marques Pessanha, Jose Eduardo
   dos Santos, Michelli
   dos Santos Pereira Andrade, Ana Claudia
   Camargos, Vidyleison Neves
   Alves, Stenio Nunes
   Oliveira, Claudia Di Lorenzo
   Taranto, Alex Gutterres
   dos Santos, Luciana Lara
   de Magalhaes, Jose Carlos
   Kroon, Erna Geessien
   Figueiredo, Leandra Barcelos
   Drumond, Betania Paiva
   Siqueira Ferreira, Jaqueline Maria
TI Dengue outbreaks in Divinopolis, south-eastern Brazil and the geographic
   and climatic distribution of Aedes albopictus and Aedes aegypti in
   2011-2012
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE Aedes albopictus; Aedes aegypti; dengue; entomological index; ovitraps;
   Aedes albopictus; Aedes aegypti; dengue; indice entomologique; pieges a
   OEufs; Aedes albopictus; Aedes aegypti; dengue; indice entomologico;
   ovitrampas
ID RIO-DE-JANEIRO; DIPTERA; CULICIDAE; VIRUS; TEMPERATURE; DYNAMICS;
   HISTORY; TRANSMISSION; REEMERGENCE; MOSQUITOS
AB ObjectiveTo entomologically monitor Aedes spp. and correlate the presence of these vectors with the recent epidemic of dengue in Divinopolis, Minas Gerais State, Brazil.
   MethodsOvitraps were installed at 44 points in the city, covering six urban areas, from May 2011 to May 2012. After collection, the eggs were incubated until hatching. In the 4th stage of development, the larvae were classified as Ae.aegypti or Ae.albopictus.
   ResultsIn total, 25633 Aedes spp. eggs were collected. February was the month with the highest incidence, with 5635 eggs collected and a hatching rate of 46.7%. Ae.aegypti eggs had the highest hatching rate, at 72.3%, whereas Ae.albopictus eggs had 27.7%. Climate and population density influenced the number of eggs found. Indicators of vector presence were positively correlated with the occurrence of dengue cases.
   ConclusionThese data reinforce the need for entomological studies, highlight the relevance of Ae.albopictus as a possible disease vector and demonstrate its adaptation. Ae.albopictus, most commonly found in forested areas, comprised a substantial proportion of the urban mosquito population.
   ObjectifSurveiller entomologiquement Aedes spp. et correler la presence de ces vecteurs avec l'epidemie recente de dengue a Divinopolis, dans l'Etat de Minas Gerais, au Bresil.
   MethodesDes pieges a OEufs ont ete installes a 44 points de la ville, couvrant 6 zones urbaines, de mai 2011 a mai 2012. Apres la collecte, les OEufs ont ete incubes jusqu'a l'eclosion. Au 4(eme) stade de developpement, les larves ont ete classees comme Ae. aegypti ou Ae. albopictus.
   ResultatsAu total, 25 633 OEufs d'Aedes spp. ont ete collectes. Fevrier etait le mois avec l'incidence la plus elevee, avec 5635 OEufs collectes et un taux d'eclosion de 46,7%. Les OEufs d'Ae. aegypti avaient le taux d'eclosion le plus eleve de 72,3% par rapport a 27,7% pour les OEufs d'Ae. albopictus. Le climat et la densite de population influencaient le nombre d'OEufs trouves. Les indicateurs de la presence de vecteurs etaient positivement correles a la survenue des cas de dengue.
   ConclusionCes donnees renforcent la necessite d'etudes entomologiques, mettent en evidence la pertinence de Ae. albopictus comme un possible vecteur de la maladie et demontrent son adaptation. Ae. albopictus, plus souvent retrouve dans les zones boisees, comprend une proportion importante de la population de moustiques urbains.
   ObjetivoRealizar una monitorizacion entomologica de Aedes spp. y correlacionar la presencia de estos vectores con la epidemia reciente de dengue en Divinopolis, Estado de Minas Gerais, Brasil.
   MetodosSe instalaron ovitrampas en 44 puntos de la ciudad, cubriendo 6 areas urbanas, entre Mayo del 2011 y Mayo del 2012. Tras su recoleccion, los huevos se incubaron hasta que eclosionaron. En el 4to estadio de desarrollo, las larvas se clasificaron como Ae. aegypti o Ae. albopictus.
   ResultadosEn total se recolectaron 25,633 huevos de Aedes spp. Febrero fue el mes con la mayor incidencia: se recolectaron 5,635 huevos con una tasa de eclosion del 46.7%. Los huevos de Ae. aegypti tenian la mayor tasa de eclosion (72.3%) que los de Ae. albopictus (27.7%). El clima y la densidad poblacional influian sobre el numero de huevos encontrados. Los indicadores de presencia vectorial estaban positivamente correlacionados con los casos de dengue.
   ConclusionEstos datos refuerzan la necesidad de estudios entomologicos, subrayan la relevancia de Ae. albopictus como un posible vector de enfermedad y demuestran su adaptacion. Ae. albopictus, comunmente encontrado en areas forestales, es tambien una parte sustancial de la poblacion urbana de mosquitos.
C1 [da Rocha Taranto, Martinelle Ferreira; dos Santos, Michelli; dos Santos Pereira Andrade, Ana Claudia; Camargos, Vidyleison Neves; Alves, Stenio Nunes; Oliveira, Claudia Di Lorenzo; Taranto, Alex Gutterres; dos Santos, Luciana Lara; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Campus Ctr Oeste Dona Lindu, BR-35501293 Divinopolis, MG, Brazil.
   [Marques Pessanha, Jose Eduardo] Secretaria Municipal Saude Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Marques Pessanha, Jose Eduardo] Univ Fed Minas Gerais, Observ Saude Urbana, Belo Horizonte, MG, Brazil.
   [de Magalhaes, Jose Carlos] Univ Fed Sao Joao del Rei, Dept Quim Biotecnol & Engn Bioproc, Ouro Branco, Brazil.
   [dos Santos Pereira Andrade, Ana Claudia; Kroon, Erna Geessien; Figueiredo, Leandra Barcelos] Univ Fed Minas Gerais, Virus Lab, Belo Horizonte, MG, Brazil.
   [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Virol Lab, Juiz De Fora, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao del Rei, Microbiol Lab, Campus Ctr Oeste Dona Lindu, Rua Sebastiao Goncalves Coelho 400, BR-35501293 Divinopolis, MG, Brazil.
EM jaque@ufsj.edu.br
RI Santos, Luciana L/C-9688-2013; Oliveira, Claudia/O-2326-2019; Kroon,
   Erna Geessien/B-3631-2015; Taranto, Alex G/F-8618-2012; Ferreira,
   Jaqueline/E-4630-2018; Santos, Michelli dos/Q-2341-2019; Kroon,
   Erna/V-5444-2019; Camargos, Vidyleison/AAN-2202-2020; Alves, Stenio
   Nunes/B-6031-2013
OI Santos, Luciana L/0000-0001-6186-4062; Oliveira,
   Claudia/0000-0001-8533-8155; Kroon, Erna Geessien/0000-0003-2721-3826;
   Taranto, Alex G/0000-0002-6086-1043; Ferreira,
   Jaqueline/0000-0002-1779-1975; Santos, Michelli dos/0000-0003-0257-6620;
   Camargos, Vidyleison/0000-0002-7926-0950; Alves, Stenio
   Nunes/0000-0002-4103-2266; Taranto, Martinelle/0000-0001-5556-4506
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); PRONEX
   CNPq/FAPEMIGNational Council for Scientific and Technological
   Development (CNPq)Minas Gerais State Research Foundation (FAPEMIG)
   [550106/2010-3]; CapesCAPES
FX We thank Adriana Aparecida Gomes, Wanderson Teixeira and the health
   agents of the Secretaria Municipal de Saude/Prefeitura Municipal de
   Divinopolis, MG, for their contributions to this work. We are grateful
   for financial support from FAPEMIG, PRONEX CNPq/FAPEMIG 550106/2010-3
   and Capes.
CR Alencar CHM, 2008, REV APS, V11, P459
   Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009
   Chadee DD, 2009, ACTA TROP, V111, P279, DOI 10.1016/j.actatropica.2009.05.012
   Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   de Carvalho-Leandro D, 2010, REV BRAS ENTOMOL, V54, P701, DOI 10.1590/S0085-56262010000400025
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   Decker KD, 2012, JNP-J NURSE PRACT, V8, P389, DOI 10.1016/j.nurpra.2011.09.004
   Degallier N, 2003, REV SAUDE PUBL, V37, P386, DOI [10.1590/S0034-89102003000300019, 10.1590/s0034-89102003000300019]
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   Gomes AC, 1998, INF EPIDEMIOL SUS, V7, P49, DOI DOI 10.5123/S0104-16731998000300006
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Khormi HM, 2011, SCI TOTAL ENVIRON, V409, P4713, DOI 10.1016/j.scitotenv.2011.08.028
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Le Goff G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-207
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030178
   Ministerio da Saude: FUNASA-FundacAo Nacional de Saude, 2001, DENG INSTR PESS COMB, P84
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   NOGUEIRA RMR, 1991, MEM I OSWALDO CRUZ, V86, P269, DOI 10.1590/S0074-02761991000200018
   Nunes LS, 2011, BIOTA AMAZONIA, V1, P26
   Padmanabha H, 2012, J INSECT PHYSIOL, V58, P1597, DOI 10.1016/j.jinsphys.2012.09.015
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   PEDRO Antonio, 1923, Brasil-Medico, V1, P173
   Pessanha José Eduardo Marques, 2011, Rev. Soc. Bras. Med. Trop., V44, P103, DOI 10.1590/S0037-86822011000100023
   Ponce G, 2004, REV SALUD PUBLICA NU, V5, P1
   Prophiro JS, 2011, REV SOC BRAS MED TRO, V44, P300, DOI [10.1590/s0037-86822011005000025, 10.1590/S0037-86822011005000025]
   REITER P, 1991, J AM MOSQUITO CONTR, V7, P52
   Reiter Paul, 1997, P425
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   SEMUSA, 2010, B EP
   SEMUSA, 2001, B EP
   SILVA HHG, 1999, REV SOC BRAS MED TRO, V32, P349, DOI DOI 10.1590/S0037-86821999000400003
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   SINAN, 2014, SYST REP NOT COND
   Thenmozhi V, 2007, JPN J INFECT DIS, V60, P245
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
NR 51
TC 8
Z9 8
U1 1
U2 40
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD JAN
PY 2015
VL 20
IS 1
BP 77
EP 88
DI 10.1111/tmi.12402
PG 12
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA AW0GX
UT WOS:000345970400010
PM 25328988
DA 2020-09-29
ER

PT J
AU Araujo, SG
   Alves, LF
   Pinto, MEA
   Oliveira, GT
   Siqueira, EP
   Ribeiro, RIMA
   Ferreira, JMS
   Lima, LARS
AF Araujo, Sthefane G.
   Alves, Lucas F.
   Pinto, Maria Eduarda A.
   Oliveira, Graziela T.
   Siqueira, Ezequias P.
   Ribeiro, Rosy I. M. A.
   Ferreira, Jaqueline M. S.
   Lima, Luciana A. R. S.
TI Volatile compounds of Lamiaceae exhibit a synergistic antibacterial
   activity with streptomycin
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Lamiaceae; antibacterial; ethanol extracts; volatile compounds;
   streptomycin
ID ESSENTIAL OIL; INFECTIOUS-DISEASES; MEDICINE; AGENTS; PLANTS
AB Bacterial infections cause thousands of deaths in the world every year. In most cases, infections are more serious because the patient is already weakened, and often, the bacteria are already resistant to the antibiotics used. Counterparting this negative scenario, the interest in medicinal plants as an alternative to the synthetic antimicrobial drugs is blossoming worldwide. In the present work, we identified the volatile compounds of ethanol extracts of Melissa officinalis, Mentha sp., Ocimum basilicum, Plectranthus barbatus, and Rosmarinus officinalis by gas chromatography/mass spectrometry (GC/MS). Also was evaluated antimicrobial activity of ethanol extracts against 6 bacteria of clinical interest, and was tested the interaction of these extracts with a commercial antibiotic streptomycin. Phytol was a compound identified in all extracts by GC/MS, being majoritary component in Plectranthus barbatus and Rosmarinus officinalis. The Gram-positive bacteria were more sensitive to ethanol extracts, and Plectranthus barbatus and Rosmarinus officinalis were the most active extracts. Ethanol extracts exhibited a synergetic effect with streptomycin. These results encourage additional studies, in order to evaluate the possibilities of using ethanol extracts of Lamiaceae family as natural source for antibacterial activity.
C1 [Araujo, Sthefane G.; Alves, Lucas F.; Pinto, Maria Eduarda A.; Oliveira, Graziela T.; Ribeiro, Rosy I. M. A.; Ferreira, Jaqueline M. S.; Lima, Luciana A. R. S.] Univ Fed Sao Joao Del Rei, BR-35501296 Divinopolis, MG, Brazil.
   [Siqueira, Ezequias P.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Quim Prod Nat, Belo Horizonte, MG, Brazil.
RP Lima, LARS (corresponding author), Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
EM luarsantos@ufsj.edu.br
RI , Luciana/T-8434-2019; Ferreira, Jaqueline/E-4630-2018; Ribeiro, Rosy
   Iara Maciel Azambuja/C-6073-2014; Ribeiro, Rosy/O-8831-2019
OI , Luciana/0000-0002-4130-0304; Ferreira, Jaqueline/0000-0002-1779-1975;
   Ribeiro, Rosy Iara Maciel Azambuja/0000-0002-7374-4743; Ribeiro,
   Rosy/0000-0002-7374-4743
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX The authors are grateful to the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG) for their fellowships, Laboratory for
   Reference Materials of the Oswaldo Cruz Foundation, FIOCRUZ, by the
   donation of bacteria strains, and Whocely Victor de Castro for
   suggestions.
CR Arbex MA, 2010, J BRAS PNEUMOL, V36, P641, DOI 10.1590/S1806-37132010000500017
   Bereket W, 2012, EUR REV MED PHARMACO, V16, P1039
   Bozin B, 2006, J AGR FOOD CHEM, V54, P1822, DOI 10.1021/jf051922u
   Clinical and Laboratory Standards Institute, 2006, M7A6 CSLI
   Torres AFC, 2010, TOXICON, V55, P795, DOI 10.1016/j.toxicon.2009.11.013
   Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x
   Galvao LCC, 2012, EVID-BASED COMPL ALT, V13, P1
   He LL, 2006, FOOD RES INT, V39, P905, DOI 10.1016/j.foodres.2006.05.008
   Holetz FB, 2002, MEM I OSWALDO CRUZ, V97, P1027, DOI 10.1590/S0074-02762002000700017
   Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2
   Lee YS, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/618081
   Ozdemir G, 2004, PHYTOTHER RES, V18, P754, DOI 10.1002/ptr.1541
   Samy RP, 2006, J ETHNOPHARMACOL, V107, P99, DOI 10.1016/j.jep.2006.02.020
   Santoyo S, 2005, J FOOD PROTECT, V68, P790, DOI 10.4315/0362-028X-68.4.790
   Singh PK, 2000, AM J PHYSIOL-LUNG C, V279, pL799
   SOUZA VC, 2005, BOT SISTEMATICA
   Tahmourespour A, 2011, BRAZ J MICROBIOL, V42, P330, DOI 10.1590/S1517-83822011000100042
   Tavares AC, 2008, J ETHNOPHARMACOL, V119, P129, DOI 10.1016/j.jep.2008.06.012
   Tortora G. J., 2005, MICROBIOLOGIA
   Vukovic N, 2007, EVID-BASED COMPL ALT, V4, P17, DOI 10.1093/ecam/nem108
   White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914
   Yang K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001483
   Yoshiro I., 2005, ANTIMICROB AGENTS CH, V49, P1770, DOI DOI 10.1128/AAC.49.5.1770-1774.2005
NR 23
TC 9
Z9 9
U1 0
U2 24
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD OCT-DEC
PY 2014
VL 45
IS 4
BP 1341
EP 1347
DI 10.1590/S1517-83822014000400026
PG 7
WC Microbiology
SC Microbiology
GA CC2UM
UT WOS:000350200100026
PM 25763039
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Silva-Moraes, V
   Ferreira, JMS
   Coelho, PMZ
   Grenfell, RFQ
AF Silva-Moraes, Vanessa
   Siqueira Ferreira, Jaqueline Maria
   Zech Coelho, Paulo Marcos
   Queiroz Grenfell, Rafaella Fortini
TI Biomarkers for schistosomiasis: Towards an integrative view of the
   search for an effective diagnosis
SO ACTA TROPICA
LA English
DT Review
DE Biomarkers; Diagnosis; Schistosomiasis mansoni; Adult worm;
   Schistossomula; Egg
ID CIRCULATING CATHODIC ANTIGEN; PROTEOMIC ANALYSIS; MANSONI INFECTION;
   CROSS-REACTIVITY; IMMUNE-RESPONSE; URINE; SERUM; CHILDREN; ASSAY; AREAS
AB Human schistosomiasis, caused mainly by Schistosoma mansoni, S. japonicum, and S. hematobium, remains a prevalent and serious parasitic disease worldwide. Although it is a debilitating disease, a lack of sensitive methods for the precise diagnosis of active infection cases is important to prevent morbidity. The optimization of new diagnostic approaches may be accomplished by the selection of specific markers. In that manner, markers can be satisfactorily used for detection of different phases of infection, as acute and chronic phases, pre-patent and post-patent phases and after chemotherapy, improving the efficiency of methods. For that purpose, proteomics and glycomics analyses have been performed in schistosomes, in particular S. mansoni, using powerful high-throughput methodologies. These investigations have not only chartered protein, o-glycan and n-glycan profiles across developmental stages within mammalian host, but are also leading to the characterization of features of the surface tegument, the eggshell and excretory-secretory proteomes of schistosomes. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Silva-Moraes, Vanessa; Zech Coelho, Paulo Marcos; Queiroz Grenfell, Rafaella Fortini] Oswaldo Cruz Fdn Fiocruz, Res Ctr Rene Rachou, Monoclonal Antibody Facil, Lab Schistosomiasis, BR-30190002 Belo Horizonte, MG, Brazil.
   [Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao Del Rei, Microbiol Lab, BR-35501296 Divinopolis, MG, Brazil.
RP Grenfell, RFQ (corresponding author), Oswaldo Cruz Fdn Fiocruz, Res Ctr Rene Rachou, Monoclonal Antibody Facil, Lab Schistosomiasis, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM rafaella@cpqrr.fiocruz.br
RI Ferreira, Jaqueline/E-4630-2018; Silva-Moraes, Vanessa/Q-3291-2018
OI Ferreira, Jaqueline/0000-0002-1779-1975; Silva-Moraes,
   Vanessa/0000-0003-2991-7210
CR Aryeetey YA, 2013, AM J TROP MED HYG, V88, P1028, DOI 10.4269/ajtmh.12-0571
   Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351
   Beck L, 2008, ACTA TROP, V108, P229, DOI 10.1016/j.actatropica.2008.08.012
   CALL JL, 1995, J PARASITOL, V81, P742, DOI 10.2307/3283965
   Cardoso FC, 2006, CLIN EXP IMMUNOL, V144, P382, DOI 10.1111/j.1365-2249.2006.03081.x
   Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639
   CORREA-OLIVEIRA R, 1987, Memorias do Instituto Oswaldo Cruz, V82, P179, DOI 10.1590/S0074-02761987000800031
   Coulibaly JT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002109
   Coulibaly JT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001384
   Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200
   DAVIS A, 2009, MANSONS TROPICAL DIS, P1425
   de Noya BA, 2000, EXP PARASITOL, V95, P106, DOI 10.1006/expr.2000.4515
   DEELDER AM, 1994, TROP GEOGR MED, V46, P233
   DISSOUS C, 1982, J IMMUNOL, V129, P2232
   Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019
   Enk MJ, 2010, MEM I OSWALDO CRUZ, V105, P537, DOI 10.1590/S0074-02762010000400032
   Gobert GN, 2010, TRENDS PARASITOL, V26, P434, DOI 10.1016/j.pt.2010.04.009
   Gomes LI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000664
   Goulart LR, 2010, CRIT REV IMMUNOL, V30, P201, DOI 10.1615/CritRevImmunol.v30.i2.70
   Grenfell R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002054
   HAMBURGER J, 1991, MOL BIOCHEM PARASIT, V44, P73, DOI 10.1016/0166-6851(91)90222-R
   Hansell E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000262
   Harrop R, 1999, PARASITOLOGY, V118, P583, DOI 10.1017/S003118209900431X
   Hokke CH, 2007, TRENDS PARASITOL, V23, P165, DOI 10.1016/j.pt.2007.02.007
   Jenkins SJ, 2005, PARASITE IMMUNOL, V27, P385, DOI 10.1111/j.1365-3024.2005.00789.x
   Jenkins-Holick Darcy S, 2013, Urol Nurs, V33, P163
   KATZ N, 1970, J PARASITOL, V56, P1032, DOI 10.2307/3277532
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4
   Kusel JR, 2007, PARASITOLOGY, V134, P1477, DOI 10.1017/S0031182007002971
   LIBERTI P, 1986, MOL BIOCHEM PARASIT, V18, P55, DOI 10.1016/0166-6851(86)90050-2
   Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029
   Lodh N, 2013, AM J TROP MED HYG, V89, P46, DOI 10.4269/ajtmh.13-0104
   Losada S, 2005, EXP PARASITOL, V111, P182, DOI 10.1016/j.exppara.2005.07.007
   MCLAREN DJ, 1977, NATURE, V269, P147, DOI 10.1038/269147a0
   Mikhail Mary M., 1997, Journal of the Egyptian Society of Parasitology, V27, P1
   Noya O, 2002, MEM I OSWALDO CRUZ, V97, P167, DOI 10.1590/S0074-02762002000900032
   NOYA O, 1995, PARASITE IMMUNOL, V17, P111, DOI 10.1111/j.1365-3024.1995.tb01012.x
   Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7
   Perez-Sanchez R, 2008, MOL BIOCHEM PARASIT, V161, P112, DOI 10.1016/j.molbiopara.2008.06.011
   Perez-Sanchez R, 2006, PROTEOMICS, V6, pS226, DOI 10.1002/pmic.200500420
   Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455
   Grenfell RFQ, 2013, MEM I OSWALDO CRUZ, V108, P328, DOI 10.1590/S0074-02762013000300011
   Grenfell RFQ, 2012, SCI WORLD J, DOI 10.1100/2012/593947
   Grenfell RFQ, 2012, REV SOC BRAS MED TRO, V45, P505, DOI 10.1590/S0037-86822012000400018
   Ramaswamy K, 1996, J INFLAMM, V46, P13
   Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396
   Shaheen H, 1996, EXP PARASITOL, V82, P222, DOI 10.1006/expr.1996.0028
   Shane HL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000951
   Steiner F, 2013, J TRAVEL MED, V20, P380, DOI 10.1111/jtm.12069
   Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7
   Stothard JR, 2009, ACTA TROP, V111, P64, DOI 10.1016/j.actatropica.2009.02.009
   Stothard JR, 2009, T ROY SOC TROP MED H, V103, P325, DOI 10.1016/j.trstmh.2008.12.012
   Sulahian A, 2005, CLIN DIAGN LAB IMMUN, V12, P548, DOI 10.1128/CDLI.12.4.548-551.2005
   Sulbaran GS, 2010, PARASITE IMMUNOL, V32, P20, DOI 10.1111/j.1365-3024.2009.01152.x
   Taratam CA, 2010, EXP PARASITOL, V126, P146, DOI 10.1016/j.exppara.2010.04.008
   Thornhill J, 2010, MEM I OSWALDO CRUZ, V105, P387, DOI 10.1590/S0074-02762010000400007
   Utzinger J, 2011, ACTA TROP, V120, pS121, DOI 10.1016/j.actatropica.2010.08.020
   Valli LCP, 1999, AM J TROP MED HYG, V61, P302, DOI 10.4269/ajtmh.1999.61.302
   van Dam GJ, 2013, EXP PARASITOL, V135, P274, DOI 10.1016/j.exppara.2013.06.017
   van Diepen A, 2012, PARASITOLOGY, V139, P1219, DOI 10.1017/S0031182012000273
   VANLIESHOUT L, 1992, AM J TROP MED HYG, V47, P463, DOI 10.4269/ajtmh.1992.47.463
   Vendrame Celia Maria V., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P153, DOI 10.1590/S0036-46652001000300007
   Wilson RA, 2012, PARASITOLOGY, V139, P1178, DOI 10.1017/S0031182012000339
NR 64
TC 11
Z9 11
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD APR
PY 2014
VL 132
BP 75
EP 79
DI 10.1016/j.actatropica.2013.12.024
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AE5AV
UT WOS:000334001100010
PM 24412728
DA 2020-09-29
ER

PT J
AU de Oliveira, GT
   Ferreira, JMS
   Rosa, LH
   de Siqueira, EP
   Johann, S
   Lima, LARD
AF de Oliveira, Graziela Teixeira
   Siqueira Ferreira, Jaqueline Maria
   Rosa, Luiz Henrique
   de Siqueira, Ezequias Pessoa
   Johann, Susana
   Rodrigues dos Santos Lima, Luciana Alves
TI In vitro antifungal activities of leaf extracts of Lippia alba
   (Verbenaceae) against clinically important yeast species
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Lippia alba; Antifungal activity; Yeast
ID SUSCEPTIBILITY; FLUCONAZOLE; NEOFORMANS; MEDICINE
AB Introduction: There are few studies reporting the antifungal activities of Lippia alba extracts. Methods: A broth microdilution assay was used to evaluate the antifungal effects of Lippia alba extracts against seven yeast species of Candida and Cryptococcus. The butanol fraction was investigated by gas chromatography-mass spectrometry. Results: The butanol fraction showed the highest activity against Candida glabrata. The fraction also acted synergistically with itraconazole and fluconazole against C. glabrata. The dominant compounds in the butanol fraction were 2,2,5-trimethyl-3,4-hexanedione, 3,5-dimethyl-4-octanone and hexadecane. Conclusions: The butanol fraction may be a good candidate in the search for new drugs from natural products with antifungal activity.
C1 [de Oliveira, Graziela Teixeira; Siqueira Ferreira, Jaqueline Maria; Rodrigues dos Santos Lima, Luciana Alves] Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Rosa, Luiz Henrique; Johann, Susana] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [de Siqueira, Ezequias Pessoa] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
RP Lima, LARD (corresponding author), UFSJ, Campus Ctr Oeste Dona Lindu, Rua Sebastiao Goncalves Coelho 400, BR-35501296 Divinopolis, MG, Brazil.
EM luarsantos@ufsj.edu.br
RI Ferreira, Jaqueline/E-4630-2018; , Luciana/T-8434-2019
OI Ferreira, Jaqueline/0000-0002-1779-1975; , Luciana/0000-0002-4130-0304
FU Conselho Nacional de Desenvolvimento Cientfico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX Financial support and fellowships: Conselho Nacional de Desenvolvimento
   Cientfico e Tecnologico (CNPq), the Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG) and the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES).
CR [Anonymous], 2008, M27A3 CLSI
   Ara N, 2009, Pak J Biol Sci, V12, P87, DOI 10.3923/pjbs.2009.87.90
   Carvalho CR, 2012, SYMBIOSIS, V57, P95, DOI 10.1007/s13199-012-0182-2
   Casolari C, 2004, PHARMACOL RES, V50, P605, DOI 10.1016/j.phrs.2004.06.008
   Farias MR, 2010, J BRAZIL CHEM SOC, V21, P927, DOI 10.1590/S0103-50532010000500023
   Furlaneto MC, 2011, REV SOC BRAS MED TRO, V44, P595, DOI 10.1590/S0037-86822011000500013
   Holetz FB, 2002, MEM I OSWALDO CRUZ, V97, P1027, DOI 10.1590/S0074-02762002000700017
   Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245
   Johann S, 2010, PHARM BIOL, V48, P388, DOI 10.3109/13880200903150385
   Kiraz N, 2010, J MICROBIOL METH, V82, P136, DOI 10.1016/j.mimet.2010.05.002
   Menezes RD, 2011, REV SOC BRAS MED TRO, V44, P591, DOI 10.1590/S0037-86822011000500012
   Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683
   Parra-Ortega B, 2009, MEM I OSWALDO CRUZ, V104, P505, DOI 10.1590/S0074-02762009000300018
   Tempone AG, 2008, MEM I OSWALDO CRUZ, V103, P443, DOI 10.1590/S0074-02762008000500006
   White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914
NR 15
TC 6
Z9 7
U1 1
U2 4
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAR-APR
PY 2014
VL 47
IS 2
BP 247
EP 250
DI 10.1590/0037-8682-0008-2013
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AI1SF
UT WOS:000336631700022
PM 24861304
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU Silva, WF
   Cecilio, SG
   Magalhaes, CLB
   Ferreira, JMS
   Totola, AH
   de Magalhaes, JC
AF Silva, Willer F., Jr.
   Cecilio, Samyra G.
   Magalhaes, Cintia L. B.
   Ferreira, Jaqueline M. S.
   Totola, Antonio H.
   de Magalhaes, Jose C.
TI Combination of extracts from Aristolochia cymbifera with streptomycin as
   a potential antibacterial drug
SO SPRINGERPLUS
LA English
DT Article
DE Aristolochia cymbifera; Antibacterial activity; Synergism; Cytotoxicity;
   Drug discovery; Natural products
ID ANTIMICROBIAL RESISTANCE; MEDICINAL-PLANTS; DITERPENES; BACTERIA;
   LIGNANS; ACID
AB The appearance of new antibiotic-resistant bacteria is a societal problem that requires the development of new alternative treatments. Therefore, this work evaluated the antibacterial activity of ethanolic (EHI), dichloromethanic (EDI) and hexanic (EHE) extracts from Aristolochia cymbifera stems and the combination of these extracts with an antimicrobial drug to develop a new antibacterial therapy. The EDI, EHE and EHI extracts were obtained by maceration using three different solvents. The minimal inhibitory concentrations (MIC) of these extracts were determined using the microdilution test to determine the antibacterial potential of these extracts and their combination with streptomycin against Staphylococcus aureus, Bacillus cereus, Klebsiella pneumoniae and Shigella flexneri. The extract dose leading to the cytotoxicity of 50% of the cells (CC50) was evaluated using mammalian cells MA104 and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay. The extracts had a MIC under 500 mg/L and a CC50 lower than 50 mg/L. The antibiotic/extract proportion influenced the antibacterial activity of the mixtures, and the proportion that optimized the antibacterial activity of streptomycin was a mixture that contained 75 percent of extract. This composition included less than 6.5 mg/L of extract and 2.5 mg/L of streptomycin and has potential as a new antibacterial therapy.
C1 [Silva, Willer F., Jr.] Univ Fed Sao Joao Del Rei, Programa Educ Tutorial PET DPCFC, BR-36420000 Ouro Branco, MG, Brazil.
   [Cecilio, Samyra G.] Univ Fed Sao Joao Del Rei, Programa Posgrad Tecnol Desenvolvimento Sustentav, BR-36420000 Ouro Branco, MG, Brazil.
   [Magalhaes, Cintia L. B.] Univ Fed Ouro Preto, Dept Ciencias Biol DECBI, Ouro Branco, MG, Brazil.
   [Ferreira, Jaqueline M. S.] Univ Fed Sao Joao Del Rei, Divinopolis, MG, Brazil.
   [Totola, Antonio H.; de Magalhaes, Jose C.] Univ Fed Sao Joao Del Rei, Dept Quim Biotecnol & Engn Bioproc DQBIO, BR-36420000 Ouro Branco, MG, Brazil.
RP de Magalhaes, JC (corresponding author), Univ Fed Sao Joao Del Rei, Dept Quim Biotecnol & Engn Bioproc DQBIO, Campus Alto Paraopeba,Rodovia MG 443,Km 07, BR-36420000 Ouro Branco, MG, Brazil.
EM josecarlos@ufsj.edu.br
RI Ferreira, Jaqueline/E-4630-2018
OI Ferreira, Jaqueline/0000-0002-1779-1975
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); MEC/SesuSpanish
   Government
FX The authors would like to acknowledge FAPEMIG and MEC/Sesu (Tutorial
   Education Program-PET) for fellowship support, Universidade Federal de
   Sao Joao Del-Rei for other support, Dra Daniela Leite Fabrino and Dr.
   Juliano Lemos Bicas, UFSJ, Ouro Branco, MG, Brazil, Dr. Rafael Russo
   Chagas, UFSJ, Divinopolis, MG, Brazil, Dr Sidney Augusto Vieira Filho,
   UFOP, Ouro Preto, MG, Brazil, Camila Magalhaes Dias, Juliana Gomes
   Santana and Jessica dos Santos Diniz (undergraduates), Ouro Branco, MG,
   Brazil for contributions.
CR ALMASAUDI SB, 1991, J APPL BACTERIOL, V70, P279, DOI 10.1111/j.1365-2672.1991.tb02937.x
   Alviano DS, 2009, CURR PHARM BIOTECHNO, V10, P106, DOI 10.2174/138920109787048607
   Alviano WS, 2008, ARCH ORAL BIOL, V53, P545, DOI 10.1016/j.archoralbio.2007.12.001
   [Anonymous], 2003, M7A6 NCCLS
   Auwaerter PMD, 2013, 2012 2013 ANTIBIOTIC
   Carvalho CS, 2008, 31 REUN AN SBQ 26 MA
   Ceuppens S, 2012, GUT PATHOG, V3, P4
   Chen YY, 2010, ONCOL REP, V24, P141, DOI 10.3892/or_00000839
   Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894
   Cole EC, 2003, J APPL MICROBIOL, V95, P664, DOI 10.1046/j.1365-2672.2003.02022.x
   Hyeon JY, 2013, J MICROBIOL BIOTECHN, V23, P85, DOI 10.4014/jmb.1210.10022
   Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002
   Kumar SN, 2012, APPL BIOCHEM BIOTECH, V168, P2285, DOI 10.1007/s12010-012-9937-8
   Lee YS, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/618081
   LEITAO GG, 1992, PHYTOCHEMISTRY, V31, P3277, DOI 10.1016/0031-9422(92)83495-K
   LOPES LMX, 1988, PHYTOCHEMISTRY, V27, P2265, DOI 10.1016/0031-9422(88)80139-0
   LOPES LMX, 1987, PHYTOCHEMISTRY, V26, P2781, DOI 10.1016/S0031-9422(00)83590-6
   LUZZATTO L, 1968, P NATL ACAD SCI USA, V60, P873, DOI 10.1073/pnas.60.3.873
   Machado TD, 2005, PHYTOTHER RES, V19, P519, DOI 10.1002/ptr.1696
   Mangeney N, 2000, J APPL MICROBIOL, V88, P504, DOI 10.1046/j.1365-2672.2000.00989.x
   Martinez MCM, 2002, NEPHROL DIAL TRANSPL, V17, P408, DOI 10.1093/ndt/17.3.408
   Moran GJ, 2013, J EMERGENCY MED, V44, P397
   Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c
   Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301
   Reinhardt TA, 2013, J PROTEOMICS, V82, P141, DOI 10.1016/j.jprot.2013.02.013
   Rios JL, 2005, J ETHNOPHARMACOL, V100, P80, DOI 10.1016/j.jep.2005.04.025
   Sartoratto A, 2004, BRAZ J MICROBIOL, V35, P275, DOI 10.1590/S1517-83822004000300001
   Sartorelli P, 2010, PLANTA MED, V76, P1454, DOI 10.1055/s-0029-1240952
   Skoog D.A., 2007, FUNDAMENTOS QUIMICA
   Souza AB, 2011, MOLECULES, V16, P9611, DOI 10.3390/molecules16119611
   Straetemans R, 2005, BIOMETRICAL J, V47, P299, DOI 10.1002/bimj.200410124
   Tallarida RJ, 2002, PAIN, V98, P163, DOI 10.1016/S0304-3959(02)00041-6
   Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011
   Turnbull PCB, 2004, J CLIN MICROBIOL, V42, P3626, DOI 10.1128/jcm.42.8.3626-3634.2004
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Veiga VF, 2005, QUIM NOVA, V28, P519, DOI 10.1590/S0100-40422005000300026
   Wu TS, 2004, NAT PROD REP, V21, P594, DOI 10.1039/b401950d
NR 37
TC 3
Z9 3
U1 0
U2 6
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2193-1801
J9 SPRINGERPLUS
JI SpringerPlus
PY 2013
VL 2
AR 430
DI 10.1186/2193-1801-2-430
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V40FS
UT WOS:000209465100002
PM 24040585
OA Green Published, Other Gold
DA 2020-09-29
ER

PT J
AU Gomes, JAS
   de Araujo, FF
   Trindade, GD
   Quinan, BR
   Drumond, BP
   Ferreira, JMS
   Mota, BEF
   Nogueira, ML
   Kroon, EG
   Abrahao, JS
   Correa-Oliveira, R
   da Fonseca, FG
AF Silva Gomes, Juliana Assis
   de Araujo, Fernanda Fortes
   Trindade, Giliane de Souza
   Quinan, Barbara Resende
   Drumond, Betania Paiva
   Siqueira Ferreira, Jaqueline Maria
   Fernandes Mota, Bruno Eduardo
   Nogueira, Mauricio Lacerda
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
   Correa-Oliveira, Rodrigo
   da Fonseca, Flavio Guimaraes
TI Immune Modulation in Primary Vaccinia virus Zoonotic Human Infections
SO CLINICAL & DEVELOPMENTAL IMMUNOLOGY
LA English
DT Article
ID T-CELL RESPONSES; MHC CLASS-II; SMALLPOX VACCINATION; ANTIGEN
   PRESENTATION; POXVIRUS INFECTION; MONKEYPOX VIRUS; BRAZIL; IMMUNIZATION;
   PROTECTION; EVASION
AB In 2010, the WHO celebrated the 30th anniversary of the smallpox eradication. Ironically, infections caused by viruses related to smallpox are being increasingly reported worldwide, including Monkeypox, Cowpox, and Vaccinia virus (VACV). Little is known about the human immunological responses elicited during acute infections caused by orthopoxviruses. We have followed VACV zoonotic outbreaks taking place in Brazil and analyzed cellular immune responses in patients acutely infected by VACV. Results indicated that these patients show a biased immune modulation when compared to noninfected controls. Amounts of B cells are low and less activated in infected patients. Although present, T CD4(+) cells are also less activated when compared to noninfected individuals, and so are monocytes/macrophages. Similar results were obtained when Balb/C mice were experimentally infected with a VACV sample isolated during the zoonotic outbreaks. Taking together, the data suggest that zoonotic VACVs modulate specific immune cell compartments during an acute infection in humans.
C1 [Trindade, Giliane de Souza; Quinan, Barbara Resende; Drumond, Betania Paiva; Fernandes Mota, Bruno Eduardo; Kroon, Erna Geessien; Abrahao, Jonatas Santos; da Fonseca, Flavio Guimaraes] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva Gomes, Juliana Assis] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva Gomes, Juliana Assis; de Araujo, Fernanda Fortes; Siqueira Ferreira, Jaqueline Maria; Correa-Oliveira, Rodrigo; da Fonseca, Flavio Guimaraes] Fundacao Oswaldo Cruz, IRR, BR-30190002 Belo Horizonte, MG, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Dept Doencas Infecciosas & Parasitarias, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com; fdafonseca@cpqrr.fiocruz.br
RI Abrahao, Jonatas/B-3895-2015; Ferreira, Jaqueline/E-4630-2018; Kroon,
   Erna Geessien/B-3631-2015; Nogueira, Mauricio L/B-7599-2012; Kroon,
   Erna/V-5444-2019; Gomes, Juliana A. S./M-4083-2017
OI Abrahao, Jonatas/0000-0001-9420-1791; Ferreira,
   Jaqueline/0000-0002-1779-1975; Kroon, Erna Geessien/0000-0003-2721-3826;
   Nogueira, Mauricio L/0000-0003-1102-2419; Gomes, Juliana A.
   S./0000-0002-8332-2907; Correa-Oliveira, Rodrigo/0000-0001-6419-9459;
   Mota, Bruno/0000-0003-0348-4875
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [473205/2009-2]; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [CBB-APQ-00299-08]; National Institute of Science and Technology in
   Vaccines (INCTV)
FX The authors thank all patients for their willingness to participate in
   this study and Jaqueline de Oliveira and Luciana Arruda for critical
   reading of the paper. Special thanks to Clari Gandra, for administrative
   support. They also thank health officials and professionals from the
   cities of Serro, Ponte Nova, and Bambui, MG, Brazil. J. A. S. Gomes, G.
   S. Trindade, M. L. Nogueira, E. G. Kroon, R. Correa-Oliveira, and F. G.
   da Fonseca are CNPq fellowship recipients. This work was supported by
   Grants from FAPEMIG (CBB-APQ-00299-08, Universal Demand), CNPq
   (473205/2009-2, Universal Demand) and by the National Institute of
   Science and Technology in Vaccines (INCTV). Other than funding,
   supporting agencies had no role in conducting the study or writing the
   paper.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   AlYaman F, 1997, PARASITE IMMUNOL, V19, P207, DOI 10.1046/j.1365-3024.1997.d01-198.x
   Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x
   Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123
   Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100
   Blendon RJ, 2003, NEW ENGL J MED, V348, P426, DOI 10.1056/NEJMsa023184
   Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06
   da Fonseca FG, 2011, FUTURE VIROL, V6, P697, DOI 10.2217/FVL.11.46
   Dasgupta A, 2007, J IMMUNOL, V178, P1654, DOI 10.4049/jimmunol.178.3.1654
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Dunlop LR, 2003, MICROBES INFECT, V5, P1049, DOI 10.1016/S1286-4579(03)00194-1
   Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829
   Frey SE, 2004, NEW ENGL J MED, V350, P324, DOI 10.1056/NEJMp038208
   Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127
   Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917
   Hammarlund E, 2008, P NATL ACAD SCI USA, V105, P14567, DOI 10.1073/pnas.0800589105
   Johnston JB, 2003, J VIROL, V77, P6093, DOI 10.1128/JVI.77.11.6093-6100.2003
   Kennedy RB, 2009, CURR OPIN IMMUNOL, V21, P314, DOI 10.1016/j.coi.2009.04.004
   Lauterbach H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009659
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Li GY, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-88
   Li P, 2005, J IMMUNOL, V175, P6481, DOI 10.4049/jimmunol.175.10.6481
   Martinez J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000811
   Mathew A, 2000, CLIN IMMUNOL, V96, P100, DOI 10.1006/clim.2000.4887
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Moulton EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000249
   Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086
   Panchanathan V, 2010, IMMUNOL CELL BIOL, V88, P461, DOI 10.1038/icb.2009.110
   Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06
   Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363
   Putz MM, 2006, NAT MED, V12, P1310, DOI 10.1038/nm1457
   Rehm KE, 2010, VIROLOGY, V397, P176, DOI 10.1016/j.virol.2009.11.008
   Rehm KE, 2009, IMMUNOLOGY, V128, P381, DOI 10.1111/j.1365-2567.2009.03120.x
   RILEY E, 1990, IMMUNOL LETT, V25, P221, DOI 10.1016/0165-2478(90)90119-B
   Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049
   Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039
   Sepkowitz KA, 2003, NEW ENGL J MED, V348, P439, DOI 10.1056/NEJMra022500
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912
   Venkatesan G, 2010, VET ITAL, V46, P439
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74
   Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265
NR 49
TC 4
Z9 4
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1740-2522
EI 1740-2530
J9 CLIN DEV IMMUNOL
JI Clin. Dev. Immunol.
PY 2012
AR 974067
DI 10.1155/2012/974067
PG 11
WC Immunology
SC Immunology
GA 872OX
UT WOS:000298820300001
PM 22229039
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

PT J
AU de Oliveira, TML
   Rehleld, IS
   Guedes, MIMC
   Ferreira, JMS
   Kroon, EG
   Lobato, ZIP
AF Ludolfo de Oliveira, Tercia Moreira
   Rehleld, Izabelle Silva
   Maldonado Coelho Guedes, Maria Isabel
   Siqueira Ferreira, Jaqueline Maria
   Kroon, Erna Geessien
   Portela Lobato, Zelia Ines
TI Susceptibility of Vaccinia Virus to Chemical Disinfectants
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID INFECTION; CATTLE
AB Vaccinia virus (VACV) is the cause of bovine vaccinia (BV), an emerging zoonotic disease that affects dairy cows and milkers. Some chemical disinfectants have been used on farms affected by BV to disinfect cow teats and milkers' hands. To date, there is no information about the efficacy of disinfectants against VACV. Therefore, this study aimed to assess the virucidal activity of some active disinfectants commonly used in the field. Sodium hypochlorite, quaternary ammonium combined with chlorhexidine, and quaternary ammonium combined with glutaraldehyde were effective in inactivating the virus at all concentrations tested. Iodine and quaternary ammonium as the only active component were partially effective. The presence of bovine feces as organic matter and light decreased the effectiveness of sodium hypochlorite. These results show that an appropriated disinfection and asepsis of teats and hands may be helpful in the control and prevention of BV and other infections with VACV.
C1 [Ludolfo de Oliveira, Tercia Moreira; Rehleld, Izabelle Silva; Maldonado Coelho Guedes, Maria Isabel; Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Lab Pesquisa Virol Anim, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Lobato, ZIP (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Lab Pesquisa Virol Anim, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM tercialud@gmail.com; izarehfeld@gmail.com; mariaisabel.guedes@gmail.com;
   jackmaria4@gmail.com; kroone@icb.ufmg.br; ziplobato@gmail.com
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; brasileira,
   Inct Pecuaria/J-9542-2013
OI Kroon, Erna Geessien/0000-0003-2721-3826; Lobato,
   Zelia/0000-0002-9399-3691
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais,
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Pro-Reitoria
   de Pesquisa/ Universidade Federal de Minas Gerais; CNPq/ Ministerio de
   AgriculturaNational Council for Scientific and Technological Development
   (CNPq)
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais, (FAPEMIG), and Pro-Reitoria de Pesquisa/
   Universidade Federal de Minas Gerais. E. G. Kroon and Z. I. P. Lobato
   were supported by fellowships from CNPq I. S. Rehfeld was supported by a
   fellowship from CNPq/ Ministerio de Agricultura, and M. I. M. C. Guedes
   was supported by a fellowship from FAPEMIG.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   ANVISA (Agencia Nacional de Vigilancia Sanitaria) Brasil, 1994, DET QUE REG PROD SAN
   Block SS, 2001, DISINFECTION STERILI
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Centers for Disease Control and Prevention (CDC), 2003, GUID F ENV CONTR SMA
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   European Committee for Standardization, 2006, EN14675 CEN EUR COMM
   Jones GM, 1998, MILKING PRACTICES RE, P404
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Malik YS, 2006, AM J INFECT CONTROL, V34, P31, DOI 10.1016/j.ajic.2005.05.012
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Oliveira JM, 2006, INFORM DETERMINACAO
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   SCHUMANN KO, 1977, ZBL BAKT MIK HYG B, V164, P45
   TANABE I, 1976, APPL ENVIRON MICROB, V32, P209, DOI 10.1128/AEM.32.2.209-212.1976
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
NR 21
TC 5
Z9 6
U1 0
U2 7
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUL
PY 2011
VL 85
IS 1
BP 152
EP 157
DI 10.4269/ajtmh.2011.11-0144
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 788GK
UT WOS:000292433200027
PM 21734141
OA Green Published, Bronze
DA 2020-09-29
ER

PT J
AU Abrahao, JS
   Drummond, BP
   Trindade, GD
   da Silva-Fernandes, AT
   Ferreira, JMS
   Alves, PA
   Campos, RK
   Siqueira, L
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Abrahao, J. S.
   Drummond, B. P.
   Trindade, de Souza G.
   da Silva-Fernandes, A. T.
   Ferreira, J. M. S.
   Alves, P. A.
   Campos, R. K.
   Siqueira, L.
   Bonjardim, C. A.
   Ferreira, P. C. P.
   Kroon, E. G.
TI Rapid detection of Orthopoxvirus by semi-nested PCR directly from
   clinical specimens: A useful alternative for routine laboratories. (vol
   82, pg 692, 2010)
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Correction
RI Ferreira, Jaqueline/E-4630-2018; Abrahao, Jonatas/B-3895-2015;
   Bonjardim, Claudio A/J-2601-2014; Campos, Rafael Kroon/AAB-5135-2020;
   Kroon, Erna/B-3631-2015
OI Ferreira, Jaqueline/0000-0002-1779-1975; Abrahao,
   Jonatas/0000-0001-9420-1791; Campos, Rafael Kroon/0000-0002-4852-0449;
   Kroon, Erna/0000-0003-2721-3826
CR Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
NR 1
TC 0
Z9 0
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0146-6615
J9 J MED VIROL
JI J. Med. Virol.
PD SEP
PY 2010
VL 82
IS 9
BP 1626
EP 1626
DI 10.1002/jmv.21885
PG 1
WC Virology
SC Virology
GA 628MS
UT WOS:000280124900021
OA Bronze
DA 2020-09-29
ER

PT J
AU Abrahao, JS
   Drumond, BP
   Trindade, GD
   da Silva-Fernandes, AT
   Ferreira, JMS
   Alves, PA
   Campos, RK
   Siqueira, L
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Trindade, Giliane de Souza
   da Silva-Fernandes, Andre Tavares
   Siqueira Ferreira, Jaqueline Maria
   Alves, Pedro Augusto
   Campos, Rafael Kroon
   Siqueira, Larissa
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Rapid Detection of Orthopoxvirus by Semi-Nested PCR Directly From
   Clinical Specimens: A Useful Alternative for Routine Laboratories
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE viral diagnosis; vaccinia outbreaks; poxvirus; Orthopoxvirus
ID VACCINIA-VIRUS-STRAINS; REAL-TIME PCR; BOVINE VACCINIA; DIAGNOSTIC PCR;
   INFECTION; ASSAY; SMALLPOX; OUTBREAK; BRAZIL; DIFFERENTIATION
AB Orthopoxvirus (OPV) has been associated with worldwide exanthematic outbreaks, which have resulted in serious economic losses as well as impact on public health. Although the current classical and molecular methods are useful for the diagnosis of OPV, they are largely inaccessible to unsophisticated clinical laboratories. The major reason for the inaccessibility is that they require both virus isolation and DNA manipulation. In this report, a rapid, sensitive and low-cost semi-nested PCR method is described for the detection of OPV DNA directly from clinical specimens. A set of primers was designed to amplify the conserved OPV vgf gene. The most useful thermal and chemical conditions were selected and minimum non-inhibitory dilutions were determined. More than 100 Brazilian Vaccinia virus (VACV) field clinical specimens were tested using this semi-nested PCR in order to confirm its applicability. Cowpox virus was also detected by PCR from the ear scabs of scarified Balb/c mice. In addition, the method was highly sensitive for the detection of VACV DNA in murine blood and excreta, which are among the suggested reservoirs of OPV. Together, these data suggest that semi-nested PCR can be used for initial screening for OPV and as a routine diagnostic laboratory method. J. Med. Virol. 82:692-699, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Abrahao, Jonatas Santos; Drumond, Betania Paiva; Trindade, Giliane de Souza; da Silva-Fernandes, Andre Tavares; Siqueira Ferreira, Jaqueline Maria; Alves, Pedro Augusto; Campos, Rafael Kroon; Siqueira, Larissa; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014;
   Kroon, Erna/V-5444-2019; Campos, Rafael Kroon/AAB-5135-2020; Abrahao,
   Jonatas/B-3895-2015; Alves, Pedro/T-7203-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Campos, Rafael
   Kroon/0000-0002-4852-0449; Abrahao, Jonatas/0000-0001-9420-1791; Alves,
   Pedro/0000-0002-9659-5621
FU CNPq CAPES FAPEMIG
FX Grant sponsor: CNPq CAPES FAPEMIG.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P4463, DOI 10.1128/JCM.38.12.4463-4470.2000
   BOUILLANT A, 1965, CAN J COMP MED VET S, V29, P125
   Damaso CRA, 2007, DIAGN MICR INFEC DIS, V57, P39, DOI 10.1016/j.diagmicrobio.2006.07.012
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   Fedorko DP, 2005, J CLIN MICROBIOL, V43, P4602, DOI 10.1128/JCM.43.9.4602-4606.2005
   Fenner F, 1989, THE ORTHOPOXVIRUSES
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   GLEDHILL AW, 1962, NATURE, V196, P298, DOI 10.1038/196298a0
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720
   JAHRLING PB, 2007, MED ASPECTS BIOL WAR, P215
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004
   Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817
   LEDERMAN E, 2008, VACCINE
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   Malorny B, 2005, J CLIN MICROBIOL, V43, P3033, DOI 10.1128/JCM.43.7.3033-3037.2005
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MOSS B, 2007, FIELDS VIROLOGY, V2, P2905
   Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814
   Putkuri N, 2009, J MED VIROL, V81, P146, DOI 10.1002/jmv.21385
   Saijo M, 2008, JPN J INFECT DIS, V61, P140
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sanchez-Seco MP, 2006, BRIT J BIOMED SCI, V63, P79, DOI 10.1080/09674845.2006.11732725
   SARKAR JK, 1974, INDIAN J MED RES, V62, P1800
   SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P517
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Singh RK, 2008, J VIROL METHODS, V154, P146, DOI 10.1016/j.jviromet.2008.08.009
   Singh RX, 2006, REV SCI TECH OIE, V25, P981, DOI 10.20506/rst.25.3.1708
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   STRENGER V, 2009, CLIN INFECT DIS, V34, P133
   Trindade GS, 2007, J VIROL METHODS, V141, P198, DOI 10.1016/j.jviromet.2006.12.006
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Tscharke DC, 1999, J GEN VIROL, V80, P2751, DOI 10.1099/0022-1317-80-10-2751
   Vestergaard L, 2008, ACTA DERM-VENEREOL, V88, P188, DOI 10.2340/00015555-0375
NR 42
TC 25
Z9 25
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2010
VL 82
IS 4
BP 692
EP 699
DI 10.1002/jmv.21617
PG 8
WC Virology
SC Virology
GA 560SA
UT WOS:000274921300021
PM 20166167
DA 2020-09-29
ER

PT J
AU Abrahao, JS
   Trindade, GD
   Ferreira, JMS
   Campos, RK
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Abrahao, Jonatas S.
   Trindade, Giliane de Souza
   Siqueira Ferreira, Jaqueline M.
   Campos, Rafael K.
   Bonjardim, Claudio A.
   Peregrino Ferreira, Paulo C.
   Kroon, Erna Geessien
TI Long-lasting stability of Vaccinia virus strains in murine feces:
   implications for virus circulation and environmental maintenance
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID OUTBREAK
AB Vaccinia virus (VACV) has been associated with several bovine vaccinia outbreaks in Brazil, causing exanthematic lesions in dairy cattle and humans. The way that VACV circulates in the environment is unknown, as is the way that this virus is transferred from wildlife to farms. Rodents are hypothetical VACV reservoirs, and murine feces has been identified as a potential source of viral shedding and transmission. In this work, we analyzed the stability of VACV infectious particles and DNA in feces from intranasally infected mice, exposed to environmental temperature and humidity, by titration assays and PCR, respectively. The results showed that VACV infectious particles were still detected at 20 days post-environmental-exposure (d.p.e.), while viral DNA was detected until 60 d.p.e. A gradual decrease in fecal viral load could be detected in all analyzed VACV strains. This work indicates long-lasting stability of VACV in murine feces and reinforces the idea that fecal matter may represent a potential source of circulating virus among rodents.
C1 [Abrahao, Jonatas S.; Trindade, Giliane de Souza; Siqueira Ferreira, Jaqueline M.; Campos, Rafael K.; Bonjardim, Claudio A.; Peregrino Ferreira, Paulo C.; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014;
   Kroon, Erna/V-5444-2019; Campos, Rafael Kroon/AAB-5135-2020; Abrahao,
   Jonatas/B-3895-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Campos, Rafael
   Kroon/0000-0002-4852-0449; Abrahao, Jonatas/0000-0001-9420-1791
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG), BrazilMinas Gerais State Research Foundation (FAPEMIG)
FX We thank Joao Rodrigues dos Santos, Angela Sana Lopes, Ilda Gama, and
   colleagues from Laboratorio de Virus (ICB-UFMG) for their excellent
   technical support. Financial support was provided by the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   BOUILLANT A, 1965, CAN J COMP MED VET S, V29, P125
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0
   Lederman E, 2009, VACCINE, V27, P375, DOI 10.1016/j.vaccine.2008.11.019
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MADUREIRA M, 2009, THESIS U FEDERAL MIN
   Mills JN, 2005, ARCH VIROL, P45
   Pastoret PP, 1996, DEV BIOL STAND, V87, P245
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   SIMONETTI BR, 2007, VIRUS REV RES, V12, P1
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 17
TC 18
Z9 18
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD SEP
PY 2009
VL 154
IS 9
BP 1551
EP 1553
DI 10.1007/s00705-009-0470-1
PG 3
WC Virology
SC Virology
GA 495GN
UT WOS:000269878900023
PM 19710997
DA 2020-09-29
ER

PT J
AU Ferreira, JMS
   Drumond, BP
   Abrahao, JS
   Lobato, ZIP
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Siqueira Ferreira, Jaqueline Maria
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
   Portal Lobato, Zelia Ines
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Brazilian vaccinia virus strains show a classical orthopoxvirus
   infection course and cross-protection
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Orthopoxvirus; Zoonoses; Balb/c mice; Intradermal injection; Vaccinia
   virus; Bovine vaccinia outbreaks
ID RIO-DE-JANEIRO; COWPOX VIRUS; POXVIRUS PATHOGENESIS; RESERVOIR HOSTS;
   HUMAN MONKEYPOX; OUTBREAK; CATTLE; MICE; HUMANS; STATE
AB Objectives: The purpose of this work was to study the infection course and cross-protection in mice after intradermal injection of Vaccinia virus (VACV) strain Western Reserve and three Brazilian VACV strains: Aracatuba, Muriae and BeAn58058 isolated from cow, human and rodent, respectively. Methods: Balb/c mice were inoculated by footpad and back scarification and daily monitored regarding lesion development and weight loss. To check cross protection after intradermal VACV inoculation, mice were subsequently infected with different VACV strains and monitored to check lesion development. Serum neutralization assays were performed to check for the presence of antibodies against Orthopoxvirus. Results: After VACV intradermal inoculation the lesion development pattern was similar in mice infected with the different virus strains. By using the footpad scarification model, cross-protection among VACV strains was observed. Moreover, neutralizing antibodies against Orthopoxvirus were detected in sera from mice infected with all VACV strains. Conclusion: Although it was not possible to observe virulence differences among VACV strains isolated from cow, rodent and human using the murine model, this inoculation route showed to be an appropriated model to study lesions development since it mimics natural infections by VACV in nature.
C1 [Siqueira Ferreira, Jaqueline Maria; Drumond, Betania Paiva; Abrahao, Jonatas Santos; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Portal Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM masc.egk@terra.com.br
RI Kroon, Erna/V-5444-2019; Abrahao, Jonatas/B-3895-2015; Ferreira,
   Jaqueline/E-4630-2018; Bonjardim, Claudio A/J-2601-2014
OI Abrahao, Jonatas/0000-0001-9420-1791; Ferreira,
   Jaqueline/0000-0002-1779-1975; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX Financial support was provided by CNPq, CAPES and FAPEMIG. Jaqueline M.
   S. Ferreira received fellowship from CAPES. R. M. E. P. C. P. Ferreira,
   C. A. Bonjardim, Z. I. P. Lobato and E. G. Kroon are recipients of
   research fellowship from CNPq.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   BAXBY D, 1994, BRIT J DERMATOL, V131, P598, DOI 10.1111/j.1365-2133.1994.tb04969.x
   Baxby D, 1981, J Hist Med Allied Sci, V36, P218
   Brandt T, 2005, VIROLOGY, V333, P263, DOI 10.1016/j.virol.2005.01.006
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423
   CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Diniz S, 2001, ARQ BRAS MED VET ZOO, V53, P152, DOI 10.1590/S0102-09352001000200003
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   FENNER F, 1949, J IMMUNOL, V63, P341
   FENNER F, 1989, RES VIROLOGY, V140, P465, DOI 10.1016/S0923-2516(89)80126-8
   Fenner F., 1988, SMALLPOX ITS ERADICA
   FERREIRA JMS, PLOS ONE, V3, pE3043
   Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Kolhapure RM, 1997, INDIAN J MED RES, V106, P441
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   MILLER CG, 1995, CELL IMMUNOL, V162, P326, DOI 10.1006/cimm.1995.1086
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Pahlitzsch R, 2006, CLIN INFECT DIS, V43, P737, DOI 10.1086/506937
   Quenelle DC, 2004, ANTIVIR RES, V63, P33, DOI 10.1016/j.antiviral.2004.02.003
   Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977
   Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
NR 38
TC 1
Z9 1
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD APR
PY 2009
VL 2
IS 2
BP 21
EP 26
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 662CU
UT WOS:000282785500004
DA 2020-09-29
ER

PT J
AU Silva-Fernandes, AT
   Travassos, CEPF
   Ferreira, JMS
   Abrahao, JS
   Rocha, ESD
   Viana-Ferreira, F
   dos Santos, JR
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Silva-Fernandes, Andre Tavares
   Pires Ferreira Travassos, Carlos Eurico
   Siqueira Ferreira, Jaqueline Maria
   Abrahao, Jonatas Santos
   de Oliveira Rocha, Eliseu Soares
   Viana-Ferreira, Flavia
   dos Santos, Joao Rodrigues
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Natural human infections with Vaccinia virus during bovine vaccinia
   outbreaks
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Bovine vaccinia outbreaks; Vaccinia virus; Zoonosis; Poxvirus;
   Epidemiology
ID RIO-DE-JANEIRO; CATTLE; BUFFALOPOX; POXVIRUS; IMMUNITY; STRAINS; BRAZIL;
   STATE
AB Background: Bovine vaccinia is an exanthematic disease caused by Vaccinia virus (VACV). This zoonosis has been associated with several cases of bovine infection, particularly in milk herds. Farmers, milkers and their close contacts developed lesions on the hands, forearms, legs and face accompanied by fever, headache, malaise, myalgia and axillary, inguinal and cervical lymphadenopathy. VACV infections have a significant public health impact due to their occupational character, high frequency of transmission and the improper medical treatment often applied.
   Objectives: To study natural human infection by VACV and to analyze clinical and epidemiological aspects, emphasizing the patients' immunological status.
   Study design: Ninety-eight individuals from rural properties with bovine vaccinia (BV) outbreaks who were at risk due to contact were submitted to epidemiological and clinical studies. From these individuals, 54 sera were analyzed by serological and molecular procedures. This study was conducted in Rio de Janeiro State from September 2002 to October 2006.
   Results: The clinical frequency of infection was 52.0%, with 57.4% ELISA and 43.0% PRNT-positive reactions. DNAemia was detected in 18.5% of the analyzed sera, and 50% of smallpox-vaccinated individuals developed symptoms.
   Conclusions: This study confirms the high clinical frequency of human VACV infection, even among vaccinated individuals. The infection was related to detection of IgG- or IgM-specific antibodies that correlates in most of the cases with positive PRNT. The DNAemia suggests viremia during VACV natural infections. Our data indicate that patients vaccinated against smallpox may no longer be protected. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Silva-Fernandes, Andre Tavares; Siqueira Ferreira, Jaqueline Maria; Abrahao, Jonatas Santos; de Oliveira Rocha, Eliseu Soares; Viana-Ferreira, Flavia; dos Santos, Joao Rodrigues; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva-Fernandes, Andre Tavares; Pires Ferreira Travassos, Carlos Eurico] Univ Estadual Norte Fluminense, Ctr Ciencias & Tecnol Agropecuarias, Hosp Vet, Lab Sanidade Anim, BR-28015620 Rio De Janeiro, Brazil.
RP Silva-Fernandes, AT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos,6627 Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM fernandeserthal@gmail.com; cakatrav@uenf.br; jackmaria4@gmail.com;
   jonatas.abrahao@gmail.com; eliseubiologia@gmail.com;
   fvianaferreira@yahoo.com.br; santosjr@icb.ufmg.br; claubonj@icb.ufmg.br;
   peregrino@icb.ufmg.br; kroone@icb.ufmg.br
RI Ferreira, Jaqueline/E-4630-2018; Bonjardim, Claudio A/J-2601-2014;
   Abrahao, Jonatas/B-3895-2015; Kroon, Erna Geessien/B-3631-2015; Kroon,
   Erna/V-5444-2019
OI Ferreira, Jaqueline/0000-0002-1779-1975; Abrahao,
   Jonatas/0000-0001-9420-1791; Kroon, Erna Geessien/0000-0003-2721-3826;
   Rocha, Eliseu/0000-0002-2854-0768; Silva Ferreira, Antonio
   Cesar/0000-0002-1188-1021
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); FAPEMIGMinas Gerais
   State Research Foundation (FAPEMIG)
FX We thank Iara A. Borges for critical reading of the manuscript, as well
   as Jaquelline G. de Oliveira PhD, Angela S. Lopes, Ilda M.V. Gamma and
   colleagues from the Laboratorio de Virus (ICB-UFMG). Financial support
   was provided by CNPq, CAPES, FAPERJ and FAPEMIG. Andre T.
   Silva-Fernandes received fellowship support from FAPERJ. Erna G. Kroon,
   Claudio A. Bonjardim, and Paulo C.P. Ferreira received fellowships from
   CNPq.
CR Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Cohen JI, 2007, VACCINE, V25, P4571, DOI 10.1016/j.vaccine.2007.03.044
   CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258
   da Fonseca FG, 1998, ARCH VIROL, V143, P1171
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON IK, 2007, FIELDS VIROLOGY, V2, P2947
   Donatele D. M., 2007, Brazilian Journal of Veterinary Research and Animal Science, V44, P275
   DUMBELL K, 1993, ARCH VIROL, V128, P257, DOI 10.1007/BF01309438
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2007, CLIN VACCINE IMMUNOL, V14, P1318, DOI 10.1128/CVI.00148-07
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leparc-Goffart I, 2005, J CLIN VIROL, V32, P47, DOI 10.1016/j.jcv.2004.07.005
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Mazur C, 2000, VET MICROBIOL, V73, P253, DOI 10.1016/S0378-1135(99)00151-0
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Nitsche A, 2007, J CLIN VIROL, V40, P160, DOI 10.1016/j.jcv.2007.07.014
   Panchanathan V, 2008, IMMUNOL CELL BIOL, V86, P80, DOI 10.1038/sj.icb.7100118
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   SAVONA MR, 2006, JAMA-J AM MED ASSOC, V26, P1898
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Singh RX, 2006, REV SCI TECH OIE, V25, P981, DOI 10.20506/rst.25.3.1708
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Zafar A, 2007, EMERG INFECT DIS, V13, P902, DOI 10.3201/eid1306.061068
NR 31
TC 57
Z9 58
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD APR
PY 2009
VL 44
IS 4
BP 308
EP 313
DI 10.1016/j.jcv.2009.01.007
PG 6
WC Virology
SC Virology
GA 436WL
UT WOS:000265446700011
PM 19243990
DA 2020-09-29
ER

PT J
AU Ferreira, JMS
   Abrahao, JS
   Drumond, BP
   Oliveira, FM
   Alves, PA
   Pascoal-Xavier, MA
   Lobato, ZIP
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Siqueira Ferreira, Jaqueline Maria
   Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Oliveira, Fernando Meireles
   Alves, Pedro Augusto
   Pascoal-Xavier, Marcelo Antonio
   Portela Lobato, Zelia Ines
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Vaccinia virus: shedding and horizontal transmission in a murine model
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID SENTINEL MICE; COWPOX VIRUS; INFECTION; ORTHOPOXVIRUS; OUTBREAK;
   POXVIRUS; STRAINS; BRAZIL; REPLICATION; ANTIBODIES
AB Vaccinia virus (VACV) has been associated with several bovine vaccinia outbreaks in Brazil, affecting cattle and humans. There are no available data about VACV environmental circulation or the role of wildlife in the emergence of an outbreak. Since VACV was isolated from rodents in Brazil, we investigated shedding and transmission of VACV strains in mice. The VACV excretion profile was assessed by PCR and chicken chorioallantoic membrane infection, revealing viral DNA and infectious virus in the faeces and urine of intranasally infected mice. Horizontal transmission was assessed by exposure of sentinel mice to wood shavings contaminated with excrement, to mimic a natural infection. Sentinel mice showed orthopoxvirus antibodies, and VACV DNA and infectious virus were detected in their faeces and intestines, even after six rounds of natural transmission. Together, these data suggest that murine excrement could play a relevant role in VACV spread and transmission, perhaps helping to explain how these viruses circulate between their natural hosts.
C1 [Siqueira Ferreira, Jaqueline Maria; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Oliveira, Fernando Meireles; Alves, Pedro Augusto; Pascoal-Xavier, Marcelo Antonio; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM masc.egk@terra.com.br
RI Bonjardim, Claudio A/J-2601-2014; Alves, Pedro/T-7203-2019; Ferreira,
   Jaqueline/E-4630-2018; Kroon, Erna Geessien/B-3631-2015; Kroon,
   Erna/V-5444-2019; Abrahao, Jonatas/B-3895-2015
OI Alves, Pedro/0000-0002-9659-5621; Ferreira,
   Jaqueline/0000-0002-1779-1975; Kroon, Erna Geessien/0000-0003-2721-3826;
   Abrahao, Jonatas/0000-0001-9420-1791; Lobato, Zelia/0000-0002-9399-3691
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX We thank Jaquelline G. de Oliveira for critical reading of the
   Marioscript; Joao R. dos Santos, Angela S. Lopes, Ilda M. V. Garnina and
   colleagues from Laboratorio de Virus (ICB-UFMG). Financial Support was
   provided by CNPq, CAPES and FAPEMIG. E.G.K., C. A. B., P. C. P. F. and
   Z. I. P. L. received fellowships from CNPq.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   FENNER F, 1989, ORTHOPOXVIRUSES, P85
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Gaertner DJ, 2003, COMPARATIVE MED, V53, P85
   GLEDHILL AW, 1962, NATURE, V196, P298, DOI 10.1038/196298a0
   Goff A, 2007, VIRUS RES, V128, P88, DOI 10.1016/j.virusres.2007.04.014
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   HJELLE B, 1995, CRIT REV CL LAB SCI, V32, P469, DOI 10.3109/10408369509082592
   Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Laakkonen J, 2006, J WILDLIFE DIS, V42, P672, DOI 10.7589/0090-3558-42.3.672
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   MOSS B, 1970, J VIROL, V5, P99, DOI 10.1128/JVI.5.2.99-108.1970
   Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P523
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tryland M, 1998, VET REC, V143, P105, DOI 10.1136/vr.143.4.105
   Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373
NR 32
TC 21
Z9 21
U1 0
U2 5
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD DEC
PY 2008
VL 89
BP 2986
EP 2991
DI 10.1099/vir.0.2008/003947-0
PN 12
PG 6
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 381HY
UT WOS:000261527800007
PM 19008383
OA Bronze
DA 2020-09-29
ER

PT J
AU Ferreira, JMS
   Drumond, BP
   Guedes, MIMC
   Pascoal-Xavier, MA
   Almeida-Leite, CM
   Arantes, RME
   Mota, BEF
   Abrahao, JS
   Alves, PA
   Oliveira, FM
   Ferreira, PCP
   Bonjardim, CA
   Lobato, ZIP
   Kroon, EG
AF Siqueira Ferreira, Jaqueline Maria
   Drumond, Betania Paiva
   Maldonado Coelho Guedes, Maria Isabel
   Pascoal-Xavier, Marcelo Antonio
   Almeida-Leite, Camila Megale
   Esteves Arantes, Rosa Maria
   Fernandes Mota, Bruno Eduardo
   Abrahao, Jonatas Santos
   Alves, Pedro Augusto
   Oliveira, Fernando Meireles
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Claudio Antonio
   Portela Lobato, Zelia Ines
   Kroon, Erna Geessien
TI Virulence in Murine Model Shows the Existence of Two Distinct
   Populations of Brazilian Vaccinia virus Strains
SO PLOS ONE
LA English
DT Article
AB Brazilian Vaccinia virus had been isolated from sentinel mice, rodents and recently from humans, cows and calves during outbreaks on dairy farms in several rural areas in Brazil, leading to high economic and social impact. Some phylogenetic studies have demonstrated the existence of two different populations of Brazilian Vaccinia virus strains circulating in nature, but little is known about their biological characteristics. Therefore, our goal was to study the virulence pattern of seven Brazilian Vaccinia virus strains. Infected BALB/c mice were monitored for morbidity, mortality and viral replication in organs as trachea, lungs, heart, kidneys, liver, brain and spleen. Based on the virulence potential, the Brazilian Vaccinia virus strains were grouped into two groups. One group contained GP1V, VBH, SAV and BAV which caused disease and death in infected mice and the second one included ARAV, GP2V and PSTV which did not cause any clinical signals or death in infected BALB/c mice. The subdivision of Brazilian Vaccinia virus strains into two groups is in agreement with previous genetic studies. Those data reinforce the existence of different populations circulating in Brazil regarding the genetic and virulence characteristics.
C1 [Siqueira Ferreira, Jaqueline Maria; Drumond, Betania Paiva; Maldonado Coelho Guedes, Maria Isabel; Pascoal-Xavier, Marcelo Antonio; Fernandes Mota, Bruno Eduardo; Abrahao, Jonatas Santos; Alves, Pedro Augusto; Oliveira, Fernando Meireles; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Virus Lab, Belo Horizonte, MG, Brazil.
   [Almeida-Leite, Camila Megale; Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Lab Neuro Imuno Patol Expt, Belo Horizonte, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Ave Antonio Carlos, Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg
RI Abrahao, Jonatas/B-3895-2015; brasileira, Inct Pecuaria/J-9542-2013;
   Arantes, Rosa ME/C-5749-2013; Kroon, Erna Geessien/B-3631-2015; Kroon,
   Erna/V-5444-2019; Alves, Pedro/T-7203-2019; Bonjardim, Claudio
   A/J-2601-2014; Ferreira, Jaqueline/E-4630-2018
OI Abrahao, Jonatas/0000-0001-9420-1791; Arantes, Rosa
   ME/0000-0003-1428-9717; Kroon, Erna Geessien/0000-0003-2721-3826; Alves,
   Pedro/0000-0002-9659-5621; Ferreira, Jaqueline/0000-0002-1779-1975;
   Lobato, Zelia/0000-0002-9399-3691; Mota, Bruno/0000-0003-0348-4875
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [fellowship]; CAPESCAPES [fellowship]; FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG); PCPF [fellowship]; CAB [fellowship]; ZILP
   [fellowship]; RMEA [fellowship]; EGK [fellowship]
FX Sources of support was provided by CNPq, CAPES and FAPEMIG. J. M. S.
   Ferreira received fellowship from CAPES and PCPF, CAB, ZILP, RMEA and
   EGK are CNPq fellows.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   ANDREW ME, 1989, IMMUNOL CELL BIOL, V67, P331, DOI 10.1038/icb.1989.48
   Baxby D, 1981, J Hist Med Allied Sci, V36, P218
   Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001
   Bray M, 2000, J INFECT DIS, V181, P10, DOI 10.1086/315190
   Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025
   BRIODY BA, 1959, BACTERIOL REV, V23, P61, DOI 10.1128/MMBR.23.2.61-95.1959
   BULLER RML, 1985, CURR TOP MICROBIOL, V122, P148
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   da Fonseca FG, 2000, J VIROL, V74, P7508, DOI 10.1128/JVI.74.16.7508-7517.2000
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON IK, 2007, FIELDS VIROLOGY, P2947
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   FENNER R, 1988, SMALLPOX ITS ERADICA
   Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22
   Jacobs N, 2006, J GEN VIROL, V87, P1157, DOI 10.1099/vir.0.81556-0
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Pahlitzsch R, 2006, CLIN INFECT DIS, V43, P737, DOI 10.1086/506937
   Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003
   Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540
   SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P523
   SEHGAL C L, 1977, Journal of Communicable Diseases, V9, P171
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977
   Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
NR 42
TC 31
Z9 32
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 26
PY 2008
VL 3
IS 8
AR e3043
DI 10.1371/journal.pone.0003043
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 427RL
UT WOS:000264796300001
PM 18725979
OA DOAJ Gold, Green Published
DA 2020-09-29
ER

EF